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Abstract
The aim of the experiment was to find the effect of intermittent normobaric 
hypoxic exercise upon a group of young adults. Thirty male subjects aged eighteen to 
twenty-eight years old were weighed and sum of four skinfolds measured before and after 
four weeks of chronic exercise. A blood sample was taken at rest pre and post chronic 
exercise to ascertain their lipid profile, plasma total homocysteine, folate and vitamin B 12
levels. Each subject completed a seven day food and fluid intake pamphlet pre and post 
chronic exercise. Aerobic power was tested normoxically and hypoxically using an 
incremental cycle test to volitional exhaustion before chronic exercise and normoxically 
after chronic exercise. A blood sample was taken immediately post acute exercise to 
measure plasma total homocysteine concentration which was adjusted to take account of 
plasma volume shifts. Fourteen subjects exercised normoxically and sixteen subjects 
exercised hypoxically three times a week. The intensity and duration of the exercise 
sessions increased throughout the period from 70 to 85% and 20 to 30 minutes. The 
Normoxic group's normoxic acute cycle test significantly increased plasma total 
homocysteine concentration (+0.6±1.3 jimol.dnr3 , p=0.035), whereas the hypoxic 
group's change was not significant (+0.2±1.2 ^mol.dnr3 , p=0.408). Normoxic chronic 
exercise significantly increased plasma homocysteine concentration (+1.2±1.0 ^moLdnr3 , 
p=0.002) whereas hypoxia showed no significant change (-0.4±1.7 ^imol.dnr3 , p=0.361). 
The changes were not physiologically significant. Normoxic and hypoxic chronic exercise 
had no effect upon the subjects total cholesterol concentration (-0.51±0.51 mmol.dnr3 ; - 
0.32±0.52 mmol.dnr3 , respectively, 2-way ANOVA p=0.339) nor upon their aerobic 
power (+3.2±4.8 cm3 .kg- 1 .min- 1 ; +5.1+10.9 cm 3 .kg- 1 .min- 1 respectively, 2-way 
ANOVA p=0.568). An advantage of training under hypoxic conditions is that it 
minimises the fluctuations in plasma total homocysteine concentration that would be 
obtained when training normoxically.
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'Life can only be understood backwards; 
but it must be lived forwards.'
Kierkegaard, Soren
1813-1855
{Concise Dictionary of Quotations
Pocket Reference Library 
Wm Collins Sons & Co Ltd. 1985. p. 185}
Chapter 1
Risk factors associated with Cardiovascular 
disease with particular reference to Homocysteine.
1. Overview
This thesis considers cardiovascular risk factors and the effect of acute and 
chronic exercise upon them. The focus is plasma homocysteine concentration and lipid 
factors (total cholesterol, high density lipoprotein cholesterol, low density lipoprotein 
cholesterol, triacylglycerol and non esterified fatty acid concentrations).
Serum total cholesterol refers to the sum of cholesterol in the serum. This is the 
sum of cholesterol sources including: very low density lipoprotein cholesterol, low 
density lipoprotein cholesterol, high density lipoprotein cholesterol and intermediate 
density lipoprotein cholesterol. A high serum concentration of total cholesterol (>4.7 
mmol.dnr3), has been associated with an increased risk of cardiovascular disease.
Low density lipoprotein cholesterol can become oxidised and get taken up by 
macrophages. These cells undergo a physical change as a consequence, becoming "foam 
cells" a reflection of their appearance histologically. White streaks in the intima of the 
conducting arteries are accumulations of foam cells. Not all cholesterol sources are 
necessarily bad with respect to cardiovascular system. High density lipoprotein 
particles contain cholesterol that has come from the tissues and is en route to the liver to 
be break down. Endurance exercise has been shown to produce a reduction in low 
density lipoprotein cholesterol and an increase in high density lipoprotein cholesterol and 
non esterified fatty acids.
Plasma total homocysteine is the sum of all the derivatives of homocysteine. 
Homocysteine is the single unit whereas homocystine is a molecule of two 
homocysteines linked by a disulphide bond. Homocysteine can also form a disulphide
bond with cysteine (cysteine-homocysteine) and cysteine amino acids in proteins 
(homocysteinyl moieties).
Plasma total homocysteine concentration has been associated with an increased 
risk of arteriosclerosis. However, normoxic exercise causes an acute increase in its 
concentration. Red blood cell folate and vitamin B 12 concentrations have been shown to
be inversely correlated to plasma total homocysteine concentration. Plasma total 
homocysteine has been shown to cause hyperplasia of smooth myocytes of the intima, it 
is also associated with increased oxygen radicals and therefore lipid peroxidation.
Although hypoxic exercise might have a smaller acute effect upon plasma total 
homocysteine, there have been no studies into this effect. There are two possible 
reasons to why plasma total homocysteine concentration may be lower under hypoxic 
than normoxic exercise conditions. The adenosine required for coronary arteries dilation 
is provided from adenosine monophosphate, whereas in normoxic conditions it is 
supplied from S-adenosine homocysteine. The second reason is that athletes train at a 
lower intensity under hypoxic conditions, so therefore probably egress less 
homocysteine from the muscles into the plasma.
1.1 Cardiovascular disease
Cardiovascular disease is a general term that groups together diseases of the heart 
and blood vessels of the body, such as weaknesses of the vessel wall (aneurysms), 
narrowing of the vessels (arteriosclerosis - coronary, cerebral and peripheral), and clot 
activation (thromboembolism - arterial and venous), (Figure 1.1). It is the highest cause 
of death in men (39%) and second highest cause of death in women (30%) under the age 





























Figure 1.1 Cardiovascular Disease
1.1.1 Coronary Heart Disease
Coronary heart disease is a chronic disease which is seldom found in young men 
<35 years old and women <45 years old, (British Heart Foundation 2000b). The major 
clinical manifestations are angina pectoris, myocardial infarction and death, (Levy & 
Wilson 1998). In men, coronary heart disease accounts for 26% of all deaths making it 
the number one cause of death, whereas in women, it was the second, (16%), (British 
Heart Foundation, 2000a, Table 1.1.1). The national death rate from coronary heart 
disease is still amongst the highest in the western world" (British Heart Foundation 
2000c), (Figure 1.1.1).
1.1.2 Peripheral Vascular Disease
Peripheral vascular disease, is also referred to as peripheral artery disease. This 
can cause intermittent claudication (exercise induced pain caused by localised ischaemia), 
a major uncorrected peripheral restriction in blood flow which can result in amputation of 
the limb. This is a particular occurrence in diabetes mellitus sufferers, (amputation rate 
seven times greater than that in non-diabetes patients with peripheral artery disease) who 
have a tendency for poor circulation in the feet which result in loss of toes and feet. 
About 70% of patients show no change or even become less symptomatic after 5 to 10 
years, whereas less than 30% will require intervention and less than 10% will require 
amputation, (Rosenfield & Isner, 1998).
1.2 Cardiovascular risk factors
There are many risk factors for cardiovascular disease related to the range of 
stresses that the body experiences: diet, smoking, psychological factors and physical 
activities. Elevated levels of serum total cholesterol, low density lipoprotein cholesterol 
and plasma total homocysteine with decreased levels of serum high density lipoprotein 







































Table 1.1.1 Deaths by cause, gender under 75, 1998, 
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Figure 1.1.1. Death rates from Coronary Heart Disease, men and women aged 
35-74, 1994, selected countries. (British Heart Foundation 2000d).
atherosclerosis, thrombosis, cerebral and peripheral vascular diseases, (Ueland & Refsum, 
1989, Boers et al., 1985). Due to the relevance of plasma total homocysteine 
concentration to cardiovascular disease. It will be dealt with in greater detail following a 
general survey of cardiovascular risk factors, (refer to 1.3).
Apart from plasma total homocysteine, investigations into other nontraditional 
cardiovascular risk factors are occurring such as: C-reactive protein; lipoprotein (a); 
plasma insulin levels and markers of insulin resistance; activation of the renin- 
angiotensin system, (Oparil & Oberman, 1999). The Lewis blood group phenotype - 
Le(a-b-), had significantly elevated triacylglycerol concentration. It was associated with 
increased risk of coronary heart disease in the Copenhagen Male Study, (Ellison et al., 
1999). The British Heart Foundation (2000e,f) estimated the effect of unhealthy diets 
and alcohol consumption as risk factors for coronary heart disease.
1.2.1 Cholesterol
Forty-five percent of deaths from coronary heart disease in men, was estimated 
to be due to a blood cholesterol level greater than 5.2 mmol.dnr3 , (201 mg.dL- 1 ). The 
mean blood cholesterol level for men aged 16 and above in England was 5.5 mmol.dnr3 , 
(213 mg.dL- 1 ). About 18% of men have blood cholesterol levels above 6.5 mmol.dnr3 , 
(251 mg-dL- 1 ), (The British Heart Foundation 2000g). In children of fathers with 
premature myocardial infarction, 16.7% of them had cholesterol levels above 6.0 
mmoLdnr3 (232 mg.dL' 1 ), compared to 4.7% of children of 'healthy' fathers, (p = 0.01), 
(Hennekens et al., 1976). Patients with homozygous familial hypercholesterolaemia had 
abnormal blood velocities in the aorta at the valvular area, (which is near the origin of the 
coronary arteries), whereas healthy controls had normal velocities measured by 
Continuous-Wave Doppler, (Faccenda et al., 1990). [Continuous-Wave Doppler 
measures the velocities of blood cell flow towards or away from the transducer along the 
scan line where there is no spatial resolution].
Adults under the age of thirty years, should be encouraged to achieve a total 
cholesterol level < 4.7mmol.dnr3 (182 mg.dL- 1 ), and those above thirty years to have a 
value < 5.2 mmol.dnr3 (201 mg.dL- 1 ), according to the National Institute of Health 
Consensus Development Panel and the study group of the European Atherosclerosis 
Society. There is a seasonal variation for cholesterol, the highest level in autumn, the 
lowest in late spring and summer, (Durrington, 1990).
1.2.2 Triacylglycerol
Body position and meals prior to the blood sampling, greatly affect serum 
triacylglycerol concentration. Illness and acute myocardial infarction, angina or coronary 
artery bypass surgery, produce increases in triacylglycerol, decreases in low density 
lipoprotein cholesterol, high density lipoprotein cholesterol and apolipoprotein B.
The Prospective Cardiovascular Munster study observed 4,849 middle-aged men 
(40 to 65 years), and in an eight-year follow-up showed a significant and independent 
association between serum triacylglycerol concentration and the incidence of major 
coronary events, (Assmann et al., 1996). Meta-analysis of seventeen studies (46,413 
men and 10,864 women) showed, after adjustment for high density lipoprotein 
cholesterol and other risk factors, the univariate relative risk for triacylglycerol was 1.14
(men) and 1.37 (women), (Hokanson & Austin, 1996). The triad of elevated 
triacylglycerol, small dense low density lipoprotein particles (LDL subclass phenotype 
B) and reduced high density lipoprotein cholesterol comprises the atherogenic 
lipoprotein phenotype (Austin et al., 1990). An Italian study has shown significantly 
more abnormal arteries between hypercholesterolaemic / hypertriacylglycerolaemic 
patients than hypercholesterolaemic / normotriacylglycerolaemic patients, (Rubba et al., 
1990).
The Adult Treatment Panel! I (NCEP 1993), considers levels of triacylglycerol 
above 4.5mmol.dm-3 (400mg.dL- 1 ) as a high risk factor and less than 2.26mmol.dm-3 (200
as a low risk factor,
1.2.3 High Density Lipoprotein
Women have higher serum high density lipoprotein concentration than age- 
matched men, (Gustafson et al., 1974; Nazir et al., 1999; male 1.09 mmol.dnv3 {42 
mg.dL}, female 1.47 mmol.dm-3 {57 mg.dL' 1 }). High density lipoprotein cholesterol is 
reduced in the summer months like the other lipids, (1.29 to 1.25 mmol.dnr3 {50 to 48 
mg-dL' 1 }, Nazir et al., 1999 statistical significant {p=0.010}, but not physiologically 
significant as the critical difference was less than 21%). High density lipoprotein levels 
are lower in the obese (Wilson & Lees, 1972), poorly controlled diabetes mellitus 
(Lopes- Virella et al., 1977), and in those who smoked (Garrison et al., 1978). The Adult 
Treatment Panel IT (NCEP 1993), considers levels of high density lipoprotein cholesterol 
below 0.9 mmol.dnr3 (35 mg.dL- 1 ) as a high risk factor and greater than 1.6 mmol.dnr3 
(60 mg.dL- 1 ) a Jow risk factor,
High density lipoprotein removes cholesterol from tissues and deposits it in the 
liver (Rader, 1998), where it undergoes catabolism.
1.2.4 Low Density Lipoprotein
The Adult Treatment Panel 11 (NCEP 1993), considers levels of low density 
lipoprotein cholesterol above 4.1 mmol.dm-3 (160 mg.dL- 1 ) as a high risk factor and less 
than 3,4 mmoJ.dnr3 (130 mg.dL- 1 ) a low risk factor.
Macrophages take up low density lipoprotein via receptor mediation or as 
oxidized low density lipoprotein by receptor-independent pathways to form foam cells. 
Foam cells accumulate in the intima to form fatty streaks, (Stevens & Lowe 1995a). 
Extracellular low density lipoprotein accumulates in the intima forming a lipid plaque. 
This develops into a fibrolipid plaque as the extracellular low density lipoprotein
calcifies and there is a loss of elastic lamina, collagenous replacement of myocytes, and 
myocyte proliferation.
1.2.5 Apolipoproteins
There is a wide range of apolipoproteins, the major ones are Aj & A 2 on high 
density lipoproteins; A4 , C l to 3 , E and (a); and B 100 and B48 on all the lipoproteins 
except high density lipoprotein.
Maciejko et al. (1983), found that apolipoprotein A } was a better marker of
angiographically documented coronary artery disease than either high density lipoprotein 
cholesterol or total cholesterol.
Plasma concentrations of apolipoprotein B 1{K) , the protein on low density
lipoproteins that bind to the low density lipoprotein receptor, has been found higher 
among patients with coronary artery disease than control subjects. Apolipoprotein B 100
is a better indicator of low density lipoprotein atherogenicity, than is cholesterol level. 
Some patients have hyperapobetalipoproteinemia and normal low density lipoprotein 
cholesterol levels, (Sniderman et al., 1980).
Naito (1985), showed the importance of both apolipoproteins Aj andB 100 over
total cholesterol, low and high density lipoprotein cholesterol levels. They concluded 
that the ratio of apolipoprotein Aj to B 100 was a better predictor of risk of coronary
artery disease.
1.2.6 Lipoprotein (a)
Lipoprotein (a) was first identified by Berg (1963) and is a family of lipoprotein 
particles. It contains apolipoprotein (a) bonded to low density lipoprotein by disulphide
10
bridges (Gaubatz et al., 1983; Fless et al., 1984). Tt is assumed that apolipoprotein (a) 
wraps itself around the low density lipoprotein particle and forms disulphide bridges 
with the apolipoprotein B-100 (hepatic origin, Mr = 550,000 daltons) or interlocks with
the low density lipoprotein particle without forming any direct covalent bonds, (Mbewu 
& Durrington, 1990). Whereas most Lipoprotein (a) contain one copy of apolipoprotein 
(a), some contain two copies of apolipoprotein (a), (Fless et al., 1989). Scanu and Fless, 
(1990) stated that apolipoprotein (a) should not be classed as an apolipoprotein because 
it does not bind directly to lipids and was water soluble, although the apoB 100-apo(a)
complex does bind to lipids via apoB 10<) . Tissue cultures of baboon hepatocytes have
shown that Lp(a) assembly can occur at the hepatocyte cell surface. Apo(a) binds to the 
cell surface via its kringle domains and then attaches to LDL apoB 100 , inducing
conformational changes and release, (White & Lanford 1994).
Apolipoprotein (a) binds to cholesteryl ester-rich lipoproteins (low density 
lipoprotein and less effectively to high density lipoprotein), and to triacylglycerol-rich 
particles (chylomicrons and chylomicron remnants, Bersot et al., 1986).
Plasminogen comprises a signal peptide, a pre-activation peptide, five kringle 
domains (Kl -K5) and a serine protease domain, whereas Apolipoprotein (a) is a 
plasminogen homologue (McLean et al., 1987), it contains the signal peptide, 15 to 37 
copies of kringle 4 with 75 - 85% identity to that of kringle 4 in plasminogen, one copy 
of kringle 5, and a serine protease domain (Scanu & Fless, 1990; White & Lanford, 
1995). The serine protease domain was an inactive form of the proteolytic site found in 
plasminogen and therefore could not lyse blood clots. Lipoprotein (a) binds to the 
endothelial cell surface receptor for plasminogen, inhibiting fibrinolysis and promoting 
thrombosis and atherosclerosis, (Hajjar et al., 1989, Gonzalez-Gronowet al, 1989).
Lipoprotein (a) does not appear to increase immediately post 30 minutes exercise 
of either low or high intensity, (Durstine et al., 1996), nor after chronic exercise 
(Hubinger & MacKinnon, 1996).
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Lipoprotein (a) does appear to increase the basal production and release of 
nitrogen(II)oxide, (Schlaich et al., 1998), and thus Lipoprotein (a) associated with 
atheroma appears to have a beneficial effect.
1.2.7 Blood Pressure
Tt is estimated that 14% of deaths in men are due to raised blood pressure (at rest, 
systolic blood pressure of 140 mmHg or over or a diastolic blood pressure of 90 mmHg 
or over), (British Heart Foundation, 2000h).
1.2.8 Smoking
Approximately 20% of deaths from coronary heart disease are due to smoking. 
The habit is more prevalent in Scotland than England and higher in the North (28%) than 
the South (26.6%) and lowest in East Anglia (23%). Tt is more prevalent in the manual 
(36%) than non manual (21%) social groups, (British Heart Foundation, 2000i). 
Cigarette smoking has been associated with increased reliance upon glycolytic 
metabolism during exercise, elevated carbon monoxide and chronotropic incompetence, so 
that smokers fatigue earlier than non smokers who exercise, (McDonough & Moffatt 
1999; Srivastava et al., 2000).
1.2.9 Psychosocial Factor
The British Heart Foundation (2000J) states four different types of psychosocial 
factor, namely: work stress, lack of social support, depression (including anxiety), and 
personality (particularly hostility), have been consistently associated with increased risk 
of coronary heart disease.
From 1986 to 1992 the male age-standardised death rates per 100,000 population 
from coronary heart disease showed that more from the partly skilled/unskilled social
12
class died when compared to the professional/intermediate class (266 to 160 
respectively, ratio manual to non manual 1.58. British Heart Foundation 2000k).
For the male population, there is a strong correlation (0.866, p=0.0006) between 
the average yearly unemployment figures as a percentage of the workforce from 1988 to 
1991 and the age standardised death rates from coronary heart disease per 100,000 
population from 1989 to 1998 (refer to Table 1.2.9). The data implies that there is a 
possible stress factor from unemployment that could be caused by psychological stress 
(depression), low physical activity status and a financial effect upon diet. Coronary 
heart disease is a chronic illness and therefore the effect of unemployment any time in 
their working life period is likely to increase their risk of a coronary event, particularly if 
they are the type of person that gets easily worried.
1.2.10 Radicals
Radicals are molecules or atoms with an odd number of electrons. This causes 
them to react quickly with other radicals (termination) or with other molecules 
producing another radical, (propagation). About 2-5 % of the oxygen used by the 
mitochondria forms the superoxide anion (O 2~ ", Reid, 1999). Other reactive oxygen
species (ROS), are the hydroxyl radicals (OH"), and hydrogen peroxide (H 2O2 ). Tn
hypoxic tissue the adenosine produced from adenosine monophosphate is deaminated to 
inosine. Inosine is converted to xanthine then to uric acid using xanthine oxidase. The 
by-product of these reactions is hydrogen peroxide, (Blakley, 1989).
Reactive oxygen species have damaging effects upon cells such as: cell membranes 
(peroxidation of lipids); DNA; thiol groups in proteins, and mitochondrial membranes. 
The net effect of this damage can be cell death, (Stevens & Lowe, 1995b). The main 
scavenging systems for removing radicals are: antioxidants (vitamin C, A and E); 
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Table. 1.2.9: Comparison of unemployment and mortality rates 
for coronary heart disease.
(The unemployment figures are averaged from the yearly statistics 
-Employment Gazette June 1992 100: SI8 - S20. The coronary heart 
disease figures are averaged from the Coronary Heart Disease Statistics 
2000Chptlp. 25}
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A wide range of fruit and vegetables are desirable to provide the antioxidants 
necessary to protect against oxidative damage and disease, (Jacob and Burri ,1996; Cao et 
al., 1998). The daily reference nutrient intakes for vitamins A, C and E are in adult males 
1.8 fimol (0.50 mg), 0.142 mmol (25 mg) and 9.3 fimol (4 mg) respectively (RHSS41 
1999). It is difficult to state a daily individual antioxidant intake quantity as the level of 
stress and the person's reaction to it are not constant, nor absorption across the 
enterocytes. Some athletes believe that their intake is low and supplement with 
multivitamin pills containing vitamins A, C, E, and mineral selenium. Alessio and Blasi 
(1997) concluded in their review that most studies showed that acute and chronic exercise 
increases antioxidant levels.
1.3 Homocysteine




Homocysteine {HSCH2CH2CH(N+H3 )CO2 -} is a ttuolated amino acid with a
relative molecular mass of 135 daltons. Homocysteine binds to proteins and its highest 
concentration is in the liver with lower levels in the kidney, brain, heart, lung and spleen 
(Svardal et al., 1986). The plasma level depends upon the age, gender, vitamin status 
(folate, vitamins B 12 , B6 and to a limited extent B2 ), protein intake (methionine), the
genetic makeup of the subject, renal function and the subject's history of smoking. 
Even after multivariate adjustment, homocysteine was independently associated with
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gender, race, serum folate, vitamin B }2 levels and systolic blood pressure (Table 1.3).
Tntracellular utilization of homocysteine:
1. It can be methylated to methionine. The methyl group could be 
transferred either from N 5 -methyltetrahydrofolate involving cobalamin 
(vitaminB 12 ){Universal} or fromBetaine {Liver}.
2. It can be adenosylated to S-adenosylhomocysteine.
3. It can under go trans-sulphuration producing cystathionine and 
cysteine, (requiring vitamin B6), and glutathione, {Liver}.
4. It is hypothesised that it can be oxidized to Homocysteic acid.
5. It may be bound to proteins via the thiol moiety.
6. Converted to homocysteine thiolactone.
7. Egresses from the cell. 
(modified from McCully 1993, Do et al. 1988, refer to Figure 1.3)
Tf relatively large amounts of homocysteine are fed to young rats (seven weeks 
old), it inhibits growth either directly or by affecting absorption across the jejunum. It 
also causes anatomical alterations in many organs, particularly in pancreatic acinar cells 
and testes. There was also damage to salivary glands, liver, gastric mucosa, Brunner's 
glands, kidneys, seminal vesicles, prostate, adrenals, thymus, spleen, lymph nodes, 
haemopoietic system, epiphyseal plates and Herder's glands, (Klavins, 1963, refer to 
section 1.3.1i Klavins et al., 1963). The rats diet included vitamins Bj 6 , it did not
include folate, nor vitamins B 12 C & E. The homocysteine could undergo trans- 
sulphuration, but might not be able to become methylated from N5 - 
methyltetrahydrofolate. Some methionine could be produced from the choline in their 
diet. As their diet was deficient in antioxidants, some damage may have been caused by 
radicals. Brown and Strain (1990) found that homocysteine in the diet of young rats 
caused a reduction in copper status, this affects ceruloplasmin, superoxide dismutase and 
cytochrome c oxidase. There were increased levels of superoxide dismutase and iron in
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geometric means of total homocysteine (umol.dnT 3 ) 
males (5.22) vs females (4.84)
blacks(5.51) vs whites(4.96) vs Hispanics(4.93) 
nonusers(5.09) vs users of multivitamins(4.82)
smokers(5.19) vs nonsmokers(5.00)
Table 1.3 Serum homocysteine levels in Teenagers









Figure 1.3 Utilization of Cellular Homocysteine
Key
Lp(a) - lipoprotein (a)
SAM - S-adenosylmethionine
SAH - S-adenosylhomocysteine
Hcy-S-S-protein - homocysteine linked to a protein molecule via the disulphide bridge
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the liver and increased levels of thiobarbituric acid reactive substances. Low dose oral 
administration of homocysteine thiolactone to rats for six weeks was found to cause an 
increase in plasma total homocysteine and triacylglycerol. There was also an associated 
decrease in beta-hydroxybutrate/3-oxobutanoate ratio, which showed inhibited fatty acid 
oxidation and therefore triacylglycerol increased, (Frauscher et al., 1995).
1.3.1 Cellular Homocysteine metabolism
Homocysteine is only produced via the methionine cycle and its intracellular 
concentration appears to be cell dependent. Non-hepatic cells appear to have a constant 
intracellular concentration, excess being exported from the cell. Hepatocytes have 
increased homocysteine under conditions of low protein diets, (Finkelstein & Martin, 
1984). Homocysteine is one of two loci in Thiol biochemical pathways, the other is 
Methionine. Homocysteine regulates re-methylation and trans-sulphuration, whereas 
Methionine regulates protein synthesis and transmethylation, (Storch et al., 1990). An 
overview of the Thiol chemistry is shown in Figure 1.3.1.
1.3.1i Methionine
Methionine is an essential amino acid. All translated polypeptides start with 
methionine and in certain polypeptides, it is removed post-translationally, (Bodley, 
1989). Methionine can be obtained from three main sources: autolysis of proteins, diet 
or re-methylation of homocysteine. It can also be synthesized from methylthioribose. 
The requirement of the cell for methionine depends upon its rate of protein anabolism 
and transmethylation. The recommended dietary allowance for methionine in the United 
States for adults is 0.9 g.day 1 , (Munro & Crim, 1988). Yet if there is excess methionine 
in the diet, it has been shown to cause inhibition of growth in young rats (7 weeks old) 
and anatomical alterations in organs (pancreas, gastrointestinal tract, salivary glands, 
kidneys, spleen, thymus, thyroid and adrenal glands, Klavins et al., 1963). They were 
unable to measure plasma methionine or homocysteine and were therefore unable to say
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Figure 1.3.1 Biochemistry of Thiol groups 




























































oxidized nicotinamide adenine dinucleotide
reduced nicotinamide adenine dinucleotide
oxidized nicotinamide adenine dinucleotide phosphate(V)
reduced nicotinamide adenine dinucleotide phosphate(V)
oxidized flavin adenine dinucleotide




whether excess methionine itself caused these changes, but the changes were similar to 
homocysteine fed in excess to rats (Klavins, 1963). In the older generation (64 years 
old) receiving multivitamins, there appears to be a significant inverse dose-response 
relationship between dietary protein and the napierian logarithm of total homocysteine, 
(Stolzenberg-Solomon et al., 1999). Thus implying that a high protein diet could reduce 
total homocysteine levels, if there were sufficient vitamins, particularly vitamin B6 .
Homocysteine is converted to methionine via two different reactions. One 
reaction uses N5-methyltetrahydrofolate, as the methyl donor and methionine synthase 
(coenzyme B 12) as the catalyst. This reaction is ubiquitous, occurring in every
mammalian cell. Methionine and S-adenosylhomocysteine inhibit methionine synthase 
(EC 2.1.1.13), whereas S-adenosylmethionine acts as a co-substrate. The other reaction 
uses betaine as the methyl donor with betaine:methionine methyltransferase as the 
catalyst and occurs only in the Liver and kidneys in primates. Methionine, S- 
adenosylmethionine and S-adenosylhomocysteine inhibit Betaine:homocysteine 
methyltransferase (EC 2.1.1.5). An in vitro system which mimics a rat's liver 
demonstrated that the enzymes that remove homocysteine may be affected by the 
amount of protein in the diet, most likely the quantity of methionine, Table 1.3.1i, 
(Finkelstein & Martin, 1984).
Mudd & Poole, (1975) showed that in humans on normal diets, the homocysteine 
moiety was converted to methionine on average, 1.9 times in males and 1.5 times in 
females before undergoing trans-sulphuration. When the diet was restricted in 
methionine and choline the average number of cycles increased to 3.9 for males and 3.0 
for females. The work by Finkelstein & Martin, (1984) implies that this increased 
cycling could be partly accounted for by the increase in Betaine:Homocysteine 




















Table 1.3.11 The percentage of Homocysteine consumed by 
each enzyme. [MS - methionine synthase; B:HMT - betaine: 
homocysteine methyltransferase; CBS cystathionine p-synthase]
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1.3.lii S-Adenosylmethionine
Methionine is adenosylated to S-Adenosylmethionine using adenosine 
triphosphate(V) and the enzyme S-Adenosylmethionine synthase (EC 2.5.1.6). S- 
Adenosylmethionine does not appear to be able to leave the cell in which it was 
synthesized. Less than 10% adenyoslated methionine is decarboxylated and the 
propylamine moiety used in the synthesis of spermine. Both spermidine and spermine 
bind tightly to nucleic acid and are therefore abundant in rapidly proliferating cells. Most 
of S-Adenosylmethionine undergoes transmethylation with the formation of S- 
Adenosylhomocysteine, which acts as an inhibitor upon the a-methyltransferase.
Transmethylation reactions are universal throughout the body: creatine synthesis, 
(Figure 1.3.lii a); methylation of noradrenaline to adrenaline, (Fonlupt et al., 1979) and 
metabolism of adrenaline and noradrenaline, (Figure 1.3.lii b); methylation of N- 
acetylserotonin to syntheses melatonin. A lack of transmethylation results in 
demyelination, this causes subacute combined degeneration, (Scott, et al., 1981). 
Subacute combined degeneration is also associated with a vitamin B 12 deficiency and thus
a S-Adenosylmethionine deficiency, (section 1.6.2). 
1.3.1iii S-Adenosylhomocysteine
Cytosolic S-Adenosylhomocysteine inhibits transmethylation reactions and is 
produced by all transmethylation reactions using S-Adenosylmethionine as one of its 
substrates. There are three routes to remove S-Adenosylhomocysteine, which are: 
hydrolysis, binding to specific proteins and transportation out of the cell. In rats' liver 
30 - 50% of S-Adenosylhomocysteine can be found bound to proteins in the plasma 
membrane and microsomes with most of the free S-Adenosylhomocysteine in the cytosol 
fraction (Svardal et al., 1986 and 1987). The kidney is the major tissue shown to absorb 
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Figure 1.3.1H b The biosynthesis and metabolism of the
catecholamines from the ammo acid tyrosine
(modified from Riederer et al., 1989).
Key:
Substrates and Products:
DA = Dopamine NA = Noradrenaline;
A = Adrenaline MN = Metanoradrenaline;
MA = Metadrenaline DOMA = 3,4-dihydroxymandelic acid
VMA = vanillylmandelic acid (3-methoxy-4-hydroxymandelic acid)
DOPEC = 3,4-dihydroxyphenylethanoic acid DOBE = 3,4-dihydroxybenzoic acid
DHPE = 3,4-dihydroxyphenylethanol HMPE = 4-hydroxy-3-metoxyphenyiethanol;
DHPG= 3,4-dihydroxyphenylethan-l,2-diol HVA = homovanillic acid
HMPG = 4-hydroxy-3-methoxyphenylethan-l,2-diol VA = vanillic acid
SAM = S-adenosylmethionine SAH S-adenosylhomocysteine
Enzymes
TH = tyrosine hydroxylase DDC = Dopa decarboxylase
PNMT = Phenylethanolamine-N-methyltransferase DBH = Dopamine B-hydroxylase
MAO = monoamine oxidase (found in mitochondria in both neuronal and non-neuronal tissue)
COMT = Catechol-O-methyltransferase (found in the cytoplasm of most cells, including neurons)
AD = Aldehyde dehydrogenase (oxidation) ED = Alcohol dehydroxygenase (reduction)
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Exercise causes an elevation in plasma adrenaline of 1200-1800% following 5-10
•
minutes intense exercise at 90-100% VO2 and an increase of 500-800% following 60-
*
90 minutes moderate exercise - 60-70% VCL (Kjaer & Dela, 1996). Adrenaline hasZlTlflX
been shown to inhibit S-Adenosylhomocysteine hydrolase in excised guinea-pigs 
papillary muscles in a concentration dependent fashion. It uses p-adrenergic receptors 
that stimulate an influx of calcium, (Suarez & Chagoya de Sanchez, 1997). This would 
imply, that during exercise there would be a transient increase in plasma S- 
Adenosylhomocysteine and a decrease in L-homocysteine which is not what has been 
found to date (refer to section 1.7.3). Intravenous injection of tritiated S- 
Adenosylhomocysteine into rats, produced less than 15% of the radioactivity 
incorporated into protein methionine or excreted in the urine as 2-oxobutyrate. The 
remainder is excreted as S-Adenosyl-Y-thio-2-oxobutyrate, (Duerre et al., 1969). The 
compound is not found in 'normal' rat urine. This implies an enzyme in the kidneys for 
catalysing S-Adenosylhomocysteine, possibly directly to S-Adenosyl-y-thio-2- 
oxobutyrate. So that, during exercise or times of stress, when adrenaline levels are 
elevated, this shunt pathway removes S-Adenosylhomocysteine that would cause a 
decrease in cytosolic S-Adenosylhomocysteine and thereby remove the transmethylation 
inhibitor; allowing the transmethylation of noradrenaline to adrenaline and therefore 
continued inhibition of S-Adenosylhomocysteine hydrolase during prolonged exercise.
Adenosine released into the coronary system is increased during hypoxia and is 
affected by L-homocysteine concentration, (Schrader et al., 1981). In an isolated guinea- 
pig heart normoxically perfused 33% of the adenosine produced came from S- 
Adenosylhomocysteine, via the transmethylation pathway and most of the produced 
adenosine is reincorporated into the adenosine triphosphate(V) pool, whereas in the 
hypoxically perfused heart the increased adenosine comes from 5'-adenosine 
monophosphate(V) hydrolysis, (Lloyd et al., 1988; Deussen et al., 1989; Lloyd & 
Schrader, 1993).
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Adenosine is believed only to play a paracrine role in coronary vasodilation 
during sustained hypoxia, when adrenergic receptors are intact, (Herrmann & Feigl, 
1992). Myocardial effects of catecholamines were inhibited by adenosine, (Schrader et 
al., 1977). Adenosine reduces the atrioventricular conduction velocity during hypoxia, 
(Belardinelli et al, 1980).
1.3.1iv Trans-sulphuration
Homocysteine can enter the trans-sulphuration pathway, where it is converted to 
cystathionine using cystathionine p-synthase (coenzyme B6) and then to cysteine using
cystathionine y-lyase (coenzyme B6 , Figure 1.3.1).
Intracellular homocysteine forms a dynamic pool between free and bound 
homocysteine. The turnover rates in rat livers were calculated as 1.2s for free 
homocysteine and 1.8s for bound homocysteine, (3s for total homocysteine, Svardal et 
al., 1986). In tissues that do not have the enzymes for trans-sulphuration (all except 
liver, kidney and pancreas), excess free homocysteine is transported out of the cell into 
plasma. This limits intracellular thiol toxicity, but exposes the vascular tissue to the mild 
reducing agent.
1.3.2 Plasma Homocysteine
The plasma homocysteine level is the summation of the export of excess 
homocysteine from cells. In vitro, homocysteine export post-methionine loading was 
dependent upon cell type and in relation to lymphocytes whether they are activated, 
(Christensen B., et al., 1991; lizasa & Carson 1985; German et al., 1983). The highest 
homocysteine export occurred during early exponential growth at low cell density in all 
proliferating cells. Christensen B., et al. (1991), hypothesised that the possible reason 
for increased egress of homocysteine in proliferating cells that are actively synthesizing 
protein and transmethylation reactions, could be due to a localised folate deficiency as it
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was used for purine and pyrimidine synthesis. This would increase cell density and 
decrease amino acid transport. It appears that by three days post methionine loading, 
the excess methionine had been converted to homocysteine, exported and removed from 
the plasma, with the greatest plasma homocysteine level about one and half days post 
methionine loading.
There are several different proteins in the plasma membrane that transport amino 
acids. One such transport system is called ASC because it has a high affinity for alanine, 
serine and cysteine, (Christensen H., et al., 1967). System ASC allows sodium 
movement in both directions and the associated amino acid movement symport with the 
sodium. System ACS is present in almost all cell types. It is possible that 
homocysteine could use other systems, such as system y+ that transports cationic and 
zwitter ionic amino acids with sodium, (Palacin et al, 1998).
There are several interactions that plasma homocysteine could undertake:
• Less than 0.05% of plasma total homocysteine is excreted unchanged in the urine, 
(Mudd & Poole, 1975).
• translocation from the cells of the body going mainly to the liver, but also to the 
small intestine, pancreas and kidneys. Tt is within these organs that the 
homocysteine undergoes trans-sulphuration, those organs also have a rapid 
turnover of glutathione (Meister, 1983). 
Reaction with endothelial nitrogen(II)oxide (refer to section 1.4.2).
• Stimulates hypertrophy of smooth myocytes (refer to section 1.4.2).
• Reacts with lipoprotein to form lipoprotein(a) (refer to section 1.5.4).
• Bound to proteins via the thiol moiety, (eg albumin).
Since 1985, homocysteine levels are quoted as plasma total homocysteine and 
include the concentrations of free reduced form of homocysteine (-1%), disulphide 
homocystine, mixed disulphide homocysteine-cysteine and protein-bound homocysteine 
(-80%, principally to albumin). The acceptable range of fasting plasma total
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homocysteine is 5 to 15umol.dnr3 . The upper end of the range has been associated with 
certain vascular diseases and is dependent upon the patient's genotype. There is a 
gender difference, males have higher homocysteine levels than females. Plasma total 
homocysteine has been shown to increase with age, males aged 40 to 42 years recorded a 
mean plasma total homocysteine level of 10.8umol.dnr3 and those aged 65 to 67 years 
12.3 umol.dm-3 .
Plasma total homocysteine concentration of between 16 and 30 umol.dm-3 is 
taken as moderate hyperhomocysteine, 31 and 100 as intermediate hyperhomocysteine 
and >100 as severe hyperhomocysteine. Some argue that moderate hyperhomocysteine 
lowest value should be greater than 10 umol.dm-3 (Omenn et al., 1998).
1.3.3 Homocysteine thiolactone
Under acidic conditions homocysteine becomes homocysteine thiolactone, 
(McCully, 1994). Acidic conditions are more likely post anaerobic exercise. 
Homocysteine and adenosine triphosphate(V) with the catalyst Lysyl-transfer 
ribonucleic acid synthetase passes through the intermediate Lysyl-transfer ribonucleic 
acid synthetase.homocysteine.adenosine monophosphate(V) before yielding Lysyl- 
transfer ribonucleic acid synthetase, adenosine monophosphate(V) and homocysteine 
thiolactone (Jakubowski, 1997). Homocysteine thiolactone is procarcinogenic and 
proneoplastic, and in normal cells, it is metabolised to sulphate(VI) via a series of 
reactions involving vitamin A and C (McCully 1971, 1994, refer to Figure 1.3.3). The 
oxidation of homocysteine thiolactone to sulphate(VI) and its incorporation in cartilage is 
under the control of thyroxine and growth hormone, (Clopath et al., 1976; McCully 
1971).
Baboons were infused with homocysteine thiolactone for three months at the end 
of which certain arteries had endothelial desquamation and early proliferative lesions and 
a shortening of platelet survival, (Harker et al., 1976). 0.1 to 1.0 mmol.dm-3 of
30
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Figure 1.3.3 Homocysteine thiolactone
(modified McCully 1994)
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dL-homocysteine thiolactone was found by Wall et al. (1980), to induce endothelial cell 
detachment in direct proportion to its concentration
1.3.4 Gender
De Laet et al. (1999) found no significant difference between boys and girls under 
fifteen years old, whereas when most boys and girls were post-pubescent, then girls 
tended to have a significantly lower plasma total homocysteine level than boys (refer to 
Table 1.3.6). De Laet's group did not categorise the subjects according to their puberty 
status (Tanner's scale (Marshall & Tanner, 1969 & 1970) which could mask the plasma 
total homocysteine differences. Women have lower levels of homocysteine even after 
other factors such as diets are accounted for, than males, (Nygard et al., 1995; Andersson 
etal., 1992).
1.3.5 Heredity
Higher levels of plasma total homocysteine were found in children with a 
powerful history of coronary heart disease (father, grandfather, or uncle), when 
compared to the offspring of healthy controls, (Tonstad et al., 1996; Greenlund et al., 
1999, refer to Table 1.3.5). Whereas de Jong et al. (1997), found weak evidence for a 
relationship between hyperhomocysteinemia and arterial disease in the siblings of young 
patients with vascular disease and hyperhomocysteinemia. In childhood, moderate 
hyperhomocysteinemia may result from genetical, nutritional (Ueland et al, 1993), and 
iatrogenic factors (Ueland & Refsum, 1989), renal failure (Soria et al., 1990), human 
immunodeficiency virus (Muller et al, 1996), or cancer (Ueland & Refsum, 1989). De 
Laet et al. (1999), found that the frequency of reported cardiovascular disease in the 
family was higher in the child that had a total homocysteine concentration above the 95th 
percentile. Indicating a possible behavioural/dietary problem, namely low physical 






















Table 1.3.5 Comparison of Children aged 5 to 17 years old 
with (experimental) and without (control) 
parental coronary artery disease.
(Greenland et al., 1999).
33
1.3.5i Methylenetetrahydrofolate Reductase
Methylenetetrahydrofolate Reductase is the enzyme complex that reduces N5 ,N 10 
methylenetetrahydrofolate to N5 methylhydrofolate. A number of mutations have been 
identified that are associated with hyperhomocysteinemia (Goyatta et al., 1994; Frosst 
etal., 1995).
Heredity deficiency of methylenetetrahydrofolate reductase is the most widely 
studied inborn error of folate metabolism (Rosenblatt, 1995). Phenotypes of patients 
with severe deficiency of methylenetetrahydrofolate reductase (0-20% activity in 
fibroblasts) covers the gambit of symptoms from asymptomatic (Haworth et al., 1993) 
to developmental delay, motor and gait abnormalities, seizures and psychiatric 
disturbance (Rosenblatt, 1995). The homozygous mutation Threonine227Methionine 
produces 0-3% enzyme activity, another mutation is Arginine157Glutamine and a third 
mutation causes termination of the synthesizing protein. The alanine/valine gene 
polymorphism is significantly correlated to strokes with an odds ratio of 1.51 (95%CT 
1.02 to 2.23) in the heterozygote and 3.35 in the homozygote. A milder deficiency of 
methylenetetrahydrofolate reductase (50% activity) has been described in patients with 
coronary artery disease (Kang et al., 1991).
Homozygosity for 677Cysteine-->Thymine was also associated with higher total 
homocysteine levels and tended to be more common in children whose parents had a 
history of cardiovascular disease than those who did not, (Tonstad et al., 1997). The 
change of 677Cysteine to Thymine alters the activity of methylenetetrahydrofolate 
reductase and therefore the production of methyltetrahydrofolate. The association 
between the homozygous mutation in the methylenetetrahydrofolate reductase gene 
(677Cysteine~>Thymine) and premature cardiovascular disease, produced an odds ratio 
of 3.1 (95%CI 1.0-9.2), (Kluijtmans etal., 1996).
In a European study, 35.5 % of working men, with total homocysteine levels in
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the top decile had the ThymineThymine genotype, whereas in the population as a whole 
it was only 11.5%, (Harmon et al., 1996), whereas in the Hordaland study, practically 
everyone with total homocysteine levels of >20 umol.dnr3 had the ThymineThymine 
genotype, (Guttormsen et al., 1996). Supplementation of 1000 ng of folic acid produced 
the following reductions in total homocysteine levels: ThymineThymine genotypes - 
21%; heterozygous genotype - 13%; CysteineCysteine genotype - 7%, (Harmon et al., 
1996; Malinow et al., 1997). A possible explanation for the greater reduction in 
ThymineThymine homozygotes is that patients with that allele tend to have higher 
baseline values of total homocysteine. Woodside et al. (1998), found using a double 
blind randomised factorial-design controlled trial, that supplementation of 1000 jig folate, 
7.2 mg B6 and 20 ug B 12 produced a reduction of approximately 27% in homocysteine
levels that was dependent upon the methylenetetrahydrofolate reductase genotype. This 
implies that the individuals underlying pathophysiology of vascular disease should be 
assessed to see if there is a genetic variant of one of the enzymes or a nutritional shortage 
either due to a deficient diet or poor absorption. Further research is required to find the 
particular quantity of each vitamin (folate, B 12 and B6), choline and serine to be
supplemented to produce the greatest reduction in total homocysteine level with the least 
potential risk for each particular pathophysiological variant. The homozygous mutation 
appears to have a protective effect against colorectal cancer, (Ma et al., 1997). Men with 
homozygous mutation that drank little or no alcohol had an eightfold decrease in risk of 
colorectal cancer in comparison to homozygous normal, (Ma et al., 1997).
1.3.5H Cystathionine (5-synthase
Fifteen Dutch homozygous cystathionine 0-synthase deficient patients had the 
833Thymine ~>Cysteine (isoleucine278threonine) mutation in 50% of their alleles, 
however sixty cardiovascular patients did not test positively for the mutation and only 
one out of 111 controls showed heterozygosity for the mutation, (Kluijtmans et al., 




Plasma total cholesterol and homocysteine concentrations tend to increase with 
age, (Mann et al., 1988; Silberberg et al., 1997; de Laet et al., 1999; refer to Table 
1.3.6). The diet changes with age, partly due to financial capacities, a lack of mobility 
and a lack of motivation to prepare, cook a meal for one and then wash up. There is a 
tendency for some elderly people to develop severe atrophy of the gastric mucosa 
(autoimmune chronic gastritis). They develop antibodies against gastric parietal cells 
(90%) and intrinsic factor (60%) which causes vitamin B 12 deficiency, (Stevens & Lowe,
1995b) and therefore mild hyperhomocysteinemia.
1.4 Homocysteine and Cardiovascular Disease
1.4.1 The Homocysteine Hypothesis
Children and adults suffering from cystathionine p-synthase deficiency had very 
high levels of homocysteine (-100 umol.dnr3 ) and atheromas (McCully, 1969; Harker et 
al., 1974). This led to the development of the homocysteine hypothesis that there was 
an association between hyperhomocysteinemia and the pathogenesis of atherosclerosis, 
(McCully, 1983; McCully & Wilson 1975).
Many trials have shown that the ratio of plasma total homocysteine 
concentrations of patients suffering from a particular cardiovascular disease to controls 
was fairly constant, (Table 1.4.1). It is possible that the range of control plasma total 
homocysteine concentrations was due to sub-optimal folate levels. They did not have 
cardiovascular disease because the sum of their risk factors was below the threshold.
From the summarised data of 750 vascular patients and 200 controls up to 1994, 
21% of patients with coronary artery disease, 24% of patients with cerebrovascular
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olasma tHcv ( umol.drrr31)
Age group
5-9 years old
10 - 14 years old











Table 1.3.6 Plasma total bomocysteine concentrations in Belgian children,
(deLaetetal, 1999).
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Familial coronary artery disease
male 11.1±2.6 14.3±7.1 
Coronary heart disease- 
male 11.3±3.7 13.1±4.3 
female 10.H5.0 13.0±7.4 



















1.3 Graham etal., 1997
1.4 Graham etal., 1997
1.3 Williams etal., 1990
1.2 Malinowetal., 1990
1.3 Malinowetal., 1990
1.1 Graham etal., 1997
1.2 Israelssonetal., 1988
1.1 Brattstrom etal., 1988a
1.1 Graham etal., 1997
1.8 Araki etal., 1989
1.5 Coull etal., 1990
1.7 Malinowetal., 1989
1.2 Graham etal., 1997
1.7 Brattstrom et al., 1988a
Table 1.4.1: Mean plasma total homocysteine levels (umoI.dm-3) from 
people suffering from different types of cardiovascular 
disease, (Kangetal., 1992).
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disease, 32% of patients with peripheral artery disease, and 2% of the control subjects 
had mild hyperhomocysteinemia post methionine load test, (Boers, 1994). The 
European Concerted Action Project tested 750 patients with documented vascular 
disease and 800 control subjects matched for age and sex, and found that their fasting 
homocysteine concentrations greater than 12.lumol.dnr3 were associated with an 
elevated risk of vascular disease independent of all traditional risk factors, (Robinson et 
al., 1998).
1.4.2 Atherosclerosis
Athero is taken from the Greek word athere meaning soft, fatty or gruel-like, 
whereas scler- (skleros) means hard. Atherosclerosis involves an atheroma, which is a 
plaque of fatty deposits in the endothelial lining of the arteries (Tunica intima) that can 
impinge upon the media. Atheroma formation in the intima can encroach upon the lumen 
and interfere with blood flow. The later stages of atheroma formation, the liquid plaque 
disrupts the internal elastic lamina, (Stevens & Lowe, 1995a).
The Committee on Vascular Lesions of the Council on Arteriosclerosis (American 
Heart Association), have proposed three stages that are clinically silent and occur before 
the advance lesions (atheroma): initial, fatty streaks and intermediate lesions. The initial 
lesion (type I), is characterized by an increase in intimal macrophages and those filled 
with lipid droplets (foam cells). The fatty streak (type II), the first grossly visible 
lesion. It contains layers of foam cells and lipid droplets within the intimal smooth 
myocytes, also a few coarse-grained particles and heterogeneous droplets of extracellular 
lipid. The intermediate lesion (type III), are morphologically and biochemically between 
the fatty streak and advanced lesion, (Stary et al., 1994). Atheromas occur in high 
pressure large and medium sized arteries (aorta, coronary, carotid, mesenteric, iliac and 
femoral arteries and the cerebral arteries derived from both the vertebrobasilar and 
internal carotid arteries), rarely in arteries under 2mm diameters, (Stevens & Lowe, 
1995a).
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Investigations using autopsies have found fatty streaks in the aortas of foetuses 
and young children. There could be a decrease in lesion area before a steady increase with 
age in aortic arch and abdominal aorta (Napoli et al., 1999). The Bogalusa Heart Study 
looked at autopsies of 204 young people between the ages of two and thirty-nine. They 
found that the extent of fatty streaks and fibrous plaques in the aorta and coronary 
arteries increased with age, (Berenson et al., 1998). Napoli et al. (1997), found that in 
spontaneously aborted foetuses less than six months old, the foetal plasma cholesterol 
levels positively correlated with maternal levels. Foetal aortas from 
hypercholesterolemic or temporary hypercholesterolemic mothers had significantly more 
and larger lesions than from normocholesterolemic mothers. Further study (Napoli et al., 
1999), revealed that the progression of the lesions was significantly faster in children 
from hypercholesterolemic mothers than children from normocholesterolemic mothers, 
(p<0.0001), ie the slope of the regression line drawn through the points of the area of the 
largest lesion divided by the section area plotted against age was steeper for children of 
hypercholesterolemic mothers. In the Pathobiological Determinants of Atherosclerosis in 
Youth study (1993), all the aortas and about half of the right coronary arteries in the 15 
to 19 age group had atherosclerotic lesions, (left anterior descending and circumflex 
branches were used for different investigations). Steinberg (1988), postulated the linkage 
between the Lipid-Infiltration hypothesis and the endothelial-injury hypothesis, (Figure 
1.4.2a).
Endothelial detachment induced by homocysteine was shown to be prevented by 
catalase, but not superoxide dismutase. This implied hydrogen peroxide was involved in 
the detachment, (Panganamala et al., 1986; Saez et al., 1982) because catalase catalyses 
the dismutation of hydrogen peroxide. Pathophysiological concentrations of 
homocysteine on human umbilical vein endothelial cells in vitro increased neutrophil- 
endothelial cell adhesion. The neutrophils were then able to migrate across the 
endothelial layer (Dudman et al., 1999), and activated neutrophils produce hydrogen 
peroxide that can be involved in desquamatization. The idea that homocysteine is 































Figure 1.4.2a Postulated Atherosclerotic mechanism
(Steinberg, 1988)
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reduce the effects of hyperhomocysteinemia upon impaired vascular response (Bonham 
et al., 1998; Chambers et al, 1999). Both groups showed that the homocysteine 
concentration was not affected by the addition of vitamin C, implying that homocysteine 
was not converted to thiolactone and reacting with vitamins A and C to produce 
sulphate(IV) (refer to Figure 1.3.3), but was reacting with radicals.
Glueck et al. (1995), found that 3.7% hyperlipidaemic patients had moderate 
Hyperhomocysteinemia and had a tendency for elevated cystathionine, methylmalonic 
acid and decreased levels of high density lipoprotein cholesterol. They had a higher 
incidence of atherosclerotic vascular events compared to those with normal homocysteine 
and cystathionine (72% & 44% respectively). They were more likely to have had at 
least 1 first-degree relative with an atherosclerotic event before the age of 65, implying a 
genetic or learnt risk factor, (78% & 50% respectively). Sutton-Tyrrell et al. (1997), 
showed that in a normotensive group (systolic blood pressure less than 160 mm of 
mercury) the higher homocysteine quintile was associated with a higher incidence of 
atherosclerosis. There was also an association between homocysteine and hypertension, 
but no association with atherosclerosis within their group.
Squamous endothelial cells release nitrogen(II)oxide and prostacyclin, which 
causes vasodilation and inhibits platelet aggregation, (Bunting et al., 1976; Moncada & 
Vane, 1979). Nitrogen(II)oxide nitrosates homocysteine (S-nitrosohomocysteine) 
rendering it nontoxic to the endothelium, but still inducing vasodilation and platelet 
inhibition, (Stamler & Loscalzo, 1992). Pathological concentrations of 
homocysteine (100 (imol.dm-3 ) upon aortic rings in vitro with copper, caused a copper 
concentration-dependent inhibition of nitrogen(II)oxide-mediated endothelium-dependent 
relaxation, which was reduced in the presence of either or both, superoxide dismutase and 
catalase, (Emsley et al., 1999). Homocysteine increased the inducible nitrogen(II)oxide 
synthase III, which interleukin-lp had stimulated in vascular smooth myocytes, (Ikeda et 
al., 1999). Endothelium appears to have a mechanism for coping with moderately 
elevated levels of homocysteine by interleukin-l|3 stimulated/homocysteine enhanced
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nitrogen(II)oxide synthesis. Increasing nitrogen(II)oxide production in the short term, so 
that the nitrogen(II)oxide can react with the increased homocysteine levels. In the 
presence of copper ions and low antioxidants, homocysteine reacts with the copper ions 
to produce the radicals, superoxide and hydrogen peroxide which could damage 
endothelium. The loss of homocysteine and nitrogen(II)oxide reduces their ability to 
cause vasodilation.
Homocysteine appears directly to injure endothelial cells in vitro, (Wall et al, 
1981). Serum from familial hypercholesterolemia patients inhibited both endothelial and 
arterial smooth muscle cells migration, (Wall et al., 1981). Homocysteine has been 
shown on several occasions to cause desquamatization (deendothelialization), (baboons- 
Harker et al., 1976; rats-Hladovec, 1979). Homocysteine increases the uptake of low 
density lipoprotein by macrophages and monocytes, which get trapped in the intimal 
layer. Homocysteine (10-50umol.dnr3 ) inhibits deoxyribonucleic acid synthesis in 
vascular endothelial cells and has no effect upon vascular smooth muscle cells (Wang et 
al., 1997). This is because homocysteine increases S-adenosylhomocysteine in vascular 
endothelial cells, but not in vascular smooth muscle cells. Homocysteine (10-50 
umol.dm-3 ) decreases carboxyl methylation of p21 ras in vascular endothelial cells and 
there is an associated reduction in extracellular signal-regulated kinase 1/2 which modify's 
vascular endothelial cell growth, (Wang et al., 1997; Figure 1.4.2 b).
Two studies have shown no association between homocysteine and 
atherosclerosis, (Donahue et al., 1974; Smolin et al., 1983). Donahue's group tried to 
repeat McCully and Ragsdale (1970), work of inducing arteriosclerotic lesions by giving 
homocysteine with rabbit chow. They used weanling New Zealand white rabbits and 
found gross fibrous thickening in the ascending and arch of the aorta in three of the four 
experimental animals and two of the four control animals, whereas in McCully and 
Ragsdale (1970), all their experimental rabbits had aortic fibrous plaques (4/4) and just 
one of their controls (1/3). With such small numbers, there is little confidence in the 


























Atherogenic pathways of homocysteine
(modified Stamler & Slivka, 1997)
LDL, low-density lipoprotein; oxLDL, oxidized LDL; Mo, monocytes; M<j>, macrophages; 
apo(a), apolipoprotein (a); Lp(a), lipoprotein(a); MCP-1, monocyte chemoattractant protein-1; 
VSMC, vascular smooth muscle cells; TNF-a, Tumour necrosis factor-a; IL-lp, interleukin-1 p.
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1.4.3 Coronary Heart Disease
Malinow (1997), concluded from a review of the literature that most of the 
studies support the hypothesis that hyperhomocyst(e)inemia is a risk factor for 
coronary artery disease. Higher levels of mean plasma homocysteine levels were found 
associated with a greater degree of atherosclerosis, (Table 1.4.3). The patients and 
controls were age and gender matched, and they found no association between the 
presently accepted risk factors for coronary artery disease: smoking, 
hypercholesterolemia, diabetes and obesity, and higher levels of plasma homocysteine.
A prospective investigation was conducted into the relationship between plasma 
total homocysteine levels and mortality among 587 patients with angiographically 
confirmed coronary artery disease (at least 50% stenosis of any coronary vessel 
diameter). After four years, 3.8% of patients with homocysteine levels < 9umol.dnr3 
had died (overall mortality), compared with 24.7% of those with levels of >15umol.dnv3 . 
78% of the deaths were classified as due to cardiovascular causes, (Nygard et al., 1997). 
Ueland et al. (1992), summated the data from 1500 vascular patients and 1400 controls 
up to 1992. 10 to 24% of the patients with coronary artery disease, and 23 to 47% of 
patients with cerebrovascular or peripheral artery disease had fasting 
hyperhomocysteinemia, whereas only 7% of the control subjects had it. Landgren et al., 
(1995) found that plasma homocysteine levels post acute myocardial infarction 
increased over a period of six weeks from 13.1 ± 4.6 to 14.8 ± 4.8umol.dnr3 . Folate was 
then administered for a further six weeks and this produced a decrease of 4.4umol.dnr3 
in the homocysteine level. These results show that the low homocysteine is associated 
with lower mortality risk post acute myocardial infarction and if folate is administered 
the homocysteine level will is reduced. There is no threshold, just a continuum of risk 
dependent upon homocysteine concentration, (Robinson & Loscalzo, 1998).
In the Framingham Study, elderly United State women (58.9%) and men (41.1%) 
with a mean age of 70±7 years had their nonfasting plasma total homocysteine levels
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Mean plasma total 
Homocysteine 
((imol.dtrr3)
p (between the coronary 
patient
Coronary patients 
(Coronary artery disease only) n=50
11.7±0.7
Coronary artery disease and 










Table 1.4.3 Mean plasma homocysteine concentration and level of 
cardiovascular disease. (Montalescotetal., 1997).
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compared to mortality. The upper quartile (>14.26umol.dnr3 ) vs the lower three 
quartiles (<14.26umol.dnr3) were associated with relative risk estimates, (adjusted for 
several other risk factors): 1.54 for all-cause mortality; 1.52 for cardiovascular disease 
mortality, (Bostom et al., 1999). There are several studies that have not shown any 
association between homocysteine and cardiovascular disease. After adjustment for 
other risk factors the Multiple Risk Factor Intervention Trial showed no association 
between total homocysteine and cardiovascular disease (relative risk 0.94; confidence 
interval, 0.56 to 1.56, Evans et al., 1997). The Atherosclerosis Risk in Communities 
Study also showed no association between total homocysteine and the incidence of 
cardiovascular disease, (Folsom et al., 1998). Therefore, the association between 
homocysteine and cardiovascular disease has not been shown unequivocally. In my 
opinion this shows the problem of trying to adjust for a multitude of risks that in some 
case are synergistic.
In patients that had unstable angina or myocardial infarction there was a threshold 
for total plasma homocysteine. Patients with total plasma homocysteine concentration 
greater than 12.2|imol.dm-3 had a 2.6-fold increase in risk of a cardiac event, (Stubbs et 
al., 2000). Robinson et al. (1998) found that fasting total plasma homocysteine 
concentrations greater than 12.1(j,mol.dnr3 was associated with an elevated risk of
vascular disease. Graham et al. (1997) found that the geometric mean of total plasma 
homocysteine concentration for cardiovascular disease was 11.25|,imol.dnr3 . Omenn et 
al. (1998) believe that total plasma homocysteine concentration should be down to the 
range of 9 to lO^imol.dnr3 .
1.4.4 Peripheral Vascular Disease
Molgaard et al. (1992) showed that patients with intermittent claudication only 
had significantly higher levels of total plasma homocysteine than the controls when their 
serum folate levels were less than ll.Onmol.dnr3 , (normal serum folate level 7.0 to 28.1 
nmol.dm-3 ). Serum folate levels above 11.0 nmol.dnr3 , there was no significant
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difference between the patients' and controls' total plasma homocysteine. Boers et al., 
(1985) investigated 75 patients, that were under 50 and had clinical signs of ischemic 
disease. They found that 28% (7/25) of patients with occlusive cerebrovascular disease 
and 28% (7/25) with occlusive peripheral artery disease and none (0/25) that had 
myocardial infarction had post methionine load hyperhomocysteinemia (serum 
homocysteine concentration above the mean+2 standard deviations of the control group) 
and had low cystathionine synthase activity (they were heterozygous for cystathionine 
synthase). This implies that 28% of patients with premature vascular disease are 
heterozygous for cystathionine |3-synthase.
1.4.5 Thrombosis
Thrombosis is the process of blood clot formation (thrombus) in the body's 
circulatory system. Endothelial cell damage can activate the extrinsic and intrinsic 
coagulation pathways, (Aoki et al., 1998, Figure 1.4.5). Hydrogen peroxide has been 
indicated as the mediator of homocysteine-induced endothelial damage in vitro because of 
the effect of catalase, (Wall et al., 1980; Starkebaum & Harlan, 1986). The exposure of 
tissue factor in the plasma membranes of subendothelial cells like fibroblasts and other 
cells in the walls of blood vessels, allows the binding of plasma protein factor V1T 
triggering the extrinsic coagulation pathway, (Higashi & Iwanaga, 1998).
The plasma total homocysteine concentrations found in homocystinuria patients 
(100 to 300umol.dnr3 ) were sufficient to cause an increase in tissue factor messenger 
ribonucleic acid in endothelial cells, (Fryer et al., 1993). Homocysteine has been shown 
to activate the Hageman factor (factor XII - Ratnoff, 1968) and factor V in arterial 
endothelial cells, (Rodgers & Kane, 1986).
Elevated levels of plasma activated protein C and the ratio of activated protein 
C/protein C were found to be significantly higher in venous thromboembolism patients 

























































Figure 1.4.5 The Coagulation pathways
(modified from Tortora & Anagnostakos 1990)
Key:
Hey - homocysteine; I - XIII - blood factors;
la - Xllla - activated blood factors; Ca2+ - calcium.
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28.8±19.5um.dm-3; VTE-NormalHcy 12.0±5.2um.dnr3 & control 11.0±5.3um.dm-3 of 
homocysteine. Cattaneo et al., 1998). Yet, there was no correlation between fasting 
plasma levels of activated protein C and the ratio of activated protein C/protein C with 
total homocyst(e)ine. Homocysteine has been shown to down-regulate protein C 
activation, (Rodgers & Conn, 1990). In my opinion this shows that plasma total 
homocysteine is not the only factor that affects activation of protein C
Olszewski & McCully, (1993) suggests that lipoprotein (a) is synthesized in the 
liver by the action of homocysteine on low density lipoprotein (LDL) and the formation 
of homocysteinyl low density lipoprotein which forms disulphide bridges with 
apolipoprotein (a) (apo(a)) (high concentrations) to form lipoprotein (a) [LDL- 
NHCOCH(NH2 )CH2CH2 SS-apo(a)]. Harpel et al., (1992) found that homocysteine
concentrations as low as Sumol.dnr3 significantly increases the affinity of lipoprotein (a) 
for fibrin.
1.4.6 Fibrinolysis
The fibrinolytic system (Figure 1.4.6), digests the clot and there is normally a 
balance between the fibrinolytic and coagulating systems. The effect of homocysteine 
upon tissue-plasminogen activator is equivocal. Bienvenu et al. (1993), found that 
plasma total homocysteine concentrations were significantly correlated to tissue- 
plasminogen activator concentrations in vivo (p<0.001) in patients with deep-venous or 
arterial thrombosis, whereas Kottke-Merchant et al. (1990) found that homocysteine or 
homocysteine thiolactone, had no effect on tissue-plasminogen activator production in 
vitro.
1.4.7 Venous thromboemholism
Venous thromboembolism appears to account for 50% of vascular complications 
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(modified from Verstraete & Vermylen 1984)
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Although, there appears to be no relationship between mean homocysteine and 
thromboembolism, at least twice as many patients compared to controls have 
hyperhomocysteinemia (Table 1.4.7). The variability illustrates the multifactorial nature 
of the disease, but also the non standardization of hyperhomocysteinemia.
1.5 Homocysteine and its interaction with cardiovascular risk factors 
1.5.1 Cholesterol
A review by Boushey et al. (1995), concluded that every 5umol.dnr3 increase in 
plasma total homocysteine, conferred the same increase in risk for coronary artery 
disease as O.Smmol.dnr3 (19 mg.dL- 1 ) increase in total cholesterol.
Elevated levels of cholesterol, low density lipoprotein and homocysteine with 
decreased levels of high density lipoprotein, folate and vitamin B 12 are associated with
increased risk of coronary atherosclerosis, cerebrovascular disease, peripheral vascular 
disease and thrombosis, (Ueland & Refsum, 1989; Boers et al., 1985). A study by 
Olszewski et al. (1989), found a correlation between plasma homocysteine and serum 
total cholesterol in 52 males aged 30 to 60 years old. They obtained a reduction in plasma 
homocysteine and serum total cholesterol levels when treating the patients with vitamins 
B6 , folate, B 12 , B2 , choline and troxerutin.
Zulli et al. (1998), found a synergistic effect of homocysteine and cholesterol 
feeding upon the plasma total homocysteine, serum total cholesterol and triacylglycerol 
levels. When 4mmol.dnr3 (over 200 times the mild hyperhomocysteinemic level) was 
used to incubate human hepatoma cell line HepG2, there were significant increases in the 
production and secretion of cholesterol and the secretion of apolipoprotein B-100. 
Intracellular 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity 
was also increased, (Karmin et al., 1998). Thus implying that apart from a poor diet for
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Authors Thrombosis Age 
type
Brattstrom Venous <50 
etal., (1991)
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Bienvenu Venous + <58 
etal., (1993) arterial
Fasting 13.8±6.0 (50) 8.1±2.2 (49) 36
Falcon Juvenile 
etal., (1994) venous
<40 Fasting 7.4±5.5 (80) 7.9±2.1 (51) 8.8 
PML(A)* 10.3±5.1 (79) 8.3±3.4 (40) 18.8
13.2(2.82, 83.0)







































































Table 1.4.7 Relationship between plasma homocysteine and thrombosis
(Selhub & D'Angelo, 1997)
Key:
# males only;
## males & females;
(A)* net increase in homocysteine after methionine load, ie fasting levels substracted from total;
(T)* 
(T)
total plasma homocysteine level after methionine load (fasting homocysteine level was not subtracted), 




N/A data not available
OR odds ratio
CI confidence interval
PML post methionine load
F fasting
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the association between elevated plasma total homocysteine levels and serum total 
cholesterol, it could be that homocysteine increased the activity of hepatic intracellular 
HMG-CoA reductase and thus the synthesis of cholesterol.
1.5.2 Triacylglycerol
A study of peripheral arterial occlusive disease patients reported a significantly 
higher mean concentration of homocysteine than the control subjects. The patients also 
had significantly lower levels of high density lipoprotein cholesterol (HDLC), and the
subgroup HDL3 c and the apolipoprotein A-1 whereas their triacylglycerol was elevated, 
(Rassouletal.,2000).
1.5.3 Low Density Lipoprotein
Homocysteine binds to lipoproteins: low density lipoprotein, very low density 
lipoproteins and high density lipoprotein by peptide bonds (Olszewski & McCully, 
1991). The 'free' amino groups of apolipoprotein B in low density lipoprotein are 
thiolated by homocysteine thiolactone (Vidal et al., 1986). This causes aggregation and 
increased uptake of low density lipoprotein by macrophages (Naruszewicz et al., 1994), 
and the formation of foam cells.
The highest concentration of thiolated proteins was present in the low density 
lipoprotein fraction and 4.1 times higher in hypercholesterolaemic to normolipaemic 
group. The atherogenic index for homocysteine, low density lipoproteinhomocysteine/high
density lipoproteinhomocysteine is 3.5 times higher in the hypercholesterolaemic than the 
normolipaemic group, (Olszewski & McCully, 1991).
Lipid peroxidation reduces membrane fluidity, permeability and excitability, 
(Vladimirov 1987, Poli et al., 1987). Low levels of homocysteine can oxidize low density 
lipoprotein in the presence of copper(II) ions, (6 and 25 umol.dnr3 ) and act as an
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antioxidant in high concentrations as found in homocystinuria patients (100, 250 and 500 
umol.dnr3 ), (Halvorsen et al., 1996). This implies that with the exception of 
homocystinuria patients, normal homocysteine levels are in the range that would produce 
oxidized low density lipoprotein in the presence of transition metals.
Raal et al. (1999), have shown using multivariate analysis, that for familial 
hypercholesterolemia subjects, homocysteine was not a predictive factor for carotid 
intima media thickness but low density lipoprotein cholesterol and cholesterol-years 
(appendix 1) score are.
1.5.4 Lipoprotein(a)
Olszewski and McCully (1993), state that thiolation of low density lipoprotein 
results in the formation of a peptide bond between the N-terminal end of apolipoprotein 
B-100. The sulphydryl group of the bonded homocysteine is free to form a disulphide 
bond with apolipoprotein (a). The apolipoprotein (a) molecule bonded this way, could 
explain how some low density lipoprotein appears to have two apolipoprotein (a) 
molecules per apolipoprotein B-100.
1.5.5 Radicals
Radicals are unstable, hydrogen peroxide formed in the mitochondria could 
oxidize homocysteine forming disulphides with membrane bound proteins, thereby 
altering their function. The sulphydryl group of homocysteine acts catalytically with 
Iron(III) and Copper(II) ions in a mixed function oxidation system to generate hydrogen 
peroxide, oxygen radicals and homocysteinyl radicals within cultured endothelial cells, 
(Starkebaum & Harlan, 1986). Two to five percent of the oxygen consumed might be 
reduced to the superoxide anion radical (Boveris and Chance 1973). The superoxide 
radical in the presence of the copper(II) ion modified low density lipoprotein which was 
taken up more readily by mouse peritoneal macrophages and degraded, than native low
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density lipoproteins, (Heinecke et al., 1987).
1.5.6 Blood Pressure
Plasma total homocysteine is positively related to blood pressure, (Nygard et al., 
1995).
1.5.7 Smoking
Plasma total homocysteine is also positively related to the number of cigarettes 
smoked daily, (Nygard et al., 1995). Targher et al. (2000), showed that plasma total 
homocysteine was significantly elevated in type 1 diabetic patients compared to 
nondiabetic subjects and that diabetic smokers had significantly elevated plasma total 
homocysteine verses nonsmokers. This could be due to their diet and lifestyle.
1.5.8 Psychosocial Factors
Stoney (1999), gave pre and postmenopausal women some psychological 
stressors (mental arithmetic and speech stressors) and measured plasma total 
homocysteine. She found that the plasma total homocysteine had significantly increased 
by the end of the ten minute acute psychological stress similarly in both groups, but 
only by 0.4 umol.dnr3 , (p = 0.002). She found no effects of menopausal status or 
endogenous oestrogens on plasma total homocysteine. As there was an associated 
increase in heart rate and blood pressure, she suggests that the elevation of homocysteine 
could have been mediated sympathetically. So does the sympathetically generated influx 
of sodium ions, cause an egress of homocysteine as the sodium ions are returned 
extracellularly from smooth muscle cells? (ASC transport system - section 1.3.2), If 
this change in homocysteine is an actual change then it calls into question all the papers 
on homocysteine. If there was an elevation in homocysteine, was this due to the actual 
or perceived stress or was it the patients' actual baseline? This is not to deny the effects
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of homocysteine upon endothelial cells, myocytes, lipids or nitrogen(II)oxide, what it 
implies is maybe that homocysteine is not continually high in the plasma, but fluctuates 
depending upon the persons' ability to deal with stress. This suggests that there are two 
groups of people:
A - those with temporarily elevated level, because they were under a stressful
situation, eg exercise. 
• B - those with high plasma total homocysteine levels due to genetic mutation
and/or vitamin deficiency.
1.6 The Effect of Diet
The British Heart Foundation (2000e) estimates that about 30% of deaths from 
coronary heart disease are due to unhealthy diets. The socioeconomic difference is quite 
marked in the consumption of fresh fruit and vegetables. The volume of leafy salads and 
fruit juice consumed is three times as great in the richest 10% of households compared to 
the poorest. Five percent of coronary heart disease is estimated to be due to obesity 
(Body Mass Index greater than 30 kg.nr2 ).
The serum levels of several vitamins have been shown to effect the level of 
homocysteine (Woodside et al, 1998; Selhub et al., 1993). Both folate and B 12 are
required in the conversion of homocysteine to methionine and B6 in the conversion of
homocysteine to cysteine. Vitamin A in the conversion of homocysteine thiolactone to 
thioretinamide and ascorbic acid in the conversion of thioretinamide to sulphate(IV). 
Mildly elevated homocysteine can be caused by deficiencies in folic acid and/or vitamin 
B 12 and/or vitamin B6 .
Malinow et al. (1997), found a negative correlation between total homocysteine 
and basal levels of folate, pyridoxal-5 '-phosphate(V) (a form of vitamin B6 ) and vitamin
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B 12 . Total homocysteine increases post puberty and is inversely related to parental 
educational level. It is also inversely related to intakes of folate, vitamin C, fruits and 
vegetables, a similar finding was found for serum folate and vitamin B 12 .
The European Concerted Action Project study, found that red blood cell folate 
concentration below the lowest tenth percentile (<513nmol.dnr3 ), and vitamin B 6
concentrations below the twentieth percentile (<23.3nmol.dnr3 ) for control subjects 
were associated with increased risk of cardiovascular disease, which was independent of 
conventional risk factors. The risk factor for folate could be partially explained by 
increased homocysteine, whereas B6 and the atherosclerosis relationship were
independent of the homocysteine level, (Robinson et al., 1998). Vitamin B6 deficiency
would effect not just the trans-sulphuration of homocysteine, but it would also effect 
niacin production. Niacin is essential for almost all neurotransmitter synthesis or 
metabolism and in the synthesis of many hormones, such as insulin and growth hormone. 
A shortage of niacin can effect the circulation by increasing blood pressure and 
cholesterol.
Graham et al. (1997), found that patients using vitamin preparations (folate, 
vitamins B 12 & B6) experienced protection from vascular disease with a relative risk of
0.38 (95% CI, 0.2-0.72) compared with the non users of vitamin supplements. 
However, they stated that it was a small sample group and that the vitamin users may 
have been more health conscious than the non users. A reduction in homocysteine 
occurred when patients on haemodialysis took a standard multivitamin supplement 
containing B vitamins and Img of folate, (House & Donnelly, 1999).
A meta-analysis of the trials of vitamins (folate, B 12 & B6 ) upon plasma total 
homocysteine concentrations (Homocysteine Lowering Trialist's Collaboration, 1998) 
concluded that supplementation of folate reduced plasma total homocysteine 
concentrations, which was particularly noticeable in the highest quintile of homocysteine
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(>18.5^mol.dnr3 ) and the lowest quintile of serum folate (<6.9nmol.dnr3 ). According to 
Clarke & Armitage (2000), there are a number of large-scale clinical trials that are ongoing 
or planned around the world. They are designed to answer the question of the 
importance of the vitamins separately or together upon the cardiovascular risk factors.
Verhoef et al. (1996) found a negative correlation between plasma total 
homocysteine and plasma folate and also vitamin B 12 . Whereas, Quinlivan et al., (2002)
found that the correlation between plasma total homocysteine and a high folate intake 
was poor, but the vitamin B 12 showed a greater negative correlation.
1.6.1 Folate
One-carbon tetrahydropteroylglutamate (folates) are involved in many 
biochemical pathways that are necessary for growth, development and the homeostasis 
of humans. Unfortunately, humans are unable to synthesize folates de novo. A 
deficiency of this vitamin is associated with neural tube defects and cardiovascular 
disease whereas folate supplementation could affect zinc absorption. Iron deficiency can 
mask folate deficiency.
The folate stays in the red blood cell throughout the cells life of between 100 and 
120 days, (Berlin et al., 1959). Red blood cell folate could be a reliable indicator of 
folate intake over time. Smoothing the troughs and peaks that could have occurred, as 
people tend not to eat the same foods every day, but on weekly and seasonal cycles.
Jacob et al. (1994), found that in ten healthy adult men, their plasma total 
homocysteine levels rose during folate depletion. In fact the response of homocysteine 
to changes in folate intake varied among individuals from very strong to absent. This 
illustrates people's genetic differences, which is their differences in folate-binding 
proteins in the enterocyte membranes, serum and their other tissues.
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Folate deficiency can occur because of:
a) decreased dietary intake - alcoholics and the elderly who have inadequate or improper 
diets;
b) decreased intestinal absorption - as in coeliac disease or tropical sprue;
c) increased requirement - multiple pregnancies, lactation, haemolytic anaemia and in
leukaemia;
Exercise causes an increase in plasma adrenaline (Kjaer & Dela 1996), which was
synthesised from the methylation of noradrenaline. Running increases plasma total
homocysteine (WeiB et al 1999, refer to section 1.7.3). Is there, therefore an increased
need for folate?
d) effects of drugs - eg diphenylhydantoin (used in its sodium salt form, in the treatment 
of grand mal epilepsy);
e) alcoholism - chronic exposure to ethanol decreases folate transport into enterocytes, 
reduces hepatic uptake and increases the excretion of folic acid by the kidney, (as 
mentioned in a review by Halsted, 1990).
The United Kingdom set its reference nutrient intake at 200ug.dy 1 which is two 
standard deviations above estimated average requirement, (ISOug.dy 1 ).
Brattstrom et al. (1988b), found that enhanced folate intake reduced plasma total 
homocysteine concentration, since which, many other groups have also found that folate 
supplementation reduces plasma total homocysteine concentration (Riddell et al., 2000; 
Jacques et al., 1999; den Heijer et al., 1998; Malinow et al., 1997, 1998; Shimakawa et al., 
1997; Ward et al., 1997; Landgren et al., 1995). Lewis et al. (1992), reported that 
subjects with a plasma folate >15nmol.dnr3 had a low, plateau homocysteine level.
Malinow et al. (1998), fortified breakfast cereals with the recommended dietary 
allowances of vitamins B 6 (1.8±0.1mg per 30g of cereal) and B 12 (6.1±0.3mg per 30g of 
cereal) and altered the level of folic acid. Seventy-five men and women with coronary 
artery disease ate breakfast cereals containing either zero (placebo), 127±11, 499±6, or
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665±48ng of folic acid per 30g of cereal which approximately produced daily folic acid 
intakes of either HO-HOug.day 1 , three times the recommended dietary allowance and 
four times the recommended dietary allowance respectively. After taking the folate 
supplement their plasma folate increased by 30.8%, 64.8% and 105.7% respectively, and 
their plasma total homocysteine levels decreased by 3.7%, 11.0% and 14.0% 
respectively. Omenn et al. (1998), in their editorial stated that a supplement containing 
400ug of folic acid would be expected to produce on average a total homocysteine 
reduction of Sumol.dnr3 in non-supplement users and the serum folate should reach > 
15nmol.dnr3 , which was based on Boushey et al. (1995). Yet they recommend that 
folate should never be given on its own, but with vitamin B 12 , because it could mask
anaemia. So they recommend 200-lOOOug of cobalamin (B 12) with the 400|j.g of folic
acid supplement daily. The United States of America have now legalized the 
supplementation of certain foods with folate. Yet oral folate supplementation may 
reduce zinc absorption (Simmer et al., 1987).
The homocysteine lowering trialists' collaboration (1998), used meta-analysis on 
12 trials (1114 people) and found that for Western populations, supplementation with 
folic acid of at least O.Smg.day" 1 and vitamin B 12 about O.Smg.day" 1 would reduce blood
homocysteine by about a quarter to a third, but they did not take into account variants in 
enzyme genotypes. Ward et al. (1997), tested 30 men aged between 34 and 65 (mean 45) 
years and divided them into three groups, based on their baseline total homocysteine 
level, (10.9±0.83; 9.11±0.49; 7.07±0.84). They were given 100, 200 and 400^^^ of 
folic acid during the intervention period. Even though all tertiles showed reduced total 
homocysteine and increased serum folate levels, 400ug.day 1 did not produce a 
significant reduction in total homocysteine from that produced by 200ug.day 1 and only 
in those subjects that were in the top two tertiles. Thus, implying a threshold of plasma 
homocysteine in its ability to respond to folic acid. This variable response to folate 
intake as previously stated is most likely related to the folate binding proteins and 
therefore there is a genetical feature. Work by Mitchell et al. (1997), using twins found 
that 46% variance in red blood cell folate was attributed to additive genetic effects.
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A study where hyperhomocysteinemic subjects were given folic acid for one year 
showed a decline in plasma total homocysteine concentrations and an improvement in 
flow-mediated dilation (Woo et al., 2002). Yet to just reduce the plasma total 
homocysteine levels and not the cholesterol levels as well appears not to reduce the 
cardiovascular risk. The effect of feeding an atherogenic diet for seventeen months with 
or without vitamin supplements (folic acid and vitamins B12 and 6) to 16 cynomolgus 
monkeys (Macaco fascicularis} with hypercholesterolaemia, showed that vitamin 
supplementation reduced the plasma homocysteine levels, but failed to prevent Tunica 
intimal thickening in the carotid or iliac arteries (Lentz et al., 2001). This could be 
interpreted that once the damage as occurred, initiated by hyperhomocysteine, to remove 
that risk, but leave hypercholesterolaemia, still poses a risk, but reduces the rate of 
progression. As the elevated cholesterol levels are associated with elevated low density 
lipoproteins which can become oxidised and form plaques.
Landgren et al. (1995), found that plasma Homocysteine levels post acute 
myocardial infarction increased over a period of six weeks from 13.1±4.6 to 14.8±4.8 
umol.dnr3 (p=0.001). Folate was then administered for a further six weeks and this 
produced a decrease of 4.4umol.dnr3 in the homocysteine level.
1.6.1! Glutamine-Glutamate Cycle
Glutamate is important in the rate of reaction of folates and in preventing the 
cellular egress of N5 -methyltetrahydrofolate. Folate is only kept within the cell if 
bonded to at least three molecules of glutamate. Glutamate taken up by muscle is 
transported by System-X'ac, which in rats has a high affinity, low capacity and is
sodium-independent, but H+-dependent. It maintains a concentration gradient greater 
than 50-fold between muscle and blood, (Bergstrom et al., 1985).
Rohde et al. (1996), found that two hours after a long course triathlon (2.5km 
swim, 81km cycle and 19km run), the athletes had a significant decrease of nearly 50% in
62
plasma glutamine concentration. Lehmann et al. (1995), found that after the 1993 
Colmar ultra-triathlon that lasted over 23 hours, serum glutamine concentration was 
unchanged, even though there was a significant 18% decrease in total ammo acid levels. 
Neither paper appeared to consider any plasma volume shift that would have occurred 
due to sweating. So the variation in the effect of exercise duration, and intensity upon 
plasma glutamine concentration could be due at least partly by plasma volume shift. Yet 
if exercise causes a decrease in plasma glutamine concentration, this could cause a loss of 
glutamine from the cells and consequently might cause a loss of folate, which would 
result in an increase in cellular homocysteine and then its equilibration by egression to the 
plasma.
1.6.2 Vitamin B12
Vitamin B 12 is water soluble and found in liver, beef, pork, eggs milk, cheese and
kidney, it is not recommended to be taken with alcohol because alcohol is believed to 
interact with the ileal B ̂ -intrinsic factor receptor (Halsted & Mclntyre, 1972).
Changes in the oxidation state of the central cobalt ion affect the strength of the 
sigma bond between the cobalt and the R-group. The principle R groups are 5'- 
deoxyadenosyl (5'-deoxyadenosylcobalmin), -CH 3 (methylcobalamin) and -OH
(hydroxocobalamin; Scott 2000). Methylcobalamin is the vitamin B 12 coenzyme for
methionine synthetase (homocysteine —> methionine), whereas 5'- 
deoxyadenosylcobalamin is the coenzyme for the mitochondrial methylmalonyl-CoA 
mutase, (methylmalonyl CoA —> succinyl-CoA).
Methylcob(III)alamin enzyme reacts with 5-methyltetrahydrofolate and 
homocysteine, the ternary complex forms cob(I)alamin enzyme. It then releases 
methionine and tetrahydrofolate reforming methylcob(III)alamin, (Banerjee et al., 1990). 
Occasionally the cob(I)alamin enzyme is oxidized to the inactive form cob(II)alamin
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which is then reduced by flavodoxin and methylated by S-Adenosylmethionine (refer to 
Figures 1.3.1), thus S-Adenosylmethionine acts as cosubstrate.
Approximately 70% of the dietary vitamin B 12 (physiological levels) is absorbed, 
but decreases to less than 10% at levels five times greater than the recommended dietary 
allowance (Herbert, 1987). Cooper & Rosenblatt (1987), demonstrated that at least 95% 
of vitamin B 12 was bound to either cytoplasmic methionine synthase or to mitochondrial
methylmalonyl-CoA mutase. The body pool of B 12 is 2 to 3mg, of which 80% is in the 
liver and daily excretion was 1.2 to 1.3ng (Hall, 1964). The United Kingdom reference 
nutrient intake for vitamin B 12 l.Sug.day" 1 for males and females 15 to 50 + years.
Vegans should take 2-3 ug. day" 1 vitamin B 12 and elderly people should take 10-25
ug.day 1 because of their impaired gut absorption preferably with calcium and iron 
which assist the absorption of this vitamin.
Heavy protein consumers may also require more vitamin B 12 , because it works
synergistically with almost all B vitamins, A, E and C vitamins. Smoking also affects 
vitamin B 12 metabolism, (Flickinger et al., 1987).
Young (1996), found that sheep fed a cobalt deficient diet for twenty-eight weeks 
had elevated plasma homocysteine, increased hepatic triacylglycerol and free fatty acid 
concentrations.
Herzlich et al. (1996), reported a significant association between B 12 < 221 
pmol.dnr3 and Homocysteine > 16 nmol.dnv3 and low left ventricular ejection fraction.
1.6.3 Vitamin B6
Vitamin B6 is a group of substances that are water soluble and excreted within 
eight hours of ingestion. They are found in the following types of food; wheat bran and
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germ, liver, kidney, heart, beef, pork, poultry, walnuts and banana. Yet only 60-80% of 
the dietary vitamin is absorbed in comparison to the pure form, (Tarr et al., 1981). 
Pregnant and lactating women, body builders and other people on high protein diets 
require higher levels of vitamin B 6 . The recommended daily adult intake is 1.6 to 2.0mg.
Doses greater than 50mg can affect sensory nerve function, (Schaumburg et al., 1983). 
Normal plasma pyridoxal-5'-phosphate(V), levels are 5 to 23ng.cnr3 (McCormick, 
1988). Vitamin B 6 , ten times or one hundred times the recommend dose fed to female
rats, has been shown to affect concentrations of glutamate, taurine, methionine and the 
sum of the essential amino acids in the caudate nucleus, increase serum serine 
concentration and increase both the antagonist binding affinity and the maximal number 
of binding sites for cortical serotonin, (Schaeffer et al., 1998). As serotonin, has been 
implicated in central fatigue, an increase in number and affinity of receptors could 
initially increase the severity of the response and could be implicated in chronic fatigue 
syndrome.
The active form of vitamin B 6 is pyridoxal-5'-phosphate( V) and is a coenzyme
for numerous reactions related to protein and glycogen metabolism, and sphingolipid 
synthesis in the nervous system (McCormick, 1988). Tryptophan can be converted to 
niacin (vitamin B 3 ) with the assistance of vitamin B6 . Vitamin B6 is also required for
haem, antibody synthesis and for proper absorption of vitamin B 12 . Pyrodoxal-5'-
phosphate(V)-dependent decarboxylation such as L-aromatic amino acid decarboxylase is 
involved in the synthesis of Dopamine from L-DOPA and adrenaline, and also 5- 
hydroxytryptamine from 5-hydroxytryptophan.
Pyridoxal-5'-phosphate(V) in the liver is bound to its apoenzymes, in red blood 
cells bound to haemoglobin, and circulates in the blood bound to serum albumin.
An association between vitamin B6 deficiency and the accelerated development of 
atherosclerosis was first shown by McCully in 1969. Pyridoxine is the vitamin B 6 form
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that is the cofactor for cystathionine |3-synthase and cystathionine Y-tyase. One 
homocystinuric patient has been shown to have no active cystathionine p-synthase due 
to a mutant form missing about sixty amino acid residues (Mr 56,000 daltons), (Skovby 
et al., 1984a). The cystathionine p-synthase gene is located on chromosome 21, (Skovby 
et al., 1984b). In rats, the polypeptide translational (Mr 63,000 daltons) undergoes a 
slow post-translational proteolysis to produce the active form (Mr 48,000 daltons), 
(Skovby etal., 1984c).
Wilcken & Wilcken (1997), found that patients deficient in cystathionine P- 
synthase treated with pyridoxine, folic acid and hydroxocobalamin maintained on average 
plasma total homocysteine levels <20umol.dnr3 . Non-pyridoxine-responsive patients 
were additionally given betaine and their plasma total homocysteine levels were 
33±17umol.dnr3 . During the treatment period there were fewer mortalities.
Homocysteine levels were higher in cardiovascular disease patients who smoked 
than in those who did not, and in non-cardiovascular disease adults who smoked or did 
not smoke. It was also discovered that smokers had lower levels of vitamin B6 ,
(Bergmark et al., 1993). 50 - 80% of chronic alcoholics have low serum levels of 
pyridoxal-5'-phosphate(V) (Halsted & Heise, 1987) caused by poor diet, decreased 
release of the vitamin from binding proteins in food, and increased degradation and 
excretion of the vitamin.
Pyridoxine supplementation does not affect fasting plasma total homocysteine 
because under fasting conditions methionine and transmethylation are still required so 
homocysteine-methionine pathway is favoured. Yet it lowers the post-methionine load 
total homocysteine peak because methionine loading favours the trans-sulphuration 
pathway and thus the vitamin B 6 dependent enzymes (cystathionine p-synthase & 
cystathionine y-Lyase), (Ubbink et al., 1996). Bostom et al. (1995), found that in the 
Caucasian population, a 'normal' fasting plasma total homocysteine is not synonymous
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with a 'normal' methionine load test whereas in the 'black' community the total 
homocysteine peak post methionine load test is significantly lower despite the lower 
vitamin B 6 status, (Ubbink et al., 1995). Ubbink (1997), suggested that a possible
explanation for the racial difference could be due to genetic difference in the cystathionine 
fj-synthase, that is the black people tend to have cystathionine p-synthase with higher 
affinity for pyridoxal-5'-phosphate(V).
1.6.4 Vitamin B2
Vitamin B 2 (riboflavin) is phosphorylated to form flavin mononucleotide, or via
condensation with adenosine diphosphate(V) to form flavin adenine dinucleotide. Both 
flavin mononucleotide and flavin dinucleotide are involved in the production of adenosine 
triphosphate(V) from glucose. Flavin dinucleotide also acts as co-factors for other 
enzyme complexes.
There are a number of places in the biochemistry of the methylation of 
Homocysteine that require the reduced form of flavin dinucleotide. Sometimes the 
methionine synthase is deactivated, that is the cobalt ion in the cobalamin enzyme 
complex is only oxidized to di- rather than trivalency. It then uses the reduced form of 
flavin dinucleotide and S-Adenosylmethionine to produce a methylcob(III)alamin 
enzyme complex, (refer to Figure 1.3.1).
1.6.5 Vitamin C
Herbert (1993) in his review of mega vitamin doses (>500mg.day-l) stated that 
oral vitamin C releases iron from body stores, causing a sharp increase in serum iron level 
which has been associated with increased risk of heart attack. It also increased absorption 
of iron. Iron oxidizes vitamin C, preventing it acting as an antioxidant. Olson and Hodges 
(1987), recommended against large daily intakes of vitamin C ingested routinely over 
several months or years because it had been found to lower plasma vitamin B 12 . There is
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a fine intracellular balance between the reactive oxygen species and the antioxidants, 
which is influenced by dietary intake of vitamins like vitamin C.
Scorbutic cartilage had decreased synthesis of chondroitin sulphate(VI), (Reddi & 
Norstrom, 1954). McCully (1971), found similar derivatives for 14C-Homocysteine 
thiolactone as for 35 S-Homocysteine thiolactone in normal guinea-pig liver. They were 
converted to homocysteic acid and homocysteine sulphinic acid, whereas in scorbutic 
livers homocysteine accumulated and the derivatives were diminished. This implied that 
some homocysteine was converted to thiolactone and was used in the production of 
chondroitin sulphate(VI) as long as vitamin C was present, (refer to Figures 1.3.3 and 
1.3.1). Whereas the studies of Bonham et al. (1998), and Chambers et al. (1999), 
showed that the homocysteine concentration was not affected by the addition of vitamin 
C.
1.7 Physical Exercise
According to Shepherd (1999), exercise is the voluntary performance of physical 
activity to improve fitness, physical performance or health. This can take the form of an 
acute or chronic response. An acute response is taken as a single bout of physical 
activity whereas a chronic response, consists of repeated bouts of physical activity 
(Shepherd, 1999).
Exercise stimulates the chromaffin system to release adrenaline, (Kjaer & Dela, 
1996). Adrenaline reacts with p2-adrenoceptors on smooth muscle and bronchial cells to 
cause dilation. This is achieved via cyclic adenosine monophosphate(V) which opens 
calcium ion channels and allows calcium influx. It is hypothetically possible that this 
localised alteration in ionic homeostasis is rebalanced using many membrane transport 
systems, one of which could be ASC system and the co-efflux of homocysteine and 
sodium ions. The intensity, duration and history of physical activity, appear to affect
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the hormonal response. Trained athletes tend to have a lower hormonal response to a 
given absolute work load as compared to untrained subjects (Kjaer et al., 1988), but a 
higher response at similar work loads, (Kjaer, 1989).
Endurance trained individuals (80 - 115 km.wk' 1 ) have enhanced muscle capacity 
to metabolise fat, (Costill et al., 1979), which could be explained by increased 
sympathetic activity. Depending upon the type of training, they may have improved 
lactate tolerance and caused hypertrophy in specific subclasses of muscle fibres. In 
addition reduced resting heart rate, a strengthening of the respiratory muscles, and 
increased minute ventilation rate have been reported (Booth & Thomason, 1991).
1.7.1 Exercise and Cardiovascular Disease
According to Drygas et al. (2000), the greatest benefit from exercise upon 
cardiovascular risk factors occurs in those subjects that exercised most (>8.3MJ per 
week using the approximate metabolic costs of leisure time sports activities). A group of 
men aged 28 to 65 years were divided into four groups according to the amount of 
exercise they undertook per week over a two to nine year period. When the high exercise 
group were compared to the sedentary group, it was discovered that they had a lower 
risk of cardiovascular disease (refer to Table 1.7.1).
1.7.2 Lipid profile and exercise
Exercise increases the rate of lipolysis in adipose tissue, (Wolfe et al., 1990). 
Thirty minutes cycling was shown to produce a 35 -50% increase in glycerol in 
catecholamine-stimulated isolated (pre & post exercise) gluteal cells, (Wahrenberg et al., 
1987 & 1991). It has been shown that trained individuals preferentially utilize fat during 
endurance exercise compared to sedentary individuals, (Costill et al., 1979). Lipoprotein 
lipase increases in response to exercise and most of the elevation occurs within the first 
week of training.
69



















Table 1.7.1 Comparison between the highest exercise group (>8.3MJ per week) 
and the sedentary group. (Dygas et al., 2000)
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Hurley et al. (1984), found that steroid-free strength-trained athletes 
(bodybuilders) matched for age and body fat against runners and untrained controls had 
lipoprotein-lipid profiles significantly higher than runners. Lipson et al. (1980), found 
that when body mass was kept constant, exercise produced no significant change in 
plasma triacylglycerol, very low density lipoprotein cholesterol, low density lipoprotein 
cholesterol or high density lipoprotein cholesterol levels. High density lipoprotein two 
increased and there was no significant change in high density lipoprotein three or in their 
composition (proteins, phospholipids, cholesterol and triacylglycerol).
1.7.21 Total Cholesterol
Rimmer & Looney (1997), found that an aerobic exercise programme practised 
four times a week for fifteen weeks produced a reduction in the total cholesterol levels 
and no change in high density lipoprotein levels in adolescents (14-17 years old). Yet, in 
a review by Durstine and Haskell (1994), stated that when gender, dietary intake, plasma 
volume changes and body mass were allowed for, the physically active individuals did 
not have a significantly lower plasma cholesterol concentration than inactive individuals.
1.7.2ii Triacylglycerol
Haskell (1984), reported that exercise had little or no influence upon the plasma 
total cholesterol levels, whereas it did reduce triacylglycerol levels, when age, adiposity 
and pre-training cholesterol levels were allowed for. The reduction in triacylglycerol 
levels appeared to have both acute and chronic components and was not evident when 
pre-training levels were low. Lower levels of triacylglycerol were found in active middle- 
aged men, (Wood et al., 1976), elite marathon runners (Martin et al., 1977) and men and 
women runners (Wood et al., 1977).
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1.7.2iii High Density Lipoprotein
Factors that affect high density lipoprotein concentrations are age, length and 
intensity of exercise, maximal oxygen uptake, body mass and the percentage of body fat. 
Active individuals had high density lipoprotein concentrations higher than sedentary 
individuals mean difference ISumol.dnr3 (0.5mg.dH), whereas endurance trained 
individuals had even higher differences of high density lipoprotein, mean differences 31- 
52umol.dnr3 (1.2 - 2.0mg.dH) (Haskell et al., 1980). Wood et al. (1983), found that 
runners who ran less than 12.9km per week produced no effect upon their high density 
lipoprotein concentration, whereas Williams et al. (1982), found no effect upon high 
density lipoprotein concentration for those who ran less than 16km per week. It appears 
that as long as the exercise is above a threshold level and maintained for at least nine 
months then the subject changes high density lipoprotein cholesterol and low density 
lipoprotein cholesterol. When a subject exercises above the weekly threshold there is a 
decrease in total cholesterol and triacylglycerol, and increased levels of high density 
lipoprotein which cause increases in lipoprotein lipase. Yet, when the subject ceases to 
exercise above the threshold level the benefits are lost completely. Kokkinos et al. 
(1995), showed a dose-response relationship between the miles run per week and high 
density lipoprotein cholesterol levels with a significant difference to the non-exercise 
group at seven miles or more per week (>11.2km. wk' 1 ).
A study of middle age males who took up running for two years showed an 
increase in high density lipoprotein cholesterol and a decrease in low density lipoprotein 
cholesterol. In addition the percentage of body fat decreased and the caloric intake 
(mainly as carbohydrate) increased, (Wood et al., 1985).
1.7.2iv Low Density Lipoprotein
DuFaux et al. (1982), identified twenty-two studies that showed that endurance- 
trained people had lower levels of low density lipoprotein in comparison to sedentary
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people. A review of the short term effects of exercise upon low density lipoproteins 
found no significant difference in twelve, significant decreases in seven and significant 
increases in three studies, over a range of exercises and intensities, (Pronk 1993).
1.7.2v Very Low Density Lipoprotein
Gyntelberg et al. (1977), found that people with type IV hyperlipoproteinemia, 
who had spent 30 minutes of treadmill walking daily for four days showed decreased 
very low density lipoprotein concentration.
1.7.2vi Apolipoprotein A
Apolipoprotein A-I levels was 32% higher in athletes than in age-matched 
controls, but there was no difference for apolipoprotein A-II levels, (Lehtonen et al., 
1979; Thompson et al., 1983; Wood & Haskell, 1979).
1.7.2vii Free Fatty Acid (non esterified fatty acid)
Mild to moderate exercise increases fatty acid oxidation, which is obtained from 
the plasma free fatty acid pool. The initial uptake of free fatty acid from the plasma can 
be greater than that released from the adipocytes, so there is an initial drop in the plasma 
concentration. As the duration of the exercise continues the rate of free fatty acid 
released from adipose tissue outstrips muscle requirements so the concentration of 
plasma free fatty acid increases, (Saltin & Astrand, 1993).
1.7.3 Homocysteine and exercise
Nygard et al. (1995), found an inverse relationship between Homocysteine levels 
and physical activity levels. They used a very brief description for leisure time activity, 
namely: sedentary/no activity, level one; walking, cycling or other type of moderate
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physical activity for at least four hours a week, level two; exercise, gardening, or similar 
activity for at least four hours a week, level three and regular heavy training or 
competitive sport several times a week level four. They argued that their physical 
activity questionnaire was validated because they also found an inverse relationship 
between activity level and triacylglycerol levels. Durstine and Haskell (1994), in their 
review stated that the reduction in plasma triacylglycerol concentration was dependent 
upon the pre-training concentration and the volume of exercise completed during the 
training program.
If the exercise session was anaerobic, it could reduce the spontaneous conversion 
of homocysteine thiolactone back to homocysteine, if the intensity was sufficient to 
cause a reduction in the pH below 7.4 . At pH 7.0, 37°C and low ionic strength 
homocysteine thiolactone has a half-life of more than thirty hours. Prolonged existence 
of homocysteine thiolactone in an environment of relative high concentrations of 
homocysteine would most likely increase the concentration of homocysteine 
diketopiperazine polymer, (refer to Figure 1.3.3). Homocysteine diketopiperazine 
polymer can damage the intimal surface of artery walls (Dudman & Wilcken, 1982).
Weiss et al. (1998, 1999), found homocysteine levels corrected for plasma volume 
shift, had increased post acute aerobic exercise (2.5h. run). They reckoned that the 
increase, lasting over 24h was due to a loss of serum serine which would affect the trans- 
sulphuration of homocysteine and the methylation of tetrahydrofolate (refer to Figure 
1.3.1). This may not be the whole answer as the level of stress (cortisol) during the 
exercise would have increased and this impairs vitamin B6 absorption that would affect 
the trans-sulphuration of homocysteine long term, or increased egress due to stress (refer 
to section 1.4.8) or muscle fibre damage due to the stress of the run. De Cree et al. 
(2000), found a non significant increase in plasma total homocysteine concentration in 
seven male subjects (21.6±1.3years) after performing one hour of submaximal exercise on 
a cycle ergometer (10.89±2.05 and ll.21il.81nmol.dm-3 , pre and post respectively,
o
60% of their VO2 max ). They stated that the intra-assay coefficient of variation
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and inter-assay coefficient of variation (cvb) for the homocysteine assay were 2.0 and
7.0% respectively which gives a power of the test of 0.33 for a significant level of 0.05. 
So with increased numbers (36 subjects) there may have been a significant change. 
Wright et al. (1998), had twenty subjects in their acute exercise study (24-39 years old). 
They found a significant increase in plasma total homocysteine (11.5%) which was still 
elevated thirty minutes later. When the plasma total homocysteine levels were corrected 
for plasma albumin changes, the increase was non significant.
A comparison study between fourteen elite athletes and fourteen leisure time 
athletes, found that strength training for eight weeks (2-6 sessions per week of 45 - 60 
minutes each) produced no significant change in plasma total homocysteine. The elite 
athletes had significantly lower plasma total homocysteine level than the leisure time 
athletes. They believed it was due to addition of folate and vitamins B 6 and B 12 to their
diet, (GroBe-Scharmann et al., 1995).
The Heritage Family study found that females had lower levels of plasma total 
homocysteine levels than males (7.5 vs S.Sfxmol.dnr3 , p<0.001). Parents had higher 
levels than their children (8.7 vs 7.8^imol.dnr3 p<0.05). Subjects responded to the 
twenty-week endurance training programme with a significant 5.5% mean increase in 
plasma total homocysteine, (p = 0.0003; Lussier-Cacan et al., 1998).
These studies imply that exercise as a stressor causes a change in plasma total 
homocysteine. There appears to be a threshold over which the exercise stressor 
produces a significant increase in plasma total homocysteine. The threshold appears to 
be affected by the subject's diet.
1.8 Hypoxia
Hypoxia is a deficiency of oxygen at tissue level (Vander, Sherman, Luciano
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1994), that can occur naturally in the environment. At sea level assuming dry air, the 
inspired partial pressure of oxygen (P1O2 ) is 19.9kPa, at 1000m P]O2 17.6kPa and at
5500m P1O2 9.7kPa that is equivalent to the following percentages of oxygen at sea level
barometric pressure: 20.9%, 18.5% and 10.2% respectively, (Roach, 2000). Any 
physiological changes that occur at altitude, may not be due to the decline in partial 
pressure of oxygen, but to the decrease in temperature, atmospheric pressure or the 
increase in certain hormonal secretions due to increased physical stress. At 5500m, 
atmospheric pressure is 50% that of sea level and the induced hypoxia is called 
hypobaric hypoxia because of the reduction in atmospheric pressure.
Due to the constant partial pressure of the water vapour in the alveoli (P^ 6 
kPa), and the partial pressure of carbon dioxide CPCO2 5kPa), the alveoli oxygen partial
pressure is about 12kPa, which can be slightly raised by hyperventilation (greater loss of 
CO2 , PO2 15kPa). It can only really be increased by two ways, either by increasing the
ambient pressure (hyperbaric) or by increasing the inspired oxygen fraction (F ̂  > 0.21).
If the lungs are normal then there should be no decline in arterial oxygen tension during 
exercise (Harries, 1998).
Pick's law state that "the rate of transfer of a gas through a sheet of tissue is 
proportional to the tissue area and the difference in gas partial pressure between the two 
sides and inversely proportional to the tissue thickness", (Pick, 1855).
vgas «A.D. (Pi _p2)
Sol
Equation 1.8 Pick's Law
A - area of tissue through which diffusion occurs; D - diffusion constant, which is proportional to the 
solubility of the gas and inversely proportional to the square root of its relative molecular mass; P,-P2 - 
partial pressure difference either side of the tissue barrier; T - tissue thickness
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1.8.1 Hypoxia and Physiological Changes
Moderate hypoxia has been shown to have no effect upon endothelial cells or 
smooth muscle cells viability, proliferation and migration, (Wall et al., 1981). Yet 
hypoxia causes the release of hypoxia-inducible factor la and the accumulation of p53 
protein, (Graeber et al., 1994), via its stabilization (Won et al., 1998). Hypoxia-inducible 
factor-1 regulates elements of the endothelial layer, (Minchenko et al., 1994(a)). In vivo, 
hypoxia was a potent inducer of vascular endothelial growth factor expression in heart, 
brain, liver, kidney and muscle, (Minchenko et al., 1994(b), Levy et al., 1995). Hypoxia- 
inducible factor induces a number of genes that produce changes in enzymes, the vascular 
system and breathing, (refer to Figure 1.8.1). Hypoxia induces glycolytic enzymes and 
GLUT 1 genes, therefore hypoxic exercise would have a reduced effect upon lipid 
metabolism in comparison to normoxic exercise.
1.8.2 Hypoxia and Cardiovascular Disease
To the author's knowledge there is only one report of people suffering from 
cardiovascular disease at altitude, (Fisher, 1990). It looked exclusively at highlanders in 
Papua New Guinea (~4000m), and found cor pulmonale and valvular heart disease as the 
commonest heart diseases. They also had an increased ischaemic heart disease in relation 
to the other two studies in Papua New Guinea, but the numbers were very small (n=5). 
All the patients were male and under 45 years old, with sedentary lifestyles and a long 
history of smoking (n = 4).
1.8.3 Homocysteine and hypoxia
Deussen et al. (1989), found that for guinea-pigs 34% of the cardiac adenosine 
relaxation under normoxic conditions was supplied by the transmethylation pathway 
(SAM ->SAH + A), whereas under hypoxic conditions the adenosine was predominantly 
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Figure 1.8.1 Model of the HIF-1 Hypoxia Response Pathway








At reduced oxygen tension, oxygen leaves the haemoprotein oxygen sensor (S«Heme). 
The freed Haemoprotein triggers a protein phosphorylation signal cascade. This activates 
a hypothetical regulator (Factor X) which up regulates the expression of HIF-la and -IB 
subunits. The heterodimer then activates a number of genes.
- hypoxia-inducible factor;




- glucose transporter-1; Glc - glucose.
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vitro heart was not enhanced under hypoxic conditions (Lloyd et al., 1988) although 
there was a twenty-fold increase in the free cytosolic adenosine level, (Deussen et al., 
1988). In dogs under hypoxic conditions most of the vasodilation that occurs is due to 
adrenergic activation, but adenosine also assists in increasing coronary blood flow, 
(Herrmann & Feigl, 1992). The increase in adenosine appears related to adrenergic ex- 
receptor activation (Hori et al., 1989, Kitakaze et al., 1987), and not from SAH 
(Herrmann & Feigl, 1992). Thus, at least in the heart under hypoxic conditions there 
appears to be no increase in intracellular homocysteine.
Enzymes involved in thiol biochemistry have been shown to be affected by 
hypoxia. This is usually the effect of very low oxygen levels of less than 10%, which is 
equivalent to oxygen levels experienced on top of Everest converted to sea level (7 % 
oxygen). Methionine adenosyltransferase mRNA was down-regulated in rat hepatocytes 
(in vitro) via reduced transcription and destabilization of the mRNA and induced the 
expression of nitrogen(II)oxide synthesis (NOS), (Avila et al., 1998).
Long duration exercise has been shown to cause an increase in plasma cortisol, 
(Kjaer, 1989). Sutton (1977), found that hypobaric hypoxic exercise (PjO2 llkPa),
produced greater increased concentrations of plasma cortisol, whereas Kjaer et al. 
(1988), found no difference in plasma concentrations cortisol (PjO2 13kPa). Cortisone
{can be converted to cortisol by 11 (3-hydroxysteroid dehydrogenase type 1} impairs 
vitamin B6 absorption. Vitamin B 6 is the coenzyme for cystathionine p-synthase and 
cystathionine y-lyase. Vitamin B6 is also required in the synthesis of niacin (Vitamin B 3) 
from tryptophan. Vitamin B 3 is essential for sex hormone synthesis as well as 
cortisone, thyroxin, and insulin, thereby providing a control upon vitamin B 6 absorption. 
Yet if the reduction is prolonged, insulin could be affected and therefore also 
carbohydrate, fat and cholesterol metabolism. Changes in the level of vitamin B6 could 
alter the catabolism of homocysteine producing increased plasma total homocysteine.
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1.8.4 Hypoxia and exercise
Hypobaric hypoxic exercise produced greater increases in the concentrations of 
plasma glucose, free fatty acids, lactate concentrations than normobaric normoxic 
conditions, implying increased fat mobilization and gluconeogenesis, (Sutton, 1977; Kjaer 
et al., 1988). Whereas there was no difference in plasma adrenaline in sedentary controls 
at rest and exercising in hypobaric hypoxia or normobaric normoxia, (Kjaer et al., 1988). 
Rostrup (1998), reviewed the effect of acute and prolonged hypoxia on catecholamines 
and found that 14 out of 15 laboratory studies showed no changes in plasma or urinary 
noradrenaline and only four showed significant increases in plasma or urinary adrenaline. 
Thirteen out of fourteen field studies with subjects staying for more than one week at 
high altitude showed increased plasma or urinary excretion of noradrenaline whereas only 
three studies showed increased plasma or urinary excretion of adrenaline. There appears 
to be a temporary reduction in plasma catecholamines in unacclimatized subjects that 
experience a short-term hypoxic effort, (Rostrup, 1998). Havel and Goldfien (1959), 
showed in dogs a relationship between adrenaline and free fatty acid mobilization. An 
acute hypoxic exercise challenge would not change sympathetic activity and therefore 
neither affect free fatty acid mobilization. Chronic exercise challenge would increase 
noradrenaline, but not adrenaline and therefore have no effect upon free fatty acid 
metabolism. The effect of acute and chronic hypoxic exercise upon adrenaline and 
therefore possibly homocysteine and free fatty acid metabolism is equivocal.
1.9 Summary
Methionine is an essential amino acid involved in protein synthesis, (the initiation 
of all peptide chains from mRNA require methionine) and methyl group transference via 
the formation of S-Adenosylmethionine. S-Adenosylmethionine has two very important 
roles namely as an allosteric inhibitor of N 5 ,N 10-methylenetetrahydrofolate reductase 
and as a cosubstrate for methionine synthase
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Homocysteine is the lynchpin, as it is at the junction of two very important 
pathways. It can be methylated in one of two ways to form methionine or 
desulphurated to form cysteine that can be converted to glutathione and taurine 
important cellular antioxidants. Under certain cellular conditions homocysteine can be 
oxidized to homocysteine thiolactone and then to homocysteric acid.
The duality of homcysteine, is demonstrated in the finally balanced coagulation 
and fibrinolysis pathways, in that it activates the Hageman factor (Figures 1.4.5 & 1.4.6). 
It's negative side is demonstrated in that it is involved with oxidation of low density 
lipoprotein, the production of lipoprotein (a), hyperplasia of smooth muscle, inhibition 
of endothelial cell proliferation and the formation of atheromas. Whereas its positive 
side, is demonstrated in that it increases nitrogen(II)oxide synthesis and reacts with it to 
form a potent vasodilator, S-nitrosohomocysteine.
Poor diet that lacks fresh vegetables or meat can cause an increase in 
Homocysteine because of the reduction of the vitamin B complex (B 2 , B 3 , B6 , B 12 and
folate). Folate is required in the transmethylation reactions, (SAM + NA -> SAH + A), 
and vitamin B6 for L-dopa to dopamine and homocysteine to cysteine. Excess
homocysteine and methionine (high protein diet) are associated with changes in growth 
and organ development in young rats. Moderate to high alcohol intake raises serum 
homocysteine concentration.
The literature could be interpreted, that if the psychological and physiological 
stresses are summated and are above a certain intensity level (threshold), it causes an 
increase in plasma total homocysteine. This could be transitional, due to the transient 
increased sympathetic activity and egression and ingress into the liver and kidneys. The 
duration of the elevated plasma total homocysteine would depend upon folate and 
vitamins B 12 and B6 tissue levels, (GroBe-Scharmann et al., 1995). Chronic intermittent 
hypoxia would down regulate S-Adenosylmethionine synthase and therefore cause a 
change in the methionine biochemical pathways. The evidence that hypoxia alters
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adrenaline secretion or affects free fatty acid metabolism is equivocal.
Adrenaline inhibits S-adenosylhomocysteinase, hypoxic and normoxic exercise 
would produce a temporary block in the cycle so that homocysteine could not be 
produced from S-adenosylhomocysteine. However, under hypoxic conditions adenosine 
is obtained from adenosine monophosphate and not from S-adenosylhomocysteine in 
cardiac muscle, and therefore would reduce the production of homocysteine.
Hypoxia increases vasodilation, by increasing constitutive nitrogen(II)oxide 
synthase and decreasing endothelin-1. It also increases Glut-1, so more glucose can be 
taken up by the cells. There is an increase in lactate dehydrogenase activity causing a 
decrease in lactate levels. Hypoxia also increases the net uptake of low density 
lipoprotein. The effect of hypoxia upon homocysteine is inconclusive.
It would appear that plasma homocysteine is a double-edge sword. The effect of 
acute variations in plasma total homocysteine upon cardiovascular disease would depend 
upon the total risk factors and would more than likely be a dependent as opposed to an 
independent factor. Yet chronic elevated homocysteine could be an independent factor 
for cardiovascular disease. The problem is the basal level of plasma total homocysteine. 
Is the measured basal plasma total homocysteine level, the actual level or an increased 
level due to the perceived stress of taking blood, recent history and what the person is 
about to do?
Exercise has been linked to a decrease in cardiovascular disease by altering the 
subject's lipid profile. This change appears to be significant when the exercise was over 
a threshold value, (Drygas et al., 2000; Kokkinos et al., 1995; Wood et al., 1983; 
Williams et al., 1982). The research investigating the relationship between homocysteine 
and exercise is at present, equivocal. The relationship appears to be dependent upon 
intensity, duration and repetition of the exercise stressor, (Nygard et al., 1995). It also
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appears to be affected by other types of stress and emotional states, (Stoney, 1999; 
Stoney & Engebretson, 2000) and the person's vitamin B 12 , B6 and folate intake,
(GroBe-Scharmannetal., 1995).
Plasma total homocysteine level is the subject of experimental measurement, not 
the intracellular. Therefore, any change in the plasma total homocysteine level would be 
due to the difference between the summation of production, subsequent "excretion" and 
uptake by cells.
The presented literature clearly suggests that plasma total homocysteine level is a 
risk factor for cardiovascular disease, (Kang et al., 1992). Therefore it is imperative that 
ways are found to decrease plasma total homocysteine.
The present study was designed to ascertain the influence of exercise on plasma 
total homocysteine levels. In addition, because highlanders (people who live at altitude) 
are believed to have a low incidence of cardiovascular disease, it was decided to examine 
the influence of hypoxia and exercise on the plasma total homocysteine levels.
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Part II
"There is no scientific method. 
There are only scientific methods"
Otta Neurath
Cartwright, N. et al., (1996)
Otta Neurath: Philosophy between Science and Politics 
(Cambridge: Cambridge University Press).
Chapter 2
2.1 Aims of Study
1. To compare the responses of plasma total homocysteine levels and selected metabolic 
coronary heart disease risk factors following a single bout of exercise, under normoxic and 
hypoxic conditions.
2. To compare the metabolic responses of acute normoxic exercise following 
intermittent normoxic and hypoxic chronic exercise.
2.2 Null Hypotheses (H0)
Null Hypothesis (1) There is no difference in the effect of acute and chronic 
normoxic and hypoxic exercise upon plasma total 
homocysteine concentration, as adrenaline released by the 
stress of exercise would inhibit S-adenosylhomocysteinase. 
Further more, the adenosine required by the cardiac muscle 
comes from two different sources, dependent upon 
hypoxic (adenosine monophosphate) and normoxic (S- 
adenosylhomocysteine) exercise; there is no difference in 
the affect upon homocysteine egression.
Null Hypothesis (2) There is no difference in the effect of chronic normoxic and 
hypoxic exercise upon the lipid profile, as both groups 





3.1 Derivation of sample size
The study recruited young, non-smoking men (age range 18 to 28 years), with no 
known cardiovascular problem.
In order to calculate the minimum number of subjects required for statistical 
significance with the recognised variation, a number of factors were needed to be 
considered. These factors include, analytical variance (the variance that is inherent in the 
analysis of plasma total homocysteine concentration) and biological variance (the 
variance in the population within the normal range).
The minimal number (sample size - n) for each of the two independent groups for 
a given power against a specified difference (minimal detectable difference - 5j)
n > 2
(Armitage et al. 2002a)
An exercise study (Weiss et al., 1998) with 13 sports students (age 24.6 years) 
had a pre exercise plasma total homocysteine concentration of 9.3 jimol.dnr3 with a 
standard deviation of 1.7|imol.dnr3 (a). The minimal detectable difference between the 
groups (6j) was obtained from the coefficients of variances based on previous work, 
(appendix VII, biological critical variance 0.081 and analytical critical variance 0.028). 
The sample size (n), for a significance of 5% (a = 0.05, z2a = 1.960, Armitage et al.,
2002b) for a given power (90%, z 2p=1.342, Armitage et al., 2002b), against the specified
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difference (2.20n,mol.dnr3 , appendix VII) was :




There should be at least thirteen subjects in each group and therefore a total of 
twenty-six subjects in the two groups.
3.2 Pre-Investigation to establish work loads
Eight male subjects in their late second or third decade of life undertook 
normobaric normoxic incremental submaximal cycle tests, (Monark 824E). The height of 
the saddle had been adjusted so that the leg was 150° when the pedal of the cycle, was in 
the fully down position. The subjects cycled for five, three minute stages, at a pedal 
frequency of seventy revolutions per minute, (refer to Table 3.2 for Mass, power output 
and times). A minute from the end of each stage their blood pressure was recorded, 
(using a mercury sphygmomanometer and stethoscope). Thirty seconds from the end of 
each stage, an 80mm 3 capillary blood sample was taken from the ear lobe. The sample 
was tested for lactate concentration (Analox P-LM5), packed cell volume and 
haemoglobin concentration (Hemocue-Hb). Heart rates were recorded at the end of each 
stage using a telemetry system (Polar), and the rate of perceived exertion was ascertained 
using a 1-20 scale, (Borg, 1982). The subjects repeated the cycle test on alternate days 
four times. A personal communication from Dr. D.M. Bailey stated that there was no 





















































































Table 3.2: Mass, Power output and times associated with each 




Ethical approval was obtained from Bro Taf Local Research Ethics Committee. 
The subjects were completely informed about the protocol and study. Forty Caucasian 
males between the age of eighteen and thirty volunteered to take part in the experiment 
and signed the consent form, (appendix 2). They were randomly assigned to either the 
normoxic or hypoxic exercising groups to produce a randomized double blind placebo 
controlled experiment. All subjects were non smokers and kept their own training and 
diet constant throughout the experimental period .
3.4 Outline of method
The subject's food and fluid intake were assessed using a seven day self-report 
questionnaire (NutriCheck, Health Options Ltd., UK) which they completed seven days 
before the experiment started. They also completed a health questionnaire. On the 
morning of the venepuncture the subjects had undertaken no physical activity for forty- 
eight hours and abstained from alcohol and caffeine for twenty-four hours. They arrived 
at the laboratory having fasted overnight for twelve hours. Post venepuncture they sat 
on the cycle ergometer (Monark 824E) and the saddle height was adjusted until the leg 
was 150° using a goniometer.
On one of the following two days the subjects ensured they were fully hydrated 
and consumed a high carbohydrate meal three hours before attending the laboratory. 
Upon arrival in the laboratory they were seated for fifteen minutes at the end of which 
their resting heart rate (Polar Vantage NV™, Polar Electro Oy, Finland) and systemic 
blood pressure using a mercury sphygmomanometer (Accoson Freestyle, Cardiokinetics, 
UK) and anaethescope (Littman™, 3M, USA) were determined. Following which the 
subject's anthropometric measurements were taken using a calibrated Harpenden skinfold 
caliper (British Indicators Ltd. UK) and balanced weighing scales and stadiometer (Seca, 
Cardiokinetics, UK).
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Two or three days post venepuncture, the subjects ensured they were fully 
hydrated and consumed a high carbohydrate meal three hours before the maximal cycle 
test. They undertook the normobaric maximal cycle test to volitional exhaustion, either 
normoxically or hypoxically. Forty-eight hours later, those that were going to exercise 
hypoxically returned to repeat the cycling test, either normoxically or hypoxically, (refer 
to Table 3.4). Immediately post maximal cycling tests, the subjects were seated and the 
blood samples were drawn.
The intermittent exercise training was four weeks in duration and throughout the 
last week, a food and fluid diary (NutriCheck, Health Options Ltd., UK) was kept. 
Four days after the last exercise session, at the same time as the pre-intermittent exercise 
venepuncture (forty-eight hours of no physical activity, twelve hours fast, no alcohol or 
caffeine) the venepuncture was repeated, and a health questionnaire completed. Over 
the next two days anthropometric measurements, heart rate and blood pressure were 
taken. Two or three days post venepuncture, the subjects ensured they were fully 
hydrated and consumed a high carbohydrate meal three hours before the maximal cycle 
test. They undertook a normobaric normoxic maximal cycle test to volitional exhaustion 
at the same time of day as their pre-intermittent exercise test. Immediately post maximal 
cycle test, blood samples were drawn.
This was a randomised placebo controlled double-blind study. All measurements 
were conducted at the same time of day and by the same investigators to control for 
biological variation and minimise inter-subject analytical variation.
3.5 Dietary Analysis
The subjects completed a seven-day self-report dietary questionnaire seven days 
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Blood drawing in the morning - all subjects [A]
Anthropometric data, resting blood pressure, orthostatic test and 
heart rate.
Normoxic maximal 
cycle test to volitional 
exhaustion. 
Blood drawn post 
acute maximal cycle 
test [B]
Hypoxic maximal 
cycle test to 
volitional 
exhaustion. Blood 
drawn post test 
[C]
Normoxic maximal 
cycle test to 
volitional exhaustion. 
Blood drawn post 
test [B]
Normoxic maximal 
cycle test to 
volitional 
exhaustion. Blood 
drawn post test 
[B]
Hypoxic maximal 
cycle test to 
volitional 
exhaustion. Blood 
drawn post test 
[C]
70% heart rate peak for 20 mins. 3 sessions per week
75% heart rate peak for 20 mins. 3 sessions per week
80% heart rate peak for 30 mins. 3 sessions per week
85% heart rate peak for 30 mins. 3 sessions per week
Blood drawing in the morning - all subjects [D]
Anthropometric data, resting blood pressure, orthostatic test and 
heart rate.
Normoxic maximal cycle test to volitional exhaustion 
Blood drawn post acute maximal cycle test [E]
Table 3.4 Chronology of the experiment
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Their average daily protein intake was calculated for each of the recorded weeks 
using a commercialized software package (NutricCheck, Health Options Ltd., UK). The 
subject's average daily protein intake was divided by his body mass at the 
commencement or termination of the experiment, (g.day 1 .kg(BM)- 1 ).
3.6 Blood sampling
Blood samples were taken early in the morning between 08.00 and lO.OOh., 
upon arrival in the environmentally controlled laboratory (21 ±2 °C, relative humidity 
40%±5%). The subjects sat and rested for thirty minutes before the blood sample was 
taken to control for plasma volume shifts. The blood was drawn from the cubital vein 
using a tourniquet and a vacutainer needle. The vacutainers were filled in the following 
sequence: Lithium Heparin (pale green traditional stopper), K 3EDTA (tripotassium 1,2-
bis[bis(carboxymethyl)amino] ethane, hemogard purple closure) and lastly SST (serum 
separation tube, yellow/black traditional stopper). Each vacutainer was labelled with the 
subject's name, code, date and exercise code (pre-rest, pre-ex(N), pre-ex(H), post-rest and 
post-ex(N)), whereas each eppendorf was labelled with the subject's code, test date, 
exercise code, test name and number.
The filled vacutainers were immediately inverted eight times. One EDTA 
vacutainer was analysed for complete blood count and red blood cell folate. The other 
EDTA vacutainer was kept in the refrigerator and centrifuged within fifteen minutes of 
blood draw at 3000rpm for fifteen minutes at 4°C. The plasma was divided as required 
for each test, (Table 3.6). The lithium heparin and SST tubes were kept in the 
refrigerator until centrifuged. They were centrifuged within thirty minutes of blood draw 
at 4°C for ten minutes at 3500rpm. The plasma/serum was divided as required for each 
test (Table 3.6). The eppendorfs were stored in the -70°C freezer until analysed. The 
serum B 12 eppendorf was wrapped in silver foil as it is photosensitive, stored in the


















































red blood cell folate
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non essential fatty acid;
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3.6.1 Complete Blood Count
The complete blood count required a whole blood sample collected in an EDTA 
tube. The tube was not spun, but placed in the refrigerator until required (within 24h). 
The cell types and numbers were counted using electrical impedance on a Coulter 
counter. Approximately llmm 3 of whole blood was diluted by the isotonic solvent 
(1:50,000). Approximately 5mm3 was analysed for erythrocytes and 5mm 3 analysed for 
white blood cells. If the sample was abnormal, then a blood smear was produced and the 
cells stained before examination using bright field light microscopy, but if due to 
coagulation a fresh sample was obtained.
The complete blood count was a multiple assay reported on a haemogram, 
including the following tests: erythrocyte, reticulocyte, leucocyte, monocyte, neutrophil, 
eosinophil, basophil, lymphocyte, platelet, differential white, cell counts and 
haemoglobin, packed cell volume, mean corpuscular haemoglobin, mean corpuscular 
volume, and mean corpuscular haemoglobin concentration.
3.6.2 Plasma volume shifts 
3.6.21 Haemoglobin
The hemocue was checked for accuracy using a standard haemocuvette. A 
haemocuvette was filled with capillary blood drawn from the right ear lobe and placed in 
the hemocue. It gave a reading of the amount of haemoglobin in the sample in grams per 
millilitre.
3.6.2H Packed Cell Volume
The packed cell volume was obtained from a Hawksley heparinized capillary 
tube, filled with capillary blood obtained from the right ear lobe. One end of the capillary
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tube was gentle twisted in the CRISTA seal (Hawksley) to seal it. The sealed ends of 
the capillary tubes were placed against the rubber gasket, the lid of the rotor screwed on. 
It was then centrifuged (Hawksley microhaematocrit centrifuge) at ll,800rpm for five 
minutes. The tube was removed from the rotor and placed on the Hawksley reader and 
the cell percentage read.
The following equations were used to calculate the plasma volume post acute 
exercise, (Dill & Costill, 1974).
Calculated blood volume(after) = Hb(before) / Hb(after) x 100 
(Hb = Haemoglobin quantity}
Calculated cell volume(after) = Calculated blood volume(after) x PCV(after) 
(PCV = packed cell volume}
Calculated plasma volume/afteiA= Calculated blood volume^afte . - Calculated cell
V°lume(after)
3.6.2iii Post-chronic exercise hypervolemia
Plasma volume shift was not measured, as Evans Blue dye is now considered 
carcinogenic, but an average blood volume expansion of 7% was used, (Convertino, 
1991). In his review on blood volume, he stated that the increase in blood volume in the 
first two to four weeks was accounted for by exercise-induced hypervolemia, which was 
related to sympathetic activity and total body dehydration during the exercise training 
sessions. He also stated that the degree of hypervolemia induced by endurance exercise 
training was affected by the subject's initial level of fitness, history of exercise, and 
genetic factors.
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3.6.3 red blood cell folate
The Abbott IMx Folate assay is based on ion capture, (Pennington et al., 1991; 
Wilson et al., 1993). It was used to measure the folate concentration in red blood cells, 
the assay was performed according to the manufacturer's method, which has been 
evaluated against cloned enzyme donor immunoassay (CEDIA, correlation r=0.97, 
Steijns et al., 1996). Whole blood was stored in the refrigerator at 4°C for less than 
twenty-four hours and protected from light. The whole blood sample was vortexed in 
the tripotassium l,2-bis[bis(carboxymethyl)amino]ethane tube to ensure a homogeneous 
sample. Packed cell volume (haematocrit) was determined and then the red blood cells 
were lysed.
Into a clean test tube was pipetted 1cm3 of the lysis reagent (ascorbic acid and 
stabilizers) and then vortexed with 50mm3 blood sample. It was either frozen (-20°C) or 
the assay run. Into the sample well of the ion capture reaction cell was placed 150 mm 3 
of the thawed haemolysate.
The predilution well of the ion capture reaction cell was filled with denaturant 
(dithiothreitol in ethanoate buffer), which was then transferred with the sample to the 
incubation well. Potassium hydroxide (O.Smol.dnr3) was then added to the incubation 
well.
Mouse monoclonal anti-folate binding protein coupled to polyanion and folate 
binding protein in a borate buffer were added to the reaction well and incubated. An 
aliquot of the reaction was transferred to the positively charged glass fibre matrix that 
was pre-coated with a high molecular mass quaternary ammonium compound.
The positively charged matrix captures the polyanion folate binding protein 
analyte complexes. The matrix was washed to remove unbound materials and then the 
'folate' reagent (folate {0.3ng.cnr3 }: alkaline phosphatase conjugate in TRIS buffer with
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protein stabilizers and sodium azide) was added to the matrix and which bounds to the 
unoccupied folate binding protein sites.
The matrix was washed to remove the unbound conjugate. 4-Methylumbelliferyl 
Phosphate(V) was added to the matrix and the fluorescent product measured by the 
microparticle enzyme immunoassay optical assembly. The printed folate result was 
then used in the following equations to calculated the red blood cell folate concentration.
, r - . ,. _ 3 . IMx folate printed result (ng.cm ~ 3 ) x 21 x 100rbc [folate](ng.cm ) = —————— „ _. , .—77^-;——-——————
v 5 ' % Packed cell volume
concentration in nmol.dnr3 = concentration in ng.cm'3 x 2.265
The National Health reference range of red blood cell folate is 408 - 1133 
nmol.dnr3 (180 to 500ng.dnr3 ), and the indeterminate (deficient-normal values) is 317 - 
408 nmol.dm-3 (140-1 SOug.dnr3 ).
The assay was calibrated using at least four known folate concentrations in 
duplicate, at the same time as the subjects' sample if the reagents and reaction cells have 
changed their set number, if not a control was run. All levels were run at least once 
during the eight-hour shift when the assay was run. If the control value was outside the 
specified range, the subject's samples were rerun with the calibration samples.
Blood from subjects that had received mouse monoclonal antibodies for diagnosis 
or therapy may contain human anti-mouse antibodies. Human anti-mouse antibodies 
could interfere with the immunoassay that uses mouse monoclonal antibodies.
3.6.4 serum vitamin B12
The Abbott IMx B 12 assay is based on the microparticle enzyme immunoassay 
technology, (Fiore et al., 1988). It was used to measure serum vitamin B, 2
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concentration, the assay was performed according to the manufacturer's method, which 
has been evaluated against cloned enzyme donor immunoassay (CEDIA, correlation 
r=0.97, Steijns et al., 1996).
Whole blood collected in serum separation vacutainer was centrifuged and 1cm 3 
of serum was placed in an eppendrof, wrapped in silver foil and stored in the refrigerator 
at 4°C for less than a day, (Mastropaola & Wilson, 1993).
The predilution well in the first reaction cell was filled (approximately twelve 
drops) with extractant 1 [cobinamide dicyanide in borate buffer with ovalbumin and 
sodium azide], and that in the second reaction cell, with extractant 2 (a- 
monothioglycerol in l,2-bis[bis(carboxymethyl)amino]ethane}. Into the third reaction 
cell's predilution well was delivered via the probe/electrode assembly aliquots of 
extractant 1 and 2 which became the working extractant.
The sample (150mm 3 of subjects' serum) and denaturant reagent (sodium 
hydroxide {O.Smol.dnr3 } with 0.005% potassium cyanide) was delivered to the third 
reaction cell's incubation well. Then the microparticles coated with intrinsic factor (in 
borate buffer with protein stabilizers and sodium azide) were added to the incubation 
well.
An aliquot of the B12: intrinsic factor coated microparticles reaction mixture was 
transferred to the glass fibre matrix, which bound irreversibly the microparticles. The 
matrix was washed and then B12: alkaline phosphatase conjugate in TRIS buffer with 
protein stabilizers and sodium azide was added to complex with the "free" intrinsic 
factor microparticle complex. The matrix was washed again to remove any unbound 
conjugate.
4-Methylumbelliferyl Phosphate(V) was added to the matrix and the fluorescent 
product measured by the microparticle enzyme immunoassay optical assembly.
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B 12 concentration in pmol.dnr3 = B 12 concentration in pg.cm'3 x 0.7378
The National Health reference range of serum vitamin B 12 is 163-590 pmol.dnr3
(221 to SOOng.dnr3 ), and the indeterminate (deficient-normal values) is 125-162 
pmol.dm-3 (170 to 220ng.dnr3 ).
The assay was calibrated using at least four known B 12 concentrations in 
duplicate, at the same time as the subjects' sample if the reagents and reaction cells have 
changed their set number, if not a control was ran. All levels were ran at least once during 
the eight-hour shift when the assay was ran. If the control value was outside the 
specified range, the subject's samples were rerun with the calibration samples.
3.6.5 plasma total homocysteine
Plasma homocysteine exists as free, dimerized and protein bound, the method 
releases homocysteine from proteins. S-adenosyl homocysteine hydrolase is not present 
in blood, there was no need to add an inhibitor to prevent the hydrolysis of S-adenosyl 
homocysteine.
To 150mm 3 of plasma or standard was added 15mm3 of 10% tri-n-butyl- 
phosphine in dimethylformamide. The mixture was incubated at 4°C for thirty minutes 
to reduce the disulphide bonds between homocysteine and other thiols or albumin. 
150mm3 of 10% tricloroethanoic acid (containing Immol / 1 l,2-bis[bis (carboxymethyl) 
aminojethane) was added. This mixture was centrifuged and 50mm3 of the clear 
supernatant was added to 10mm3 of 1.55mol.dm- 3 sodium hydroxide, 125 mm3 of 
0.125mol.dnr3 borate buffer (pH 9.5) containing 4mmol.dm-3 1,2- bis[bis 
(carboxymethyl)amino]ethane and 50mm3 of ammonium 7-fluorobenzo- 2-oxa-l,3- 
diazole-4-sulphonate (SBD-F) solution (Img.cnr3 dissolved in borate buffer). This 
mixture was incubated for 60 minutes at 60°C to completely derivatize homocysteine and 
the other plasma thiols. A 20mm 3 aliquot was used for reversed-phase High- 
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performance liquid chromatography, (Arki & Sako, 1987; Ubbink et al., 1991b; Kuo et 
al., 1997).
A 20mm 3 aliquot was autosampled (SA 360) onto the Spherisorb ODS2 [4.6mm 
internal diameter, 150mm long, 5um particles] analytical column (Jones 
Chromatography). The SBD-derivative was eluted with the mobile phase, O.lmol.dnr3 
potassium dihydrogen phosphate(V), pH 2.0 containing 40cm3 .dm-3 ethanenitrile at a 
flow rate of 0.8cm3 .min- 1 using High-Performance liquid chromatography pump (325- 
Kontron Instruments). The SBD-derivative's fluorescence was detected with SFM 25 
spectrofluorometer (Kontron Instruments), excited at 385nm and emission at 516nm, 
(Ubbink et al., 1991b; Kuo et al., 1997). A mobile phase with a pH 2.1 ensures that 
SBD-Homocysteine is completely resolved from SBD-cysteinylglycine, (Ubbink et al., 
1991b).
Kuo et al. (1997), used cysteamine as an internal standard. It is a naturally 
occurring substance but in very low concentrations, (<0.1umol.dnr3 Smolin & 
Schneider, 1988). It improves the within-batch imprecision (critical variance) was 2.8% 
(for low plasma homocysteine concentration 7.8nmol.dnr3 , n=10) and 2.2% ( for high 
plasma homocysteine concentration 23.6umol.dnr3 , n=10) from 8.3% and 5.3% 
respectively. The between-batch critical variances was 6.9% (n=75) and 7.9% (n=75) for 
the different plasma homocysteine concentrations with respect to 11.0% (n=142) and 
11.3% (n= 125) without the internal standard. The internal standard compensates for 
variations in injection volume or detector sensitivity. The internal standard was added 
to the plasma or standard before reducing the disulphide bonds, (30mm3 of 50umol.dnr3 
of cysteamine hydrochloride was added to 120mm 3 of plasma or standard to produce a 
concentration of the internal standard of lOumol.dnr3 ).
There is little fluctuation in plasma total homocysteine during the day (mean total 
homocysteine±10%, Guttormsen et al., 1994). Fasting plasma total homocysteine was 
used because of the variability of postpranially plasma total homocysteine (Ueland et al.,
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1993). As it is related to food intake, food intake and eating times must be kept 
constant.
3.6.6 Lipid profile
3.6.61 Serum total Cholesterol
Cholesterol is present in tissues and in plasma lipoprotein either as cholesterol or 
as cholesterol esters bound to proteins. The frozen serum was allowed to warmup 
gradually in the laboratory. 10mm 3 of the serum was placed on a Kodak Ektachem 
Clinical Chemistry Slide (CHOL). The slide was a dry, multilayered analytical element 
coated on a clear polyester support. Above the support layer was a gelatin buffer, the 
base layer, above that, was the spreading layer containing barium sulphate(VI), 
surfactant, cholesterol ester hydrolase, cholesterol oxidase, peroxidase, leuco dye (2-(3,5- 
dimethoxy-4 hydroxyphenol)-4,5-bis(4-dimethylaminophenyl) imidazol) and buffer.
Surfactant
Lipoprotein ———————*" Cholesterol + Cholesterol Esters + Proteins 
TX-100
Cholesterol ester hydrolase hydrolyses the cholesterol esters to cholesterol.
Cholesterol _, , . , _ ., . ,Cholesterol Esters + H2O———————*• Cholesterol + Fatty acids
ester hydrolase
The cholesterol was oxidized by cholesterol oxidase to cholestenone and hydrogen 
peroxide.
^,, , i ^ Cholesterol _ Cholesterol + O2 ————————^ Cholest-4-en-3-one + H 2O2
oxidase
The generated hydrogen peroxide oxidized the leuco dye in the presence of the 
peroxidase to generate a coloured dye.
peroxidase _ 
H2O2 + Leuco dye ——————+• Dye + H2O
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The density of the coloured dye was proportional to total cholesterol 
concentration and was measured by reflectance spectrophotometry at 540nm.
Mean value of the internal quality control was 4.24mmol.dm-3 , with a critical 
variance of 2.7%. Kodak Ektachem Calibrators 1,2 and 6 were reconstituted and used to 
calibrate Kodak Ektachem 700 Analyser.
Immol.dnr3 = 38.67 mg.dL' 1 x 0.02586 
3.6.6H Serum Triacylglycerol
Triacylglycerol is present in tissues and in the plasma lipoprotein which 
dependant upon the rate of entry and removal. The frozen serum was allowed to 
warmup gradually in the laboratory. 10mm 3 of the serum was placed on a Kodak 
Ektachem Clinical Chemistry Slide (TRIG). The slide was a dry, multilayered analytical 
element coated on a clear polyester support. Above the support layer was the reagent 
layer, containing leuco dye (2-(3,5-dimethoxy-4-hydroxyphenol)-4,5-bis(4- 
dimethylamino-phenyl)imidazole), peroxidase, glycerol kinase, L-a-glycero- 
phosphate(V) oxidase, adenosine triphosphate(V), magnesium chloride and buffer. The 
next layer, was the Scavenger layer containing ascorbate oxidase and buffer. The top 
layer, the spreading layer contains Titanium(IV)oxide, surfactant and lipase.
The surfactant helps to spread the sample and in dissociating the triacylglycerol 
from the lipoprotein. The lipase hydrolyses the triacylglycerol to yield glycerol and 
fatty acids.
The glycerol diffuses through the scavenger layer to the reagent layer. It was 
phosphorylated by glycerol kinase in the presence of magnesium adenosine 
triphosphate(V). L-a-glycerophosphate(V) was oxidized by L-a-glycero-phosphate(V) 
oxidase to yield dihydroxypropanone phosphate(V) and hydrogen peroxide.
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The generated hydrogen peroxide oxidized the leuco dye in the presence of the 
peroxidase to generate a coloured dye.
The density of the coloured dye was therefore proportional to total cholesterol 
concentration and was measured by reflectance spectrophotometry at 540nm.
The analyser's dynamic range is 0.11-5.93mmol.dm-3 while the expected values 
for males are between 0.45 and l.Slmmol.dnr3 , (Tietz 1986). Mean value of the internal 
quality control was 1.29mmol.dm-3 , with a critical variance of 3.0%. Kodak Ektachem 
Calibrators 1,2 and 4 were reconstituted and used to calibrate Kodak Ektachem 700 
Analyser.
Limitation of the procedure was that free (non-esterified) serum glycerol was also 
measured with the glycerol obtained from the hydrolysis of triacylglycerol and 
diacylglycerol.
Immol.dm-3 = 88.57mg.dL- 1 x 0.01129
3.6.6iii Serum High Density Lipoprotein Cholesterol
The frozen serum was allowed to warmup gradually in the laboratory. 200 mm3 
of the serum was placed in a plastic centrifuge tube with 200mm3 of poly(ethen-l,2- 
diol), (M 6000) with a final concentration of lOOg.dm"3 (used to precipitate low and
very-low density lipoprotein). The mixture was vortexed for five minutes and then 
centrifuged at 2000g for twenty minutes. The supernatant was aspirated at room 
temperature. The CentrifiChem pipetter takes 15mm 3 of the supernatant, 45mm3 of de- 
ionized water and 350mm 3 of combined "CHOD-PAP" reagent. [The kit provide by 
Boehringer Mannheim (Roache Diagonistic) contains cholesterol ester hydrolase, 
cholesterol oxidase which produces hydrogen peroxide. The hydrogen peroxide in the 
presence of horseradish peroxidase (EC. 1.11.1.7) reacts with 4-aminophenazone and
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phenol to yield 4-(p-benzoquinone-monoimino)phenazone]. The reaction takes place at 
a temperature of 30°C. Using a wavelength of 500nm, the absorbance was read at five 
seconds and then every two minutes for twelve minutes.
High density lipoprotein cholesterol concentration was calculated from 1.30 
mmol.dnr3 (50mg. 100cm-3 ) and2.59mmol.dm-3 (lOOmg. 100cm- 3 ) cholesterol standards.
Alien et al. (1979), found that for 539 men, the high density lipoprotein 
cholesterol was 1.20±0.31mmol.dnr3 , the within-run reproducibility (critical variance) 
was 0.8% and the between-run reproducibility (critical variance) was 3.6%.
3.6.6iv Calculated Low Density Lipoprotein Cholesterol
Low density lipoprotein cholesterol was derived using the Friedwald et al. 
(1972), formula:
LDLC = tC - HDLC - —— mmol.dm" 3
Key
LDLc = Low density lipoprotein cholesterol
tC = total Cholesterol
HDLc = High density lipoprotein cholesterol
TG = Triacylglycerol.
3.6.6v Apolipoprotein
Apolipoprotein Aj was measured directly from serum micrcosamples, by rate 
immunonephelometry using a Bechman ARRAY 360 system (Beckman Instruments, 
Inc.) using antibodies and reagents supplied by Beckman Coulter(UK) limited.
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The samples were defrosted, vortexed, barcoded and loaded onto the sample 
wheel. The preprogrammed test was selected and it automatically runs the required test 
using the apo diluent, buffer and antigens. It automatically retested out-of-range results, 
and tested for excess antigen. Single-point calibration for proteins were stable for two 
weeks. Lyophilized apolipoprotein Aj was used as the serum reference material. Low- 
volume samples were diluted before being placed in the sample wheel.
Maciejko et al. (1987), have found that for the assay of apolipoprotein A-l or B 
using the Beckman reagents, the within-run and between-run coefficients of variation was 
less than 5% over the physiological range, with an accuracy of 101 to 109% compared to 
purified protein assayed by the method of Lowry.
3.6.6vi Apolipoprotein B100
Apolipoprotein B 100 was measured by rate immunonephelometry using a
Bechman ARRAY analyser using antibodies and reagents supplied by 
BeckmanCoulter(UK) limited.
Similar protocol as for apolipoprotein Aj, but a different programmed test was 
used and the liquid stabilized apo B 100 control serum for calibration.
3.6.7 Glutamine
To determine the plasma glutamine concentration, the plasma was first 
deproteinized (Bernt & Bergmeyer, 1974) and then under went the asparaginase assay 
(Windmueller & Spaeth, 1974).
To remove any fatty deposits, the frozen plasma obtained from the lithium- 
heparin vacutainers was allowed to thaw out to laboratory temperature and then
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centrifuged for thirty seconds at 1400 revolutions per minute in a micro-centrifuge 
(Heraeus Biofuge A).
300mm3 of the centrifuged plasma was placed in an eppendrof tube (1.5cm3 ) 
with 300mm 3 of chloric(VII) acid. This was repeated in another eppendrof, they were 
both centrifuged immediately for ten minutes at 3000g.
15mm3 of Universal indicator was placed in an eppendrof tube (1.5cm3 ), with 
50mm3 of triethanolamine buffer (0.5mmol.dm-3) and 100mm3 of potassium hydroxide. 
This was repeated in another eppendrof.
Precisely 460mm3 of the supernatant was added to each eppendrof containing the 
universal indicator mixture and vortexed. The pH was adjusted to 7.0 to 7.5 by the 
dropwise addition of 20% potassium hydroxide and/or supernatant and the quantity 
recorded.
The deproteinized samples were aspirated with a plastic pipe and stored at -20°C 
in new eppendrof tubes.
The asparaginase was dialysed for a day against two changes of potassium 
dihydrogen phosphate(V) buffer (SOmmol.dnr3 , pH 6.5) before use.
1.06cm3 of the reaction mixture (20 units of asparaginase, 0.5mg glutamate 
dehydrogenase, bovine serum albumin 0.05%, glycerol 8%, 2-oxoglutarate 3.6 
mmol.dnr3 , oxidized nicotinamide adenine dinucleotide 172umol.dnr3 and potassium 
dihydrogen phosphate(V) 45mmol.dnr3 ) was added to the thawed deproteinized sample. 
The asparaginase hydrolyses glutamine to glutamate and the ammonium ion, where upon 
the glutamate dehydrogenase oxidises glutamate to 2-oxoglutarate and reduces 
nicotinamide adenine dinucleotide. The reduction of the nicotinamide adenine 
dinucleotide was detected spectrophotometrically at 340nm (Gilford, Stasar III, UK).
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Plasma glutamine concentration is 614±27umol.dm-3 using this enzyme method 
(Rowbottom et al., 1996).
3.6.8 Lactate concentration
The Lactate analyser (Analox P-LM5) was calibrated using Lactate standard 5 
and Smmol.dnr3 , after Lactate II reagent and standards had attained to the laboratory 
temperature. The assay was performed according to the manufacturer's method, which 
has been utilized in a number of studies (Gullstrand et al., 1994, 1996; Khanna et al., 
1996; Murphy & Hardman 1998; Fernandez-Garcia et al., 2000).
The right ear lobe was held firmly in the fingers and the lowest part cleaned with 
an alcohol swab and then stabbed with an Analox sterile lancet. The first few drops of 
blood were wiped away, before the heparinized capillary tube (Analox) was filled. The 
capillary tube was gently rotated for 4 minutes, and using a Gilson microman 7mm 3 
placed in the lactate analyser. Thirty seconds later the lactate concentration was given.
The assay is a one-step procedure. The Lactate II reagent is a buffered solution 
and can be stored in the refrigerator indefinitely, but the vial containing the enzyme - L- 
lactate: oxygen oxidoreductase (LOD) has a shelve life of about six months to a year. 
Once the vial has been added to the reagent the working life of the reagent: enzyme 
mixture is at least two months if stored at between 0 and 5°C. The buffered reagent: 
enzyme mixture was entrained into the analyser and the reaction is activated by the 
injection of the blood sample or standard.
LQD 
pH6.L-lactate + O2 „ ̂  ^ > Pyruvate + H 2 O2
The maximum rate of oxygen consumption was directly related to the lactate 
concentration.
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The calibration was checked with the standard after every subject, and at the 
beginning of each day with the lactate/pyruvate quality control serum.
The within-run precision standard deviation (SD), shows negligible variation over 
the entire assay concentration range, SD 0.05 - 0.07mmol.dnr3 . After calibration using a 
7mm3 standard and a sample of 7mm3 , then the linearity limit was 10 mmol.dnr3 .
The subject's lactate concentration was plotted against the work load, to find the 
critical load at which lactate level increased markedly (the lactate inflection point). This 
is called the lactate threshold (onset of blood lactate accumulation).
3.7 Heart Rate
The heart rate was monitored using a short-range telemetry system (Polar 
Vantage NV™, Polar Electro Oy, Finland). The heart rate was sampled and averaged 
every 5 seconds by the chest belt and then via transmitter to the monitor (watch).
3.8 Blood pressure
Blood pressure was measured by the same investigator to standardize the 
investigator potential measurement difference. A pressure cuff (correct size for subject's 
arm girth) was placed on the subject's left arm around the biceps and triceps. 
Auscultatory blood pressure measurement was recorded by occlusion of the brachial 
artery using a mercury sphygmomanometer (Accoson Freestyle, Cardiokinetics, UK) and 
anaethoscope (Littmann™, 3M, USA). The pressure cuff was quickly inflated to a 
pressure of about lOOmmHg and the anaethoscope placed on the brachial artery in the 
cubital fossa on the straight left arm. When the heart sound was heard, the pressure in 
the cuff was increased until just above the pressure when the sound could not be heard. 
The cuff was slowly deflated at about 2mmHg per second until the sound was heard 
again (Korotkoff phase 1 - Systolic) and the pressure recorded, it continued to be
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deflated until the sound disappeared - Korotkoff phase 5 (Diastolic) (George et al., 
1994).
The subject was then asked to stand and thirty seconds later the heart rate was 
recorded with blood pressure.
The cuff contains a bladder in a cloth sheath. The length of the bladder should be 
sufficient to encircle nearly or completely the subject's upper arm.
standard adult size - 120 x 260mm 
"obese" size bladder -120 x 400mm 
"small" size bladder -120 x 180mm.
If the cuff was too wide for the arm, it was folded over itself. Yet, if it was too 
short and there were no large ones available then the bladder was placed over the artery. 
The bladder width should be at least 80% of the arm's circumference, (O'Brien, 1996).
3.9 Anthropometric measurements
Anthropometric measurements were undertaken in an environmentally controlled 
laboratory (21 ±2 °C, relative humidity 40%± 5%).
3.9.1 Body Mass
The body mass was measured with a calibrated Seca beam pillar balance and 
recorded to the nearest tenth of a kilogram (Ross & Marfell-Jones, 1991). The subjects 
were weighed in shorts.
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3.9.2 Height
Height was measured using a stadiometer attached to beam-pillar balance. The 
subjects stood erect, barefoot with heels together and arms hanging naturally by their 
sides. They were then told to look straight ahead and take a deep breath. Their height 
was measured from the balance platform to their vertex, at the end of a maximal 
inspiration
The vertex is the highest point on the skull when the head is held in the Frankfort 
plane, (the orbitale to the tragion is horizontal and at right angles to the long axis of the 
body. The orbitale is located on the most inferior position on the margin of the eye 
socket. The tragion is the notch superior to the tragus of the ear, at the superior aspect 
of the zygomatic bone), (Ross & Marfell-Jones, 1991).
3.9.3 Body fat
Four skinfolds were measured using a calibrated Harpenden caliper (British 
Indicators Ltd.) and recorded as the sum of four skinfolds, (Durnin & Womersley, 1974). 
The procedure was explained to the subject and the sites were marked with a water 
soluble, non toxic marker pen. All measurements were taken on the right side of the 
body with the subject standing in a relaxed condition. Each site was measured by 
drawing up a layer of skin (pulling the skin together and slightly away from the body), 
with the thumb and forefinger of the left hand. The calipers were placed perpendicular to 
the fold, approximately 10mm distally from the examiner's left hand. The pressure on 
the calipers was released and likewise the examiner's left hand. Two seconds were 
allowed before the measurement in millimetres (interpolated to the nearest O.lmm) being 
recorded The calipers were completely removed from the site and the procedure was 
repeated. Three readings were obtained and the closest two, if different by <lmm were 
averaged, if not more measurements were recorded. For reliability and validity, the 
repeated measurements were attempted to be taken at the same time of day, preferably in
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the morning, (Ross & Marfell-Jones, 1991).
The anatomical position of the skinfolds were identified as follows: 
Biceps fold: - the anterior side of the right arm (right angles) and one centimetre above the 
level of the triceps mark, over the belly of the biceps muscle, (midway between the 
acromion process and the head of the radiale), (Robergs & Roberts, 1997).
Triceps fold: - the posterior side of the straightened, relaxed arm, a vertical fold mid 
region between the acromion and olecranon processes, (Robergs & Roberts 1997).
Subscapular fold: - the arm was drawn up behind the back and then relaxed, an angular 
fold taken at 45° one to two centimetres below the inferior angle of the scapula, (Robergs 
& Roberts, 1997).
Supraspinale :- Relax abdominal muscles and raise a fold at the intersection of the 
border of the ilium (about 70mm above the spinale) on a line from the spinale to the 
anterior axillary border (armpit). The caliper was applied 10mm anteriorly to the left 
thumb and index finger, (Ross & Marfell-Jones, 1991).
3.10 Exercise
3.10.1 Acute maximal exercise
Before commencing the cycle test the cycles were calibrated. Four kilograms 
were placed on the basket and the cranks rotated by hand. The tension on the cord raised 
the basket so that it was between 30 and 80mm above the flywheel, if not the tension in 
the cord was altered.
The first stage the three minute stage was without any resistance on the cycle 
ergometer, the second three minute stage was with no load on the kilogram basket and the
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next three sub-maximal three minute stages the mass increased by 0.7kg. Then the stages 
were reduced to one minute and the mass increased by either 0.4 or 0.3kg, (refer to Table 
3.2).
For the first five stages, the following submaximal data was collected: - Heart rate 
was recorded using a bipolar electrocardiograph (3 lead electrocardiograph - Lifepulse 
LP10, HME Ltd. Cardiokinetics, UK), rate of perceived physical exertion (Borg, 1982), 
blood pressure, arterial oxygen saturation, capillary lactate concentration, haemoglobin 
and pack cell volume. During the last minute of each exercise stage the expired air was 
collected and analysed for oxygen and carbon dioxide percentages and the gas volume was 
measured. The stages decreased to one minute duration, and only the blood pressure, 
arterial oxygen saturation, heart rate and the relative rate of perceived physical exertion 
(Borg, 1982) were collected. The subjects indicated one minute before exhaustion and 
the expired air was collected in a Douglas bag for analysis at the end of the test. The 
expired air was analysed using fast responding paramagnetic oxygen and infrared carbon 
dioxide analysers (Servomex 1400 Series Analyser, UK). These had been calibrated with 
precision-analysed quality gas mixtures containing pure nitrogen, 17% oxygen and 5% 
carbon dioxide. The expired air volume was measured using a dry gas meter (Harvard 
LTD, UK) which had been calibrated against a 600L Tissot spirometer (Collins Limited, 
USA). The duration of the test, maximum lactate concentration, packed cell volume, 
haemoglobin, maximum heart rate, blood pressure and rate of perceived exertion were all 
recorded.
The test was terminated if the subject experienced chest pains, dyspnoea, 
exhaustion or recorded a systolic blood pressure >250mmHg or the subject had reached
•
peak oxygen consumption (V O2 peak). Peak oxygen capacity was considered to be
attained if as a result of an increase in workload, three of the following were obtained: no 
change in the volume of oxygen consumed (2cm3 .kg- 1 .min- 1 ), maximum heart rate attained 
during the stage, respiratory exchange ratio (VCO2/VO2 ) above 1.15, rate of perceived
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exertion >20 (Borg, 1982) and a lactic acid concentration above Smmol.dnr3 . 
3.10.2 Chronic intermittent exercise
The subjects exercised for three sessions a week for four weeks using heart rate 
monitors (Polar). The intensity of the exercise was based upon the maximal heart rate 
they had obtained in their first acute maximal exercise session, breathing the same gas 
composition as they were to breathe during the intermittent exercise sessions. For the 
first and second weeks, they exercised at 70% and 75% of their maximal heart rate 
respectively, for twenty minutes, whereas for weeks three and four it was increased to 
80% and 85% respectively, for thirty minutes. The hypoxic group of students breathed 
a dry gas mixture of 84% nitrogen and 16% oxygen on average over the exercise period. 
(16% oxygen is approximately equivalent to 1.7km altitude in relation to the partial 
pressure of inspired oxygen of about 16kPa).
Blood pressure and an ear capillary sample for lactate analysis were taken in the 
last minute of the last exercise session in weeks three and four.
3.11 Statistics
3.11.1. Missing Data
Due to vein collapse, or insufficient plasma/serum obtained, some data was 
missing. Missing values were calculated using either the least squares regression line of x 
on y or y on x (appendix VI). If both the pre and post data were missing or if there was 
only one set of data, then the arithmetical mean was used. If a missing value was derived 
from another missing value, then the derived value was not calculated directly, but 
calculated from the calculated first missing value.
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3.11.2 Normality
The data's symmetry (skewness) and kurtosis were obtained using StatView 
512+ for MAC (appendix III and IV). The Shapiro-Wilks test for normality was 
calculated for all the data (appendix VI), which showed that some of the data was non 
normal. Normal and log-normal data was tested parametrically and non-normal data was 
tested non-parametrically using STATISTICA 4.1 for MAC (1994).
3.11.3 Parametric tests
The following parametric tests were used: The unpaired Student's 't' test for 
independent samples; The paired Student's 't' test for dependent samples and the 
Pearson correlation coefficient between two variables. Significance was taken as p < 
0.05.
3.11.4 Non-parametric tests
The following non-parametric tests were used: Mann-Whitney U, Wald- 
Wolfowitz run test and Kolmogorov-Smirnov for independent samples (so not just 
means or rank sums can be compared, but also the overall shape of the distribution - 
skewness); Wilcoxon signed-rank for dependent samples and the Spearman Rank 
correlation coefficient between two variables. Significance was taken as p < 0.05.
3.11.5 Analysis of Variance
The nonparametric analysis of variance (ANOVA) tests used are Kruskal-Wallis 
for between groups and Friedman for within-subjects (repeated measures) which will be 




Of the forty subjects that commenced the study, ten did not complete the study 
or were withdrawn for not meeting the criteria. Data was obtained on 30 young adult 
males of whom fourteen exercised normoxically and sixteen exercised hypoxically for four 
weeks and will be expressed as mean ± standard deviation(SD), unless otherwise stated.
4.1 Statistical Analysis
Not all the data were normally distributed.
Within the control group the following factors did not show normality: - 
age.
• plasma total homocysteine concentration post-acute cycle test, pre-chronic 
exercise.
• post-chronic exercise body mass index (BMI).
• pre- chronic exercise plasma glutamine concentrations.
• post-chronic exercise high density lipoprotein cholesterol (HDLC) concentrations.
• post-chronic exercise non-esterified fatty acid (NEFA) concentrations.
Similarly within the hypoxic group the following were not normally distributed: -
• maximum heart rate at the end of the normoxic acute cycle tests pre-chronic 
exercise.
• maximum heart rate at the end of the hypoxic acute cycle tests pre-chronic 
exercise, 
pre-chronic exercise triacylglycerol (TG) concentrations.
The logarithmic transformation (X =log(X+ 1) Zar 1996b), transformed some
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of the data into normality, such as: - 
age.
• post-chronic exercise HDLC concentrations.
• pre-chronic exercise TG concentrations.
Where the logarithmic transformation produced a reduction in the variation from a normal 
distribution, then logarithmic transformed data was investigated parametrically and non- 
parametrically (plasma total homocysteine concentrations and serum NEFA 
concentrations). If the transformation did not reduce the variation from a normal 
distribution, the data was investigated parametrically and non-parametrically using the 
original data (heart rate, plasma glutamine and BMI).
Independent samples were compared non-parametrically using Mann-Whitney U 
test and parametrically using the Student's 't' test. Matched samples were compared 
non parametrically using Wilcoxon matched pairs and parametrically using the paired 
Student's 't' test. Interactions were investigated using a two way ANOVA and 
relationships checked using post hoc Tukey honest significant difference tests and non- 
parametrically using the Kruskal-Wallis ANOVA by ranks (independent samples), and 
the Friedman ANOVA with the Kendall's coefficient of concordance (paired samples).
All blood metabolites obtained post-chronic exercise, were assumed to have 




The non-paired Student's 't' test showed no significant difference between the 
normoxic and hypoxic groups for their log-normal age (means±SD 22±2 and 22±3 years
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old respectively, p =0.849); body mass (means±SD 74.5±6.3 and 74.6±8.6 kg 
respectively, p =0.980) or sum of skinfolds, (means±SD 30.1±7.3 and 30.4±7.5 mm 
respectively, p =0.932).
Their body mass index (BMI, means±SD 23.90±1.26 and 23.23±1.88 kg.nr2 
respectively) showed no significant difference parametrically or non-parametrically 
(p=0.267 and p=0.261 respectively).
4.2.2 Homocysteine and related compounds
There was no difference between the normoxic and hypoxic groups' logarithmic 
plasma total homocysteine concentrations and related compounds, (refer to Table 4.2.2)
However, there tended to be a stronger correlation (Pearson r) in the hypoxic 
group than the normoxic group with respect to: red blood cell folate concentration and 
logarithmic plasma total homocysteine concentration (r = -0.716 and -0.081 
respectively); rbcfolate concentration and red blood cell number (r = -0.043 and -0.256 
respectively); rbcfolate concentration and plasma glutamine concentration (r = +0.363 
and +0.177 respectively); serum vitamin B 12 concentration and logarithmic plasma total
homocysteine concentration (r = -0.570 and -0.411 respectively); Vitamin B 12 
concentration and daily protein intake per kilogram body mass (r = +0.294 and -0.071 
respectively).
4.2.3 Plasma Lipid Data
There was no difference between the normoxic and hypoxic groups' pre-chronic 
exercise log-normal lipid profiles, (refer to Table 4.2.3).
There tended to be strong correlations (Pearson r) in the normoxic and hypoxic 














































Table 4.2.2 Statistical significance for logarithmic plasma total homocysteine 
concentration and related compounds
Key:
plasma total homocysteine concentration (fimol.dm-3 )
red blood cell folate concentration (nmol.dm-3 )
serum vitamin 612 concentration (pmol.dm-3 )
number of red blood cells per dm3
plasma glutamine concentration (jAmol.dm-3 )
daily protein intake per kilogram body mass (g.day- 1 .kg(BM)- 1 )
not applicable, data was normally distribute
If the logarithmic transformation produced normality, then it was used with parametric
statistics.
If the logarithmic transformation of the data had not produced normal distribution, but
had reduced the variation, parametric and non-parametric statistics were used on the
logarithmic transformed data.
If the logarithmic transformation of the data had not produced normal distribution, nor






























































AI serum apolipoprotein AI (g.dm-3 ) 
serum apolipoprotein BIQO (g.dm-3 ) 
serum total cholesterol concentration (mmol.dm-3 ) 
serum high density lipoprotein cholesterol concentration (mmol.dm-3 ) 
calculated low density lipoprotein cholesterol concentration (mmol.dm-3 ) 
non-esterified fatty acid concentration (mmol.dm-3 ) 
not applicable, data was normally distribute
If the logarithmic transformation produced normality, then it was used with parametric
statistics.
If the logarithmic transformation of the data had not produced normal distribution, but
had reduced the variation, parametric and non-parametric statistics were used on the
logarithmic transformed data.
If the logarithmic transformation of the data had not produced normal distribution, nor
had reduced the variation, parametric and non-parametric statistics were used on the
original data.
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apolipoprotein A : (r =+0.906 and +0.757 respectively) and between their logarithmic 
calculated LDL cholesterol concentration and apolipoprotein B 100 (r =+0.886 and +0.954 
respectively).
4.3 The effect of exercise and hypoxia upon plasma total 
homocysteine concentration
4.3.1 The effect of acute cycle test upon plasma total 
homocysteine concentration
4.3.1i Pre-chronic, acute normoxic cycle test
A two-way ANOVA, comparing the normoxic and hypoxic groups' logarithmic 
plasma total homocysteine concentrations, pre- and post-acute cycle test showed no 
interaction (p=0.286). Only the normoxic group's non-parametric Friedman ANOVA 
(pre-post acute cycle test), showed a significant increase in plasma total homocysteine 
(p<0.033, refer to Table 4.3).
4.3.lii Post-chronic, acute normoxic cycle test
A two-way ANOVA, comparing the normoxic and hypoxic groups' logarithmic 
plasma total homocysteine concentrations, pre- and post-acute cycle test showed no 
interaction (p=0.121). Only the hypoxic group's non-parametric Friedman ANOVA 
(pre-post acute cycle test), showed a significant increase in plasma total homocysteine 









Friedman ANOVA - AD 
Kendall's coefficient
[tHCy]E




























































plasma total homocysteine concentration (nmol.dm-3 ) 
at rest, pre-chronic exercise, pre-acute cycle test, 
pre-chronic exercise, post-acute normoxic cycle test, 
pre-chronic exercise, post-acute hypoxic cycle test. 
at rest, post-chronic exercise, pre-acute cycle test, 
pre-chronic exercise, post-acute normoxic cycle test, 
difference between [tHCy]A-[tHCy]B 
difference between [tHCy]D-[tHCy]E 
p<0.05-significant 
p<0.01 - very significant
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4.3.1iii Pre-chronic, acute hypoxic cycle test
The hypoxic acute cycle test produced no change in logarithmic plasma total 
homocysteine concentration using parametric (Student's 't' test p=0.376) and non- 
parametric (refer to Table 4.3) statistics.
4.3.2 The effect of chronic exercise upon plasma total 
homocysteine concentration
4.3.2i Pre-/Post-chronic exercise
A 2-way ANOVA, with the group as the independent variable and the 
logarithmic plasma total homocysteine concentration pre- and post-chronic exercise as 
the dependent variables showed a significant interaction, (p=0.015). The post hoc Tukey 
honest significant difference test for the normoxic group pre-/post-chronic exercise 
plasma total homocysteine concentration significantly increased (p=0.043), whereas the 
hypoxic group did not change (p=0.857). The post hoc Tukey honest significant 
difference for unequal sample size test, comparing the normoxic and hypoxic groups' 
post-chronic exercise plasma total homocysteine concentrations were significantly 
different (p=0.045), whereas the pre-chronic exercise were not (p=0.868). Only the 
non-parametric Friedman ANOVA for the normoxic group showed a significant increase 
in plasma total homocysteine concentration (p<0.001, refer to Table 4.3).
4.3.2H Comparison of acute normoxic cycle test, pre/-post-chronic 
exercise
A 2-way ANOVA, with the group as the independent variable and the plasma 
total homocysteine concentration differences (pre-/post-acute normoxic cycle test), pre- 
and post-chronic exercise as the dependent variables showed no significant interaction, 
(p=0.050). The post hoc Tukey honest significant difference tests showed no significant
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differences. The Kruskal-Wallis ANOVA non-parametric test showed a significant 
difference between the groups' pre-chronic exercise acute cycle test plasma total 
homocysteine concentration difference (pH).044, refer to Table 4.3).
4.4 The effect of chronic exercise upon the Lipid profile
4.4.1 Serum total Cholesterol
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - logarithmic total cholesterol) had no significant interaction 
(p=0.301, normoxic group pre-chronic exercise 4.36±0.94 mmol.dm-3 ; post- 3.86±0.61 
mmol.dm-3 ; hypoxic group pre- 4.56±0.68 mmol.dm-3 ; post- 4.24±0.53 mmol.dm-3 ).
4.4.2 Serum Apolipoprotein Aj
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - apolipoprotein Aj) had a significant interaction (p<0.001,
normoxic group pre-chronic exercise 1.44±0.16 g.dnr3 ; post- 1.24±0.12 
g.dnr3 ; hypoxic group pre- 1.37±0.16 g.dnr3 ; post- 1.37±0.24 g.dnr3 ). Post hoc Tukey 
tests showed that there were significant changes in the normoxic pre-/post-chronic 
exercise apolipoprotein A } concentration (pO.OOl), and between the normoxic and
hypoxic post-chronic exercise concentrations (p=0.005).
4.4.3 Serum High Density Lipoprotein
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - log-normal high density lipoprotein cholesterol) had showed no 
interaction (p=0.577, normoxic group pre-chronic exercise 1.6±0.4 mmol.dm-3 ; post-
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1.5±0.3 mmol.dm-3 ; hypoxic group pre- 1.6±0.4 mmol.dm-3 ; post- 1.6±0.5 mmol.dm-3 ).
4.4.4 Serum Apolipoprotein B100
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - apolipoprotein B 100) had a significant interaction (p=0.003, 
normoxic group pre-chronic exercise 0.86±0.25 g.dm-3 ; post- 0.76±0.15 g.dnv3 ; hypoxic 
group pre- 0.83±0.22 g.dm-3 ; post- 0.88±0.24 g.dm-3 ). Post hoc Tukey tests showed 
that there were significant changes in the normoxic pre-/post-chronic exercise 
apolipoprotein B 100 concentration (p=0.0005), and between the post-chronic exercise
concentrations, (p=0.005).
4.4.5 Calculated serum Low Density Lipoprotein
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - logarithmic calculated low density lipoprotein cholesterol) had no 
interaction (p=0.923, normoxic group pre-chronic exercise 2.59±0.95 mmol.dm-3 ; post 
2.47±0.53 mmol.dm-3 ; hypoxic group pre- 2.77±0.82 mmol.dm-3 ; post- 2.68±0.68 
mmol.dm-3 ).
4.4.6 Serum triacylglycerol
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; dependent 
variables log-normal serum triacylglycerol) had a significant interaction (p=0.034, 
normoxic group pre-chronic exercise 0.93±0.33 mmol.dm-3 ; post- 0.99±0.40 mmol.dm-3 ; 
hypoxic group pre- 0.98±0.40 mmol.dm-3 ; post- 1.23±0.40 mmol.dm-3 ). Post hoc 
Tukey tests showed that there were significant changes in the hypoxic pre-/post-chronic 
exercise serum triacylglycerol concentration (p=0.028), and between the post-chronic 
exercise concentrations, (p=0.004).
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4.4.7 Serum non-esterified fatty acid
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - serum non-esterified fatty acid) had a significant interaction 
(p=0.028, normoxic group pre-chronic exercise 0.26±0.15 mmol.dnr3 ; post- 0.18±0.09 
mmoLdnr3 ; hypoxic group pre- 0.33±0.13 mmol.dm-3 ; post- 0.16±0.09 mmol.dnr3 ). 
The post hoc comparison Tukey honest significant difference for equal samples showed a 
significant decrease in the normoxic group's non-esterified fatty acid concentration pre- 
/post-chronic (p=0.022) and hypoxic group's (p=0.0002). Whereas, non-parametric 
analysis showed no difference between the normoxic and hypoxic NEFA concentrations 
pre- and post-chronic exercise (p=0.096 and p=0.835, respectively). The effect of 
chronic exercise upon the hypoxic group's NEFA concentration was to significantly 
reduce it QxO.OOOl, W=0.938 ).
4.5 The effect of chronic exercise upon aerobic power, lactate 
threshold and heart rate.
4.5.1. Comparison of the Normoxic acute cycle tests pre-/post- 
chronic exercise
4.5. li Aerobic power
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - normoxic acute cycle tests) had no interaction (p=0.568, refer to 
Table 4.5.1).
4.5. lii Lactate



































































Table 4.5.1 The effect of chronic exercise upon certain parameters 
of the acute cycle test
Key:
•
V02 peak (BM) = aerobic power 
[La] = maximum lactate concentration 
HRjnax = maximum heart rate at exhaustion. 
N = normoxically exercised 
H = Hypoxically exercised subjects. 
B = acute normoxic cycle test, pre-chronic exercise 
E = acute normoxic cycle test, post-chronic exercise. 
HSD = honest significant difference 
coef = coefficient 
* p<0.05 = significant difference
[maximum heart rate data was not normally distributed, therefore it was investigated using 
parametric and non-parametric statistics]
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dependent variables - normoxic acute cycle tests maximum lactate concentrations) had a 
significant interaction (p=0.010). The post hoc comparison Tukey test showed a 
significant difference (pre-chronic exercise) between the normoxic and hypoxic groups, 
(p=0.019, refer to Table 4.5.1).
4.5.1iii Heart rate
A 2-way ANOVA fixed effects (independent variable -normoxic/hypoxic; 
dependent variables - normoxic acute cycle tests' maximum heart rates) showed no 
significant interaction (p=0.941). Non-parametrically, the groups did not show any 
change in their maximum heart rates pre- to post-chronic exercise (refer to Table 4.5.1).
4.5.2. Comparison of the Normoxic and Hypoxic acute cycle tests 
pre-chronic exercise
4.5.2i Aerobic power
There was no change between the aerobic power obtained from the normoxic 
acute cycle test and that obtained from the hypoxic test (refer to Table 4.5.2).
4.5.2U Lactate
There was no change between the maximum lactate concentration obtained from 
the normoxic acute cycle test and that obtained from the hypoxic test (refer to Table 
4.5.2).
4.5.2iii Heart rate
There was no change between the maximum heart rate obtained from the normoxic 



























Table 4.5.2 Comparison of the Normoxic and Hypoxic acute 






VO2 p^ (BM) = aerobic power
[La] = maximum lactate concentration
= maximum heart rate at exhaustion. 
= acute normoxic cycle test, pre-chronic exercise 
= acute hypoxic cycle test, pre-chronic exercise. 
= honest significant difference 
* p<0.05 = significant difference
[maximum heart rate data was not normally distributed, therefore it was investigated 
using parametric and non-parametric statistics]
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Part III
Science needs to be lived alongside religion, philosophy,
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The following inferences, can in my opinion be drawn from the results of this 
experiment as the normoxic and hypoxic groups' baseline data showed no significant 
differences.
• Acute normoxic cycle test produces a significant but not physiological increase in 
plasma total homocysteine concentration.
• Chronic normoxic intermittent exercise produces a significant but not 
physiological increase in plasma total homocysteine concentration
• Hypoxia inhibits the effects of exercise stress upon plasma total homocysteine 
concentration.
• Chronic intermittent exercise had no effect upon the serum cholesterol 
concentrations.
• Chronic intermittent hypoxic exercise caused a significant increase in 
triacylglycerol concentration, but not a physiological increase.
• Chronic normoxic and hypoxic intermittent exercise produced a significant 
decrease in serum non-esterified fatty acid.
• The acute cycle tests produced no significant difference between the normoxic 
and hypoxic groups for aerobic power and maximum heart rate.
• The normoxic acute cycle tests pre and post chronic intermittent exercise showed 
a significant interaction for maximum lactate concentration. The post hoc test 
showed a significant difference between the groups pre-chronic exercise. The 
normoxic group decreased their maximum lactate concentrations, whereas the 
hypoxic group increased theirs.
• There was no significant difference between the normoxic and hypoxic acute cycle
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tests pre-chronic intermittent exercise for aerobic power, maximum lactate 
concentration and heart rate.
5.2 Homocysteine
5.2.1 Baseline Homocysteine
There was no significant difference in the means of the plasma total homocysteine 
concentrations between the normoxic and hypoxic groups at the beginning of this study, 
(mean±SD 6.9±1.2 umol.dnr3 , 7.5±2.2 umol.dnr3 respectively), thereby implying that 
the two groups represented the same population. The National Centre for Health 
Statistics reported that the geometric mean for serum homocysteine concentration in the 
second decade of life was 7.7 umol.dnr3 and in the third decade of life was 9.3 ^mol.dnr3 
(DHHS 1992). This study's groups spanned both decades (19-28 years old), but their 
geometric means were lower (6.8 umol.dnr3 normoxic; 7.1 umol.dnr3 hypoxic), which 
could be due to their healthier lifestyles of diet and exercise. GroBe-Scharmann et al. 
(1995) found that top athletes had significantly lower levels of homocysteine than leisure 
time athletes.
This study found that logarithmic plasma total homocysteine concentration 
was negatively correlated to red blood cell folate in the hypoxic group (Pearson r =- 
0.081 normoxic; r = -0.716 hypoxic) and also serum vitamin B 12 (Pearson r = -0.411
normoxic; r = -0.570 hypoxic). A negative correlation between plasma total 
homocysteine concentration and plasma folate and also vitamin B 12 had previously been 
reported (Verhoef et al., 1996). Quinlivan et al., (2002) found that the correlation 
between plasma total homocysteine and a high folate intake was poor, but the vitamin 
B 12 showed a greater negative correlation. Dietary experiments pointed to a plateau, 
above which, further consumption of folate and serum vitamin B, 2 concentrations 
produced no further reduction in plasma total homocysteine concentration (Ward et al.,
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1997). In this study, the groups' geometric means for red blood cell folate concentration 
(837 and 773 nmol.dnr3 normoxic and hypoxic groups' respectively) were in top end of 
the National Health reference range (folate 408 - 1133 nmol.dnr3), whereas this study's 
vitamin B 12 levels (362 and 355pmol.dm"3 normoxic and hypoxic groups' respectively) 
were at the lower end of the National Health reference range (B 12 163 - 590 pmol.dm"3 ). 
The lack of correlation between the plasma total homocysteine and rbc folate 
concentrations in the normoxic group, but not the hypoxic group could be due to the 
relatively high levels of folate and low levels of serum vitamin B 12 . Also, the poor
correlation between logarithmic plasma total homocysteine and red blood cell folate could 
be related to factors such as methylenetetrahydrofolate reductase (MTHFR) genotype 
and the type and quantity of homocysteine transport channels in the plasma membrane. 
The poor correlation was unlikely to be related to exercise, as the subjects had not 
undertaken any physical activity for forty-eight hours and Weifi et al. (1999) had shown 
that twenty-four hours post acute exercise, the plasma total homocysteine concentration 
would have started to return to pre-acute exercise levels and would be no longer 
significantly different.
The serum total cholesterol concentration was not correlated to plasma total 
homocysteine concentration in the normoxic group (Pearson, r = -0.028 normoxic group; 
r = 0.421 hypoxic group). Yet the high density lipoprotein cholesterol concentration was 
significantly correlated to plasma total homocysteine in the normoxic group, but not in 
the hypoxic group (r = 0.690, normoxic group; r = 0.333 hypoxic group). The normoxic 
group subjects did have a higher normoxic aerobic fitness and a lower negative correlation 
to plasma total homocysteine (normoxic group 53.3±9.4 cm^kg^.min- 1 , r = -0.300; 
hypoxic group 48.0±9.1 cm 3 .kg- 1 .min- 1 , r = -0.599) and this could be interpreted as that 
the fitness level and type of training affects the clearance of plasma total homocysteine 
to the kidneys and liver and/or that fitter people tend to have a better diet, but that there 
could be a plateau effect. The correlation between rbc folate and normoxic aerobic fitness 
appears to be dependent upon their mean rbc folate concentration and a possible plateau 
effect (r = -0.017 normoxic group; r = 0.425 hypoxic group). Myocardial infarction
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patients have been found to have a significant correlation between their serum total 
homocysteine concentration and their low-density lipoprotein cholesterol and high- 
density lipoprotein cholesterol concentrations, (Qujeq et al, 2001). This study's serum 
triacylglycerol concentrations were not strongly correlated, particularly in the hypoxic 
group, (r = -0.211 normoxic group; r = 0.024 hypoxic group).
The four year follow-up of the Hordaland study showed that the progressive 
increase in plasma homocysteine increased the risk of mortality, in cardiovascular and 
non cardiovascular causes of death (Vollset et al., 2001). A 5|j,mol.dm-3 was associated 
with a 49% increase in all-cause mortality, (50% increase in cardiovascular mortality, 
26% increase in cancer, and a 104% increase in non-cancer, non-cardiovascular mortality). 
Fenech (2001) commented in his review that human intervention studies show that red 
cell folate concentration above 700nmol.dm"3 , plasma B 12 concentrations above 300
pmol.dnr3 and plasma homocysteine less than 7.5^mol.dm"3 are associated with
minimization of DNA hypomethylation and chromosomal breaks. DNA 
hypomethylation has been associated with cancer (Ehrlich 2002) and atherosclerosis 
(Hiltunen et al. 2002). The baseline plasma total homocysteine, rbc folate and vitamin 
B 12 status implies that the students in this study would have minimal DNA
hypomethylation and chromosomal breaks.
5.2.2 Homocysteine and normoxic exercise
Many of the studies looking at normoxic exercise with different durations and 
intensities have shown that exercise increases plasma total homocysteine concentration, 
(GroBe-Scharmann et al. 1995; Weiss et al. 1998; Lussier-Cacan et al. 1998; WeiB et al. 
1999). The study by De Cree et al. (2000) was a one hour acute submaximal exercise and 
produced no change in plasma total homocysteine concentration in seven young males
(mean age 21.6 years), but it could be because it was at a low intensity (60% VO 2max ). 
Yet when they (DeCree et al. 1999) had looked at acute exercise to exhaustion in fifteen
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eumenorrheic women (mean age 18.7 years), they had shown a significant increase in 
plasma homocysteine. Whereas the study by Wright et al. (1998), concluded that the 
increase in plasma homocysteine post exercise was due to plasma albumin changes. The 
implication that plasma total homocysteine concentration post exercise stress above a 
threshold causes a significant increase, albeit for a short time was born out partly by this 
study's data and that this increase could be related to rbc folate concentration and 
exercise induced changes in plasma albumin concentration.
5.2.21 Homocysteine and acute normoxic exercise
Pre-chronic, acute normobaric normoxic cycle test affected the groups differently. 
The normoxic group's logarithmic plasma total homocysteine concentration significantly 
increased non-parametrically post acute exercise, but not paramertrically (mean±SD; 
pre=6.9±1.2u,mol.dnr3 , post=7.6±1.8umol.dnr3 ; Wilcoxon matched pairs p=0.035 and 
t-test p=0.095), whereas the hypoxic group showed no significant difference (mean±SD; 
pre=7.5±1.8umol.dnr3 , post=7.3±2.0umol.dnr3 , Wilcoxon matched pairs p=0.570 and 
t-test p=0.904). The two subjects in the normoxic group that showed the largest 
increase in plasma homocysteine also had the lowest rbc folate concentrations ( 564-566 
nmol.dnr3 ). The hypoxic group's difference was not just affected by their rbc folate 
levels, but probably also whether they undertook the normoxic or hypoxic acute cycle 
test first.
Post-chronic, acute normobaric normoxic cycle test also affected the groups 
differently. The normoxic group's logarithmic plasma total homocysteine concentration 
did not change significantly (mean±SD; pre=8.2±1.9 umol.dnr3 , post=8.1±1.5 
umol.dnr3 ; Wilcoxon matched pairs p = 0.638 and t-test p = 0.938), whereas the 
hypoxic group showed a significant increase (mean±SD; pre=7.1±1.9jAmol.dnr3 , 
post=8.2±2.5^imol.dnr3 , Wilcoxon matched pairs p=0.044 and t-test p=0.057).
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This study shows that an acute normoxic exercise can cause a significant increase 
in plasma total homocysteine concentration. When it did not occur there were two 
possible reasons: 1. In the hypoxic group pre-chronic exercise, some of the group had 
undertaken the hypoxic acute cycle test first; 2. In the normoxic group post-chronic 
exercise, the subjects were already at an elevated homocysteine concentration. This 
could indicate that exercise causes an increase in plasma total homocysteine concentration 
to a plateau and that further exercise stress does not increase the level further. This 
plateau concept requires further investigation as it could be related to the level of folate 
and vitamin B 12 , that is, the higher the rbc folate concentration, the lower the increase in
plasma total homocysteine concentration caused by the particular intensity and duration 
of the acute exercise session.
5.2.2H Homocysteine and chronic normoxic exercise
Chronic normoxic intermittent exercise produced a significant, but not a 
physiological increase in logarithmic plasma total homocysteine concentration, (pre- 
chronic exercise 6.9±1.2 umol.dnr3 , post-chronic exercise 8.2±1.9 fimol.dnr3 , Wilcoxon 
matched pairs p=0.002), but this was less than the calculated minimal detectable 
difference (2.20 fxmol.dnr3 , appendix VII). GroBe-Scharmann et al., (1995) only found 
a slight increase in plasma total homocysteine concentration over an eight week training 
period. Whereas Nygard et al., (1995) - found an inverse relationship between plasma 
total homocysteine concentration and physical activity levels, but people who tend to 
exercise also tend to have a healthier lifestyle. Lussier-Cacan et al. (1998) found that a 
twenty-week endurance programme produced a 5.5% mean increase in plasma total 
homocysteine. A short term increase could be beneficial, in producing more glutathione ( 
Figure 1.3.1), or glycosaminoglycan sulphate(VI) (Figure 1.3.3).
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5.2.3 Homocysteine and hypoxic exercise
5.2.31 Homocysteine and acute hypoxic exercise
Acute normobaric hypoxic cycle test did not produce a significant change in 
logarithmic plasma total homocysteine concentration (mean±SD; pre - 7.5±2.2 jimol.dm- 
3 , post-acute cycle test 7.7±2.1 fimol.dnr3 , t-test p=0.376 and Wilcoxon matched pairs 
p=0.408). This was different to the effect of acute normoxic exercise and may be related 
to a hypoxic induced vasodilation by increasing nitrogen(II)oxide synthase and decreasing 
endothelin-1, which changes blood volume and flow rates (Lee et al. 1997).
5.2.3H Homocysteine and chronic hypoxic exercise
Chronic hypoxic intermittent exercise produced no significant change (pre- 
chronic exercise 7.5±2.2 [xmol.dnr3 , post-chronic exercise 7.1±1.9 umol.dnr3 , p=0.361). 
Hypoxia was thought to increase i-NOS and HO-1 genes and thus vasodilation as well as 
VEGF gene causing angiogenesis, (refer to Figure 1.8.1), which could improve blood flow 
during exercise and thus removal of the egressed homocysteine more efficiently. Work on 
wild type (myo+/+) and myoglobin knockout (myo-7-) mice found no change in the 
hypoxia-inducible factor 1 alpha under hypoxic conditions, (HIF-1 a, Schlieper et al., 
2002). This would indicate that reduced arterial oxygen partial pressure is not required 
to up regulate HIF-1 a. Yet a similar duration and level of hypoxia in rats produced a 
25-fold increase in HIF-1 mRNA and an increase in mass of the right ventricle, (Forkel et 
al., 2002). Thus the hypoxic induced bronchial constriction caused the enlargement of 
the right ventricle. It also implied that hypoxia might not have been a direct stimulus to 
up-regulate HIF-1. It would have been interesting to use ultrasound, to see if the chronic 
hypoxic exercise had caused a right ventricular enlargement and the effect of a possible 
increase in erythrocytes (Goldberg et al. 1988), and angiogenesis (Shweiki et al. 1992) 
due to hypoxia upon blood volume.
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5.2.4 Summary of the effect of exercise upon plasma homocysteine
A 2-way ANOVA showed a significant interaction (p=0.026) between pre and 
post chronic exercise for normoxic and hypoxic groups. Post hoc Tukey tests only 
showed significance for the normoxic group pre/post chronic exercise (p=0.022) but not 
for the hypoxic group (p=998), nor between the groups pre- (p=0.948) and post-chronic 
exercise (p=0.051). Whereas, there were no significant interactions between pre- and 
post acute cycle test pre- (p=361) and post-chronic exercise (p=0.217)
The acute changes in plasma total homocysteine concentration might be related to 
the hydration, sodium and albumin plasma status of the subject, which would affect the 
sodium transporter channels. Channels which might be involved with the transport of 
homocysteine across the plasma membrane and albumin, the transport of homocysteine 
in the plasma. The hydration and sodium status are affected by exercise and the subjects 
were asked to be fully hydrated before the acute cycle tests. The chronic changes in 
plasma total homocysteine concentration is probably more related to rbc folate 
concentration and this could account for individual variation, but would not account for 
the apparent significant increase, but not physiological increase in plasma total 
homocysteine concentration post acute and chronic normoxic exercises and apparent no 
change post acute and chronic hypoxic exercises. Thus implying that the hypoxic 
stimulus affects the thiol biochemistry.
Diet (Verhoef et al. 1996), exercise (GroBe-Scharmann et al., 1995; Weift et al 
1999), mental stress (Stoney et al 1999, 2000), genetics (Goyatta et al., 1994; Frosst et 
al., 1995), transmethylation reactions (guanidinoacetate/creatine Stead et al., 2001) or 
adenosine (Harrington et al., 2000 ) and the ratio of S-adenosylmethionine / S- 
adenosylhomocysteine appear to affect cellular homocysteine. S-adenosylmethionine is 
an allosteric inhibitor of methylenetetrahydrofolate reductase (Sumner et al., 1986), an in 
vitro inhibitor of betaine-homocysteine methyltransferase (Finkelstein & Martin 1984) 
and an activator of cystathionine p-synthase (Finkelstein et al., 1975). Heart localised
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circulation is affected by adenosine, which is provided by S-adenosylhomocysteine 
during normoxic exercise, but from 5' adenosine monophosphate during hypoxic exercise 
(Deussen et al., 1989). This difference could be part of the reason for the significant 
effect upon plasma total homocysteine concentration in normoxically exercising subjects 
in comparison to hypoxically exercising subjects. The effect of this might be able to be 
reduced if the subject's rbc folate concentration was relatively high. Further study is 
required to look at the effect of adenosine in myocardial contraction and folate status in 
relation to plasma total homocysteine concentration in the athlete as the vasodilation of 
coronary vessels is not fully understood (Tune et al., 2002).
5.3 The effect of acute and chronic exercise upon the lipid profile 
5.3.1 Total Cholesterol
The subjects' serum total cholesterol concentrations were below the recommend 
maximum level (<4.7 mmoLdnr3 ). There was no significant difference between the 
normoxic and hypoxic group's pre-chronic exercise logarithmic serum total cholesterol 
concentration (p=0.427, refer to Table 4.2.3). A 2-way ANOVA showed that chronic 
exercise did not produce a significant change in the logarithmic serum total cholesterol 
(p=O.301). Wood et al. (1976) found lower quantities of cholesterol, triacylglycerol and 
low density lipoprotein cholesterol in very active middle age male runners, (running more 
than twenty-four kilometres per week), whereas Williams et al. (1982) found that the 
threshold for reductions in cholesterol was sixteen kilometres per week. This is in 
agreement with the findings of Durstine and Haskell (1994) that physically active 
individuals do not significantly lower their plasma total cholesterol concentration in 
comparison to inactive individuals. The subjects in this study were already physically 
active before under taking the study and probably already had an increased lipolysis.
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5.3.2 High Density lipoproteins and apolipoprotein Ax
The subjects' tended to have relatively high levels of high density lipoprotein 
cholesterol (1.6 mmol.dnr3 ), and this study took place in the summer months when 
cholesterol values tend to be reduced. This implied that their lipid transport system was 
favoured in cholesterol removal from tissues and transport to the liver.
There was no significant difference between the normoxic and hypoxic group's 
pre-chronic exercise logarithmic serum high density lipoprotein cholesterol concentration 
(p=0.952, refer to Table 4.2.3) or apolipoprotein A l concentration (p=0.269). As
expected, serum high density lipoprotein cholesterol and apolipoprotein Al are 
significantly correlated (normoxic group: Pearson's r=+0.906; hypoxic group: r=+0.757).
A 2-way ANOVA for Apolipoprotein Aj showed a significant interaction
(p<0.001) and Tukey tests showed significant differences between pre-/post-chronic 
exercise in the normoxic group (p<0.001) and between the groups post-chronic exercise 
(p=0.005). The hypoxically exercised group did not change their level of Apolipoprotein 
Aj whereas the normoxic group decreased it. Yet the ratio of apolipoprotein A^B^
which Naito (1985) stated was a better predictor of coronary artery disease showed no 
great change. The normoxic group (pre-chronic exercise 1:0.61, post-chronic exercise 
1:0.58) and the hypoxic group (pre-chronic exercise 1:0.61, post-chronic exercise 1:0.62).
A 2-way ANOVA showed there was no interactive effect. Hypoxic and 
normoxic chronic exercise had no effect upon high density lipoprotein concentration. As 
the subjects were already active, this additional activity did not increase the removal of 
cholesterol from the tissue and its transport to the liver.
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5.3.3 Low Density Lipoproteins and apolipoprotein B100
There was no significant difference between the normoxic and hypoxic group's 
pre-chronic exercise serum calculated low-density lipoprotein cholesterol concentration 
(p=0.494, refer to Table 4.2.3) or apolipoprotein B 100 concentration (p=0.775). As 
expected, serum calculated low-density lipoprotein cholesterol and apolipoprotein B 100
are significantly correlated, (normoxic group: Pearson's r=+0.886; hypoxic group: 
r=+0.954).
A 2-way ANOVA for Apolipoprotein B 100 showed a significant interaction
(p^O.003) and Post hoc Tukey tests showed significant differences between pre-/post- 
chronic exercise in the normoxic group (p=0.0005) and between the groups post-chronic 
exercise (p=O.005). The hypoxically exercised group did not significantly increase their 
level of Apolipoprotein B 100 whereas the normoxic group decreased it. As their low
density lipoprotein concentrations are below the upper value for low cardiovascular 
disease risk (3.4 mmol.dnr3 ), and their total and classes of cholesterol (HDL, and LDL) 
showed no significant change. The difference in apolipoprotein B 100 could be due to
recent dietary intake, as it is found on all the lipoprotein fractions except high density 
lipoprotein.
A 2-way ANOVA showed there was no interactive effect (p=0.923). Hypoxic 
and normoxic chronic exercise had no effect upon low density lipoprotein concentration. 
As the subjects were already physical active before this study, and tended to eat a 
balanced diet, this study had no effect upon their cholesterol levels.
5.3.4 Triacylglycerol
There was no significant difference between the normoxic and hypoxic groups' 
pre-chronic exercise serum triacylglycerol concentration, (p=0.720, refer to Table 4.2.3).
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A 2-way ANOVA showed there was a significant interactive effect (p=0.034). Both 
groups had increased their triacylglycerol concentrations by the end of the chronic 
exercise period, but only the hypoxic group's post hoc Tukey test was significant 
increase (p=0.028). Also, there was significance between the groups post-chronic 
exercise triacylglycerol levels (p=0.004). Low levels have been reported in athletes 
(Martin et al., 1977; Wood et al., 1977) and as the subjects had low levels to begin with, 
it implies that they were already physical active. The difference could be due to changes 
in their meals prior to the blood sampling at the end of the chronic exercise period. Yet 
these variations are not important in relation to cardiovascular disease risk as they are 
well below the low risk factor's level (TG< 2.26 mmol.dm-3 NCEP 1993).
5.3.5 Non esterified fatty Acid
There was no significant difference between the normoxic and hypoxic groups' 
pre-chronic exercise serum non-esterified fatty acid (NEFA) concentration (p=0.096, 
refer to Table 4.2.3).
A 2-way ANOVA for Apolipoprotein Aj showed a significant interactive effect
(p=0.028) and the post hoc Tukey tests showed significant decreases in both groups pre- 
/post-chronic exercise (normoxic group p=0.022 and hypoxic group p=0.0002). Non- 
parametrically, only the hypoxic group showed a significant reduction in their NEFA 
concentration pre/post chronic intermittent hypoxic exercise, (p<0.0001).
Saltin and Astrand (1993) stated that a mild to moderate increase in exercise levels 
could cause an initial drop in the plasma NEFA concentration. As the exercise duration 
increases, the rate of NEFA released from the cells exceeds the muscle cell uptake, thus 
causing an increase in plasma levels. It could be that this study's chronic exercise 
stimulus was only mild and therefore caused a decrease in NEFA concentration. 
Previous studies' results are equivocal in regards to NEFA mobilization (refer to section 
1.8.4), this study implies that an intermittent hypoxic chronic exercise challenge like
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aerobic exercise could be mobilizing lipids, but that the challenge was not sufficient to 




A 2 way ANOVA showed there was no interactive effect due to the chronic 
exercise between the two groups (p=0.568). Both groups increased their aerobic power, 
but not significantly, which can be explained by a small decrease in their body mass and a 
slight improvement in cardiac capacity. Their aerobic power was at the top end of the 
physiological norm range for males, 40 to 55 cm 3 .kg- 1 .min- 1 (Hollmann et al. 1988), it 
therefore appears that this exercise protocol was not strenuous enough on top of their 
own training programme to produce significant changes.
5.4.lii Maximum Lactate
A 2 way ANOVA showed there was a significant interactive effect between the 
two groups (p=0.010). Post hoc Tukey tests showed that there was a significant 
difference between the two groups maximum lactate levels pre-chronic exercise. 
Implying that either the hypoxic subjects were not as lactate tolerant as the normoxic 
subjects or that they did not push themselves as hard as they could have. The acute 
cycle tests were to volitional exhaustion and therefore the subject's psychological state 
could affect the end point.
5.4.1iii Maximum Heart rate
A 2 way ANOVA showed there was no significant interactive effect
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between the two groups (p=0.941).
5.4.2 Comparison between Hypoxic and Normoxic exercise 
5.4.2i Aerobic Power
A student's 't' comparing the aerobic power within the hypoxic group between 
their normoxic and hypoxic tests, showed no significant difference (p=0.094). The 
hypoxic aerobic power was 88% of its normoxic value. Roach (2000) found that the 
additional stress of the hypoxic challenge would increase ventilation rate and decrease 
aerobic power by approximately 96% of that obtain using PjO2 19.8kPa.
5.4.2H Maximum Lactate
A student's 't' comparing the maximum lactate concentration within the hypoxic 
group between their normoxic and hypoxic acute cycle tests, showed no significant 
difference (p=0.068).
5.4.2iii Maximum Heart rate
The parametric test (student's 't' test) and the non-parametric test (Wilcoxon 
matched pairs test) comparing the maximum heart rate for the normoxic and hypoxic 
acute cycle tests pre-chronic exercise, showed no significant difference (refer to Table 
4.5.2). As the acute cycle test is under taken to volitional exhaustion, if they were close 
to their actual maximum heart rate, changes in the subject's psychological state and 
therefore effort, would not produce a significant difference.
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5.5 Limitations
The main limitation in this study was due to costs and time. Both groups should 
have undertaken the acute cycle test hypoxic and normoxic challenge pre and post- 
chronic exercise. So that they both experienced the same stresses except for the chronic 
exercise. As one group undertook two acute challenges before the chronic period, it could 
have affected the data.
The blood sample for homocysteine analysis was taken immediately post acute 
exercise. A graph drawn of plasma homocysteine concentrations post acute exercise 
(Weiss et al. 1998), showed that the maximum homocysteine concentration was obtained 
five hours post exercise, and that even after 24 hours it had not returned to the pre 
exercise level. It can be interpreted in two ways either it takes longer than 24 hours to 
return to pre-exercise levels or that it does not return to pre exercise levels. Further 
work is required to see what happens to the plasma total homocysteine concentration 
after twenty-four hours post acute exercise. The normoxic group of subjects had 
increased plasma total homocysteine concentration post chronic exercise and showed no 
additional increase post acute exercise. This could mean that there is an individual upper 
limit which could possibly be minimised by increasing folate prior to the exercise session.
Further work is required to investigate the effect of hypoxic exercise upon plasma 
total homocysteine concentration in terms of exercise duration, intensity and lower 
partial oxygen pressure. This study showed no change in homocysteine concentration 
post acute and chronic hypoxic exercise. Further work is therefore required to see how 
long the effect lasts. The normoxic acute cycle test five days post last hypoxic training 
session produced a statistically significant increase in plasma total homocysteine (7.1 to 
8.2 nmol.dm-3 , p<0.012), but not a physiological one (±2.2 mmol.dm-3).
Further work is required to see if it would not be more beneficial to recommend a 




This study found that acute and chronic normoxic exercise produced a 
statistically significant increase in plasma total homocysteine, but not a physiological 
one.
Hypoxic acute and chronic exercise did not produce a significant change in plasma 
total homocysteine.
The exercise (hypoxic or normoxic) had no affect upon the lipid profile as the 
subjects were already under taking exercise prior to the study and tended to have 
balanced diets.
This shows that all the cardiovascular risk factors are inter-related and are 
positively affected by a healthy lifestyle (exercise, diet and relaxation).
An advantage of training under hypoxic conditions is that it minimises the 







serum proteins, mostly produced in the liver, which rapidly change in concentration, 
(some increases, others decrease) during the initiation of an inflammatory response.
Analysis of Variance (ANOVA):
ANOVA is a statistical method used to obtain inferences when more than two samples 
are used.
1-way ANOVA - tests the effect of one criterion (independent variable) upon another 
(dependent variable).
2-way ANOVA - tests the effect of two criteria (independent variables) upon another 
dependent variable).
C-reactive protein (CRP):
An acute phase protein which is able to bind to the surface of microorganisms where it 
functions as a stimulator of the classical pathway of complement activation, and as an 
opsonin for phagocytosis.
Cholesterol-years Score (CYS):
CYS is an estimate of the lifetime vascular exposure to hypercholesterolemia.
CYS (mmol.dnr3 .yrs) - (total cholesterol concentration at the time of 
diagnosis{mmol.dm-3 } x age of patient at diagnosis {years}) + (average cholesterol 
concentration present after the introduction of lipid-lowering drug therapy {mmol.dnr3 } 




A nonparametric analysis that is used when the data is not normally distributed, nor the 
samples have the same variance and is based on ranking the data.
geometric means:
the nth root of the product of the n data.
When the data is positively skewed, it can be mathematical changed by taking logarithms 
causes the data to take on a more nearly symmetrical distribution. 
Geometric mean can be calculated from the antilog of the mean of the log data.
intermittent claudication:
exercise induced pain caused by localised ischaemia because of atheroma.
Kruskal-Wallis test
It can be used instead of the parametric 1-way ANOVA. A nonparametric statistical test 
used when the samples are not normally distributed. It is also called analysis of variance 
by ranks.
Mann-Whitney-U
A non-parametric test that ranks the data and then numbers it.
Mann- Whitney statistic U = n l n 2 + "' 1+ — - R ,
n, and n2 are the number of observations in samples one and two respectively. Rj is the 
sum of the ranks of the observations in samples one. The calculated U is compared with 
he two-tailed value of U as the critical value, if n } >n2 and U^ if n^ .
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maximum volume of oxygen per minute (VO2 max):
The maximal aerobic power for a subject is equal to the maximum voluntary oxygen 
exchanged per minute while exercising the large muscle groups by progressively 
increasing the intensity until exhausted. Usually reported as an absolute volume per 
minute (dm 3 .min- 1 ), but in sports where body mass is supported during performance, 
then as volume per minute per kilogram body mass ( cm3 .kg- ! .min- l ; nonSI units
Physiological difference
This is the minium difference that should occur, in order to state clearly that the 
difference occurred because the experiment. Smaller changes can be accounted for by 
biological and analytical differences
plasma total homocyst(e)ine (tHcy):
total homocysteine is the sum of plasma homocysteine, homocystine, cysteine- 
homocysteine and homocy steinyl moieties of oxidized disulphide, (protein bound).
Protein C - Protein S system:
Protein C is a plasma protein activated by the thrombomodulin / thrombin complex. 
Activated protein C binds with protein S and inactivates factors VIII and V in the 
coagulation pathway.
Statistic significant difference:
Statistics is a mathematic technique that calculates the probability that the difference 
between two or more samples happened by chance. Before looking at the data, a null 
hypothesis is formulated and the significance level is stated where the null hypothesis 
would be rejected. This was stated as a< 0.05, that is there is less than a 5% chance that 
the difference between the two samples happened by chance.
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Student's 't' test:
A mathematical technique that calculates the t distribution and allows inferences to be 
made about the sample. It assumes that the distribution of the cases is normal (gaussian 
distribution).
total cholesterol (tC):
total cholesterol is the sum of cholesterol in the serum: very low density lipoprotein 
cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol and 
intermediate density lipoprotein cholesterol.
Wilcoxon matched pairs test:
A nonparametric test for dependent samples, that is used instead of the paired 't' test 
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Thank you for agreeing to take part in this study. Your participation is greatly 
appreciated. The study has been ethically approved by the ethics committee of the 
University of Glamorgan and we are therefore obliged to obtain a signed informed consent 
form from you. All information we obtain will be treated as strictly confidential.
I understand that I will be asked to give a small quantity of blood and will be requested to 
perform various physical activities requiring maximal levels of my fitness. I understand 
that these tests will be administered by the staff of Health and Exercise Science 
department of Glamorgan University.
I understand that I am free to ask any questions, about any of the tests performed. If my 
health status changes I will promptly report it to Drew Heusch.
My participation in this study is voluntary and I realize that I am free to withdraw from 
the study at any time.
If I have any further questions regarding this study I am free to contact Drew Heusch 
01443 482873 or Professor Bruce Davies 01443 482 577
I have read this form and give written consent to participate in this study
_________________________ Date ____________ 
Signature of Subject, Print name




The sample's symmetry measure
§1 = K 3 K 3
HQ : The sample is symmetrically distributed
HA : The sample is not symmetrically distributed
gj was calculated by the computer statistical package StatView 512 for MAC.
The null hypothesis was rejected if a(2) < 0.05 and g l value depends upon n, (Statistic 
Tables B.22, Zar 1996d).
Skewness
The skewness gives an indication of where the majority of the samples are in 
relation to the mean.
If gj was significantly less than 0, it indicated that the sample distribution was 
skewed to the left, that is, the mean was less than median. If gj was significantly greater 
than 0, then the distribution was skewed to the right, that is, the mean was greater than 
the median. If gj is not significantly different from 0, then the sample comes from a 
population distributed symmetrically around the mean.
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The square of the normal deviate for symmetry (Z2gl )
Method proposed by D'Agostino (1970, 1986; D'Agostino, Belanger, and 
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The sample's Kurtosis measure, (g2), otherwise known as "peakedness" or 
"tailedness" that is, dispersion around u - s and n + s, (Moors, 1986).
_ Jli
§2 ~ 4 
S
HQ : The sample is mesokurtic (normal) distribution
HA : The sample is not mesokurtic distributed
§2 was calculated by the computer statistical package Star View 512 for MAC.
The null hypothesis was rejected if a(2) < 0.05 and g2 value depends upon n, (Statistic 
Tables B.23, Zar 1996c).
If g2 was significantly less than 0, it indicated that the sample was platykurtic 
(Moors 1986). If g2 was significantly greater than 0, then the sample was leptokurtic 
If g2 is not significantly different from 0, then the sample comes from a population 
normally distributed, that is mesokurtic.
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The square of the normal deviate for Kurtosis (Z2 2 )
Method proposed by Anscombe and Glynn (1983) for n > 20
G = 24n(n-2)(n-3) 
(n+l) 2 (n + 3)(n+5)
„ (n-2)(n-3)|gl
J = 6(n -5n + 2) 6(n + 3)(n +
(n + 7)(n + 9) n(n-2)(n-3)
K = 6 + 8
214TM 1 + 7
1 + H K - 4
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Appendix V
Assessing Normality using Symmetry and kurtosis measures
D'Agostino (1986) reviewed the available methods for the testing of normality and 
concluded that the D'Agostino and Pearson (1973) test was the best, and works well for 
n>20.
The null hypothesis of population normality is tested using the statistic
K 2 = Z2gl
H0 : The sampled population is normally distributed 
HA : The sample population is not normally distributed
Type 1 error H0 is true and it is rejected 
Type 2 error H0 is false and is not rejected
Zar (1996a) stated that as the level of significance is arbitrary, test results near the level 
(0.04 to 0.06, when significance is set at 0.05) then it should be repeated with additional 
data than declare that the null hypothesis is or is not true.
The significance of K2 is determined using the chi-squared distribution (x2 ) with 
2 degrees of freedom (v). For a < 0.05 then K2 > 5.991 and the null hypothesis would 




Least squares regression line of x on y 
x = cy + d
2x = cZy + nd 
n = number of pairs of values
2xy = cZy 2 + d2y
solve simultaneously to find c and d 
for degrees of freedom for p remove one
Least squares regression line of y on x
y = ax + b 
Zy = a2x + nb
Zxy = aZx + bZx 
solve simultaneously to find a and b




According to Costongs et al. (1985), the minimum detectable difference between 
two independent groups when the variable is continuous, can be calculated, assuming that 
the variable has a normal distribution for a significance of 0.05 (5%).
CV
6 = critical difference, 
K - 2.77 for p<0.05, 
CVa = coefficient of analytical variation 
^ coefficient of biological variation.
X X
Coefficient of variance
The coefficient of variance was calculated from the following papers
paper
Garg et al., 1997









































CV. -, 0.0703 2 + 0.089 2 + 0.083 2
= 0.081
155
The analytic variance CVa
0.043 2 + 0.0146 2 + 0.031 2 + 0.028 2 + 0.011
= 0.028 
Therefore the critical difference:
= 2.7?V0.081 2 + 0.028 2
= 0.237 
Minimal detectable difference
minimal detectable difference = mean x critical difference 
6 =^XxS
6, = 9.3x0.237 = 2.20
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